id	sid	tid	token	lemma	pos
gsrj-62	1	1	psilocybin	psilocybin	NOUN
gsrj-62	1	2	,	,	PUNCT
gsrj-62	1	3	depression	depression	NOUN
gsrj-62	1	4	,	,	PUNCT
gsrj-62	1	5	and	and	CCONJ
gsrj-62	1	6	synaptogenesis	synaptogenesis	NOUN
gsrj-62	1	7	:	:	PUNCT
gsrj-62	1	8	insights	insight	NOUN
gsrj-62	1	9	into	into	ADP
gsrj-62	1	10	the	the	DET
gsrj-62	1	11	field	field	NOUN
gsrj-62	1	12	’s	’s	PART
gsrj-62	1	13	past	past	NOUN
gsrj-62	1	14	,	,	PUNCT
gsrj-62	1	15	present	present	ADJ
gsrj-62	1	16	,	,	PUNCT
gsrj-62	1	17	and	and	CCONJ
gsrj-62	1	18	future	future	ADJ
gsrj-62	1	19	anna	anna	PROPN
gsrj-62	1	20	douglas	douglas	PROPN
gsrj-62	1	21	,	,	PUNCT
gsrj-62	1	22	daniel	daniel	PROPN
gsrj-62	1	23	staas	staas	PROPN
gsrj-62	1	24	,	,	PUNCT
gsrj-62	1	25	anna	anna	PROPN
gsrj-62	1	26	hampton	hampton	PROPN
gsrj-62	1	27	,	,	PUNCT
gsrj-62	1	28	kylie	kylie	PROPN
gsrj-62	1	29	burns	burns	PROPN
gsrj-62	1	30	,	,	PUNCT
gsrj-62	1	31	fenn	fenn	PROPN
gsrj-62	1	32	suter	suter	PROPN
gsrj-62	1	33	volume	volume	PROPN
gsrj-62	1	34	three	three	NUM
gsrj-62	1	35	edition	edition	NOUN
gsrj-62	1	36	two	two	NUM
gsrj-62	1	37	spring	spring	NOUN
gsrj-62	1	38	2023	2023	NUM
gsrj-62	1	39	georgetown	georgetown	PROPN
gsrj-62	1	40	scientific	scientific	PROPN
gsrj-62	1	41	research	research	PROPN
gsrj-62	1	42	journal	journal	PROPN
gsrj-62	1	43	19	19	NUM
gsrj-62	1	44	georgetown	georgetown	PROPN
gsrj-62	1	45	scientific	scientific	PROPN
gsrj-62	1	46	research	research	PROPN
gsrj-62	1	47	journal	journal	PROPN
gsrj-62	1	48	psilocybin	psilocybin	NOUN
gsrj-62	1	49	,	,	PUNCT
gsrj-62	1	50	depression	depression	NOUN
gsrj-62	1	51	,	,	PUNCT
gsrj-62	1	52	and	and	CCONJ
gsrj-62	1	53	synaptogenesis	synaptogenesis	NOUN
gsrj-62	1	54	:	:	PUNCT
gsrj-62	1	55	insights	insight	NOUN
gsrj-62	1	56	into	into	ADP
gsrj-62	1	57	the	the	DET
gsrj-62	1	58	field	field	NOUN
gsrj-62	1	59	’s	’s	PART
gsrj-62	1	60	past	past	NOUN
gsrj-62	1	61	,	,	PUNCT
gsrj-62	1	62	present	present	ADJ
gsrj-62	1	63	,	,	PUNCT
gsrj-62	1	64	and	and	CCONJ
gsrj-62	1	65	future	future	ADJ
gsrj-62	1	66	aannnnaa	aannnnaa	ADJ
gsrj-62	1	67	ddoouuggllaass	ddoouuggllaass	NOUN
gsrj-62	1	68	*	*	PUNCT
gsrj-62	1	69	*	*	NOUN
gsrj-62	1	70	,	,	PUNCT
gsrj-62	1	71	,	,	PUNCT
gsrj-62	1	72	ddaanniieell	ddaanniieell	VERB
gsrj-62	1	73	ssttaaaass	ssttaaaass	NOUN
gsrj-62	1	74	*	*	PROPN
gsrj-62	1	75	*	*	NOUN
gsrj-62	1	76	,	,	PUNCT
gsrj-62	1	77	,	,	PUNCT
gsrj-62	1	78	aannnnaa	aannnnaa	NOUN
gsrj-62	1	79	hhaammppttoonn	hhaammppttoonn	NOUN
gsrj-62	1	80	*	*	NOUN
gsrj-62	1	81	*	*	PUNCT
gsrj-62	1	82	,	,	PUNCT
gsrj-62	1	83	,	,	PUNCT
gsrj-62	1	84	kkyylliiee	kkyylliiee	PROPN
gsrj-62	1	85	bbuurrnnss	bbuurrnnss	PROPN
gsrj-62	1	86	*	*	PROPN
gsrj-62	1	87	*	*	PUNCT
gsrj-62	1	88	,	,	PUNCT
gsrj-62	1	89	,	,	PUNCT
gsrj-62	1	90	ffeennnn	ffeennnn	NOUN
gsrj-62	1	91	ssuutteerr	ssuutteerr	NOUN
gsrj-62	1	92	*	*	PUNCT
gsrj-62	1	93	*	*	PUNCT
gsrj-62	1	94	*	*	PUNCT
gsrj-62	1	95	indicates	indicate	VERB
gsrj-62	1	96	equal	equal	ADJ
gsrj-62	1	97	contribution	contribution	NOUN
gsrj-62	1	98	department	department	NOUN
gsrj-62	1	99	of	of	ADP
gsrj-62	1	100	biology	biology	NOUN
gsrj-62	1	101	,	,	PUNCT
gsrj-62	1	102	georgetown	georgetown	PROPN
gsrj-62	1	103	university	university	PROPN
gsrj-62	1	104	,	,	PUNCT
gsrj-62	1	105	washington	washington	PROPN
gsrj-62	1	106	,	,	PUNCT
gsrj-62	1	107	d.c	d.c	PROPN
gsrj-62	1	108	.	.	PROPN
gsrj-62	1	109	,	,	PUNCT
gsrj-62	1	110	united	united	PROPN
gsrj-62	1	111	states	states	PROPN
gsrj-62	1	112	of	of	ADP
gsrj-62	1	113	america	america	PROPN
gsrj-62	1	114	e	e	PROPN
gsrj-62	1	115	-	-	NOUN
gsrj-62	1	116	mail	mail	NOUN
gsrj-62	1	117	:	:	PUNCT
gsrj-62	1	118	acd102@georgetown.edu	acd102@georgetown.edu	PROPN
gsrj-62	1	119	,	,	PUNCT
gsrj-62	1	120	djs314@georgetown.edu	djs314@georgetown.edu	PROPN
gsrj-62	1	121	,	,	PUNCT
gsrj-62	1	122	aeh157@georgetown.edu	aeh157@georgetown.edu	PROPN
gsrj-62	1	123	,	,	PUNCT
gsrj-62	1	124	kcb86@georgetown.edu	kcb86@georgetown.edu	PROPN
gsrj-62	1	125	,	,	PUNCT
gsrj-62	1	126	fcs14@georgetown.edu	fcs14@georgetown.edu	PROPN
gsrj-62	1	127	hhttttppss::////ddooii	hhttttppss::////ddooii	PROPN
gsrj-62	1	128	..	..	PROPN
gsrj-62	1	129	oorrgg//1100	oorrgg//1100	PROPN
gsrj-62	1	130	..	..	PROPN
gsrj-62	1	131	4488009911//ggssrr	4488009911//ggssrr	NUM
gsrj-62	1	132	..	..	PUNCT
gsrj-62	1	133	vv33ii22	vv33ii22	PROPN
gsrj-62	1	134	..	..	PUNCT
gsrj-62	1	135	6622	6622	NUM
gsrj-62	1	136	aabbssttrraacctt	aabbssttrraacctt	ADJ
gsrj-62	1	137	depression	depression	NOUN
gsrj-62	1	138	remains	remain	VERB
gsrj-62	1	139	one	one	NUM
gsrj-62	1	140	the	the	DET
gsrj-62	1	141	most	most	ADV
gsrj-62	1	142	commonly	commonly	ADV
gsrj-62	1	143	diagnosed	diagnose	VERB
gsrj-62	1	144	mental	mental	ADJ
gsrj-62	1	145	health	health	NOUN
gsrj-62	1	146	disorders	disorder	NOUN
gsrj-62	1	147	in	in	ADP
gsrj-62	1	148	the	the	DET
gsrj-62	1	149	united	united	PROPN
gsrj-62	1	150	states	states	PROPN
gsrj-62	1	151	.	.	PUNCT
gsrj-62	2	1	the	the	DET
gsrj-62	2	2	food	food	NOUN
gsrj-62	2	3	and	and	CCONJ
gsrj-62	2	4	drug	drug	NOUN
gsrj-62	2	5	administration	administration	NOUN
gsrj-62	2	6	granted	grant	VERB
gsrj-62	2	7	psilocybin	psilocybin	NOUN
gsrj-62	2	8	breakthrough	breakthrough	NOUN
gsrj-62	2	9	therapy	therapy	NOUN
gsrj-62	2	10	status	status	NOUN
gsrj-62	2	11	four	four	NUM
gsrj-62	2	12	years	year	NOUN
gsrj-62	2	13	ago	ago	ADV
gsrj-62	2	14	as	as	ADP
gsrj-62	2	15	a	a	DET
gsrj-62	2	16	possible	possible	ADJ
gsrj-62	2	17	solution	solution	NOUN
gsrj-62	2	18	to	to	ADP
gsrj-62	2	19	this	this	DET
gsrj-62	2	20	pervasive	pervasive	ADJ
gsrj-62	2	21	disorder	disorder	NOUN
gsrj-62	2	22	.	.	PUNCT
gsrj-62	3	1	since	since	SCONJ
gsrj-62	3	2	then	then	ADV
gsrj-62	3	3	,	,	PUNCT
gsrj-62	3	4	psilocybin	psilocybin	NOUN
gsrj-62	3	5	,	,	PUNCT
gsrj-62	3	6	and	and	CCONJ
gsrj-62	3	7	hallucinogens	hallucinogen	NOUN
gsrj-62	3	8	in	in	ADP
gsrj-62	3	9	general	general	ADJ
gsrj-62	3	10	,	,	PUNCT
gsrj-62	3	11	have	have	AUX
gsrj-62	3	12	produced	produce	VERB
gsrj-62	3	13	promising	promising	ADJ
gsrj-62	3	14	results	result	NOUN
gsrj-62	3	15	as	as	ADP
gsrj-62	3	16	alternatives	alternative	NOUN
gsrj-62	3	17	to	to	ADP
gsrj-62	3	18	classical	classical	ADJ
gsrj-62	3	19	antidepressants	antidepressant	NOUN
gsrj-62	3	20	.	.	PUNCT
gsrj-62	4	1	as	as	SCONJ
gsrj-62	4	2	more	more	ADJ
gsrj-62	4	3	research	research	NOUN
gsrj-62	4	4	confirms	confirm	VERB
gsrj-62	4	5	psilocybin	psilocybin	PROPN
gsrj-62	4	6	’s	’s	PART
gsrj-62	4	7	potential	potential	ADJ
gsrj-62	4	8	therapeutic	therapeutic	ADJ
gsrj-62	4	9	effect	effect	NOUN
gsrj-62	4	10	,	,	PUNCT
gsrj-62	4	11	research	research	NOUN
gsrj-62	4	12	surrounding	surround	VERB
gsrj-62	4	13	the	the	DET
gsrj-62	4	14	mechanistic	mechanistic	ADJ
gsrj-62	4	15	action	action	NOUN
gsrj-62	4	16	of	of	ADP
gsrj-62	4	17	these	these	DET
gsrj-62	4	18	5	5	NUM
gsrj-62	4	19	-	-	PUNCT
gsrj-62	4	20	ht2a	ht2a	NOUN
gsrj-62	4	21	receptor	receptor	NOUN
gsrj-62	4	22	agonists	agonist	NOUN
gsrj-62	4	23	has	have	AUX
gsrj-62	4	24	increased	increase	VERB
gsrj-62	4	25	as	as	ADV
gsrj-62	4	26	well	well	ADV
gsrj-62	4	27	.	.	PUNCT
gsrj-62	5	1	hallucinogens	hallucinogen	NOUN
gsrj-62	5	2	have	have	VERB
gsrj-62	5	3	different	different	ADJ
gsrj-62	5	4	downstream	downstream	ADJ
gsrj-62	5	5	effects	effect	NOUN
gsrj-62	5	6	compared	compare	VERB
gsrj-62	5	7	to	to	ADP
gsrj-62	5	8	non	non	ADJ
gsrj-62	5	9	-	-	ADJ
gsrj-62	5	10	hallucinogenic	hallucinogenic	ADJ
gsrj-62	5	11	5	5	NUM
gsrj-62	5	12	-	-	PUNCT
gsrj-62	5	13	ht2a	ht2a	NOUN
gsrj-62	5	14	receptor	receptor	NOUN
gsrj-62	5	15	agonists	agonist	NOUN
gsrj-62	5	16	,	,	PUNCT
gsrj-62	5	17	including	include	VERB
gsrj-62	5	18	the	the	DET
gsrj-62	5	19	formation	formation	NOUN
gsrj-62	5	20	of	of	ADP
gsrj-62	5	21	a	a	DET
gsrj-62	5	22	5	5	NUM
gsrj-62	5	23	-	-	PUNCT
gsrj-62	5	24	ht2a	ht2a	NOUN
gsrj-62	5	25	receptor	receptor	NOUN
gsrj-62	5	26	and	and	CCONJ
gsrj-62	5	27	metabotropic	metabotropic	NOUN
gsrj-62	5	28	glutamate	glutamate	ADJ
gsrj-62	5	29	receptor	receptor	NOUN
gsrj-62	5	30	complex	complex	NOUN
gsrj-62	5	31	.	.	PUNCT
gsrj-62	6	1	psilocybin	psilocybin	NOUN
gsrj-62	6	2	’s	’s	PART
gsrj-62	6	3	unique	unique	ADJ
gsrj-62	6	4	synaptogenic	synaptogenic	ADJ
gsrj-62	6	5	effect	effect	NOUN
gsrj-62	6	6	may	may	AUX
gsrj-62	6	7	play	play	VERB
gsrj-62	6	8	a	a	DET
gsrj-62	6	9	role	role	NOUN
gsrj-62	6	10	in	in	ADP
gsrj-62	6	11	its	its	PRON
gsrj-62	6	12	therapeutic	therapeutic	ADJ
gsrj-62	6	13	effect	effect	NOUN
gsrj-62	6	14	for	for	ADP
gsrj-62	6	15	major	major	ADJ
gsrj-62	6	16	depressive	depressive	ADJ
gsrj-62	6	17	disorder	disorder	NOUN
gsrj-62	6	18	;	;	PUNCT
gsrj-62	6	19	however	however	ADV
gsrj-62	6	20	,	,	PUNCT
gsrj-62	6	21	the	the	DET
gsrj-62	6	22	underlying	underlying	ADJ
gsrj-62	6	23	mechanism	mechanism	NOUN
gsrj-62	6	24	by	by	ADP
gsrj-62	6	25	which	which	PRON
gsrj-62	6	26	synaptogenesis	synaptogenesis	NOUN
gsrj-62	6	27	is	be	AUX
gsrj-62	6	28	induced	induce	VERB
gsrj-62	6	29	upon	upon	SCONJ
gsrj-62	6	30	psilocybin	psilocybin	NOUN
gsrj-62	6	31	administration	administration	NOUN
gsrj-62	6	32	has	have	AUX
gsrj-62	6	33	not	not	PART
gsrj-62	6	34	been	be	AUX
gsrj-62	6	35	explored	explore	VERB
gsrj-62	6	36	.	.	PUNCT
gsrj-62	7	1	psilocybin	psilocybin	NOUN
gsrj-62	7	2	’s	’s	PART
gsrj-62	7	3	distinctive	distinctive	ADJ
gsrj-62	7	4	upregulation	upregulation	NOUN
gsrj-62	7	5	of	of	ADP
gsrj-62	7	6	transcription	transcription	NOUN
gsrj-62	7	7	factors	factor	NOUN
gsrj-62	7	8	,	,	PUNCT
gsrj-62	7	9	such	such	ADJ
gsrj-62	7	10	as	as	ADP
gsrj-62	7	11	egr-2	egr-2	NOUN
gsrj-62	7	12	,	,	PUNCT
gsrj-62	7	13	c	c	NOUN
gsrj-62	7	14	-	-	PUNCT
gsrj-62	7	15	fos	fos	NOUN
gsrj-62	7	16	,	,	PUNCT
gsrj-62	7	17	and	and	CCONJ
gsrj-62	7	18	brain	brain	NOUN
gsrj-62	7	19	-	-	PUNCT
gsrj-62	7	20	derived	derive	VERB
gsrj-62	7	21	neurotrophic	neurotrophic	ADJ
gsrj-62	7	22	factors	factor	NOUN
gsrj-62	7	23	,	,	PUNCT
gsrj-62	7	24	and	and	CCONJ
gsrj-62	7	25	its	its	PRON
gsrj-62	7	26	connection	connection	NOUN
gsrj-62	7	27	with	with	ADP
gsrj-62	7	28	the	the	DET
gsrj-62	7	29	trkb	trkb	NOUN
gsrj-62	7	30	signaling	signal	VERB
gsrj-62	7	31	pathway	pathway	NOUN
gsrj-62	7	32	,	,	PUNCT
gsrj-62	7	33	may	may	AUX
gsrj-62	7	34	be	be	AUX
gsrj-62	7	35	the	the	DET
gsrj-62	7	36	answer	answer	NOUN
gsrj-62	7	37	to	to	ADP
gsrj-62	7	38	this	this	DET
gsrj-62	7	39	unexplained	unexplained	ADJ
gsrj-62	7	40	mechanism	mechanism	NOUN
gsrj-62	7	41	.	.	PUNCT
gsrj-62	8	1	keywords	keyword	NOUN
gsrj-62	8	2	:	:	PUNCT
gsrj-62	8	3	psilocybin	psilocybin	NOUN
gsrj-62	8	4	,	,	PUNCT
gsrj-62	8	5	hallucinogens	hallucinogen	NOUN
gsrj-62	8	6	,	,	PUNCT
gsrj-62	8	7	depression	depression	NOUN
gsrj-62	8	8	,	,	PUNCT
gsrj-62	8	9	synaptogenesis	synaptogenesis	NOUN
gsrj-62	8	10	,	,	PUNCT
gsrj-62	8	11	5	5	NUM
gsrj-62	8	12	-	-	PUNCT
gsrj-62	8	13	htr	htr	PROPN
gsrj-62	8	14	,	,	PUNCT
gsrj-62	8	15	mglur	mglur	PROPN
gsrj-62	8	16	11	11	NUM
gsrj-62	8	17	..	..	PUNCT
gsrj-62	8	18	iinnttrroodduuccttiioonn	iinnttrroodduuccttiioonn	PROPN
gsrj-62	8	19	while	while	SCONJ
gsrj-62	8	20	originally	originally	ADV
gsrj-62	8	21	discovered	discover	VERB
gsrj-62	8	22	in	in	ADP
gsrj-62	8	23	blood	blood	NOUN
gsrj-62	8	24	serum	serum	NOUN
gsrj-62	8	25	for	for	ADP
gsrj-62	8	26	its	its	PRON
gsrj-62	8	27	effects	effect	NOUN
gsrj-62	8	28	as	as	ADP
gsrj-62	8	29	a	a	DET
gsrj-62	8	30	vasoconstrictor	vasoconstrictor	NOUN
gsrj-62	8	31	(	(	PUNCT
gsrj-62	8	32	tonic	tonic	NOUN
gsrj-62	8	33	)	)	PUNCT
gsrj-62	8	34	and	and	CCONJ
gsrj-62	8	35	its	its	PRON
gsrj-62	8	36	effects	effect	NOUN
gsrj-62	8	37	in	in	ADP
gsrj-62	8	38	the	the	DET
gsrj-62	8	39	gut	gut	NOUN
gsrj-62	8	40	,	,	PUNCT
gsrj-62	8	41	serotonin	serotonin	VERB
gsrj-62	8	42	’s	’s	PART
gsrj-62	8	43	role	role	NOUN
gsrj-62	8	44	as	as	ADP
gsrj-62	8	45	a	a	DET
gsrj-62	8	46	neurotransmitter	neurotransmitter	NOUN
gsrj-62	8	47	was	be	AUX
gsrj-62	8	48	not	not	PART
gsrj-62	8	49	thoroughly	thoroughly	ADV
gsrj-62	8	50	confirmed	confirm	VERB
gsrj-62	8	51	for	for	ADP
gsrj-62	8	52	nearly	nearly	ADV
gsrj-62	8	53	another	another	PRON
gsrj-62	8	54	decade	decade	NOUN
gsrj-62	8	55	when	when	SCONJ
gsrj-62	8	56	the	the	DET
gsrj-62	8	57	findings	finding	NOUN
gsrj-62	8	58	of	of	ADP
gsrj-62	8	59	experiments	experiment	NOUN
gsrj-62	8	60	with	with	ADP
gsrj-62	8	61	lysergic	lysergic	NOUN
gsrj-62	8	62	acid	acid	NOUN
gsrj-62	8	63	diethylamide	diethylamide	NOUN
gsrj-62	8	64	(	(	PUNCT
gsrj-62	8	65	lsd	lsd	NOUN
gsrj-62	8	66	)	)	PUNCT
gsrj-62	8	67	on	on	ADP
gsrj-62	8	68	peripheral	peripheral	ADJ
gsrj-62	8	69	nervous	nervous	ADJ
gsrj-62	8	70	systems	system	NOUN
gsrj-62	8	71	(	(	PUNCT
gsrj-62	8	72	pns	pns	NOUN
gsrj-62	8	73	)	)	PUNCT
gsrj-62	8	74	were	be	AUX
gsrj-62	8	75	synthesized	synthesize	VERB
gsrj-62	8	76	with	with	ADP
gsrj-62	8	77	the	the	DET
gsrj-62	8	78	early	early	ADJ
gsrj-62	8	79	localization	localization	NOUN
gsrj-62	8	80	of	of	ADP
gsrj-62	8	81	serotonergic	serotonergic	ADJ
gsrj-62	8	82	receptors	receptor	NOUN
gsrj-62	8	83	in	in	ADP
gsrj-62	8	84	the	the	DET
gsrj-62	8	85	midbrain	midbrain	NOUN
gsrj-62	8	86	.	.	PUNCT
gsrj-62	9	1	serotonin	serotonin	VERB
gsrj-62	9	2	(	(	PUNCT
gsrj-62	9	3	5	5	NUM
gsrj-62	9	4	-	-	SYM
gsrj-62	9	5	ht	ht	NOUN
gsrj-62	9	6	)	)	PUNCT
gsrj-62	9	7	and	and	CCONJ
gsrj-62	9	8	lsd	lsd	NOUN
gsrj-62	9	9	were	be	AUX
gsrj-62	9	10	quickly	quickly	ADV
gsrj-62	9	11	recognized	recognize	VERB
gsrj-62	9	12	to	to	PART
gsrj-62	9	13	have	have	VERB
gsrj-62	9	14	an	an	DET
gsrj-62	9	15	intimate	intimate	ADJ
gsrj-62	9	16	relationship	relationship	NOUN
gsrj-62	9	17	,	,	PUNCT
gsrj-62	9	18	but	but	CCONJ
gsrj-62	9	19	the	the	DET
gsrj-62	9	20	subtypes	subtype	NOUN
gsrj-62	9	21	of	of	ADP
gsrj-62	9	22	5	5	NUM
gsrj-62	9	23	-	-	PUNCT
gsrj-62	9	24	ht	ht	NOUN
gsrj-62	9	25	receptors	receptor	NOUN
gsrj-62	9	26	in	in	ADP
gsrj-62	9	27	the	the	DET
gsrj-62	9	28	brain	brain	NOUN
gsrj-62	9	29	were	be	AUX
gsrj-62	9	30	not	not	PART
gsrj-62	9	31	categorized	categorize	VERB
gsrj-62	9	32	or	or	CCONJ
gsrj-62	9	33	localized	localize	VERB
gsrj-62	9	34	until	until	ADP
gsrj-62	9	35	decades	decade	NOUN
gsrj-62	9	36	later	later	ADV
gsrj-62	9	37	.	.	PUNCT
gsrj-62	10	1	one	one	NUM
gsrj-62	10	2	receptor	receptor	NOUN
gsrj-62	10	3	,	,	PUNCT
gsrj-62	10	4	5	5	NUM
gsrj-62	10	5	-	-	SYM
gsrj-62	10	6	ht2ar	ht2ar	NUM
gsrj-62	10	7	,	,	PUNCT
gsrj-62	10	8	was	be	AUX
gsrj-62	10	9	found	find	VERB
gsrj-62	10	10	to	to	PART
gsrj-62	10	11	be	be	AUX
gsrj-62	10	12	tightly	tightly	ADV
gsrj-62	10	13	linked	link	VERB
gsrj-62	10	14	to	to	ADP
gsrj-62	10	15	hallucinogenic	hallucinogenic	ADJ
gsrj-62	10	16	activity	activity	NOUN
gsrj-62	10	17	.	.	PUNCT
gsrj-62	11	1	though	though	SCONJ
gsrj-62	11	2	it	it	PRON
gsrj-62	11	3	is	be	AUX
gsrj-62	11	4	debated	debate	VERB
gsrj-62	11	5	,	,	PUNCT
gsrj-62	11	6	5	5	NUM
gsrj-62	11	7	-	-	PUNCT
gsrj-62	11	8	ht2ars	ht2ar	NOUN
gsrj-62	11	9	are	be	AUX
gsrj-62	11	10	largely	largely	ADV
gsrj-62	11	11	localized	localize	VERB
gsrj-62	11	12	in	in	ADP
gsrj-62	11	13	the	the	DET
gsrj-62	11	14	claustrum	claustrum	NOUN
gsrj-62	11	15	,	,	PUNCT
gsrj-62	11	16	cerebral	cerebral	ADJ
gsrj-62	11	17	cortex	cortex	NOUN
gsrj-62	11	18	,	,	PUNCT
gsrj-62	11	19	olfactory	olfactory	ADJ
gsrj-62	11	20	tubercle	tubercle	NOUN
gsrj-62	11	21	,	,	PUNCT
gsrj-62	11	22	striatum	striatum	NOUN
gsrj-62	11	23	,	,	PUNCT
gsrj-62	11	24	and	and	CCONJ
gsrj-62	11	25	nucleus	nucleus	PROPN
gsrj-62	11	26	accumbens.1	accumbens.1	NOUN
gsrj-62	11	27	this	this	DET
gsrj-62	11	28	debate	debate	NOUN
gsrj-62	11	29	is	be	AUX
gsrj-62	11	30	due	due	ADJ
gsrj-62	11	31	to	to	ADP
gsrj-62	11	32	the	the	DET
gsrj-62	11	33	fact	fact	NOUN
gsrj-62	11	34	that	that	SCONJ
gsrj-62	11	35	radioligands	radioligand	NOUN
gsrj-62	11	36	are	be	AUX
gsrj-62	11	37	not	not	PART
gsrj-62	11	38	entirely	entirely	ADV
gsrj-62	11	39	specific	specific	ADJ
gsrj-62	11	40	to	to	ADP
gsrj-62	11	41	individual	individual	ADJ
gsrj-62	11	42	subtypes	subtype	NOUN
gsrj-62	11	43	of	of	ADP
gsrj-62	11	44	receptors	receptor	NOUN
gsrj-62	11	45	,	,	PUNCT
gsrj-62	11	46	including	include	VERB
gsrj-62	11	47	5	5	NUM
gsrj-62	11	48	-	-	PUNCT
gsrj-62	11	49	htrs.2	htrs.2	NOUN
gsrj-62	11	50	thorough	thorough	ADJ
gsrj-62	11	51	research	research	NOUN
gsrj-62	11	52	returned	return	VERB
gsrj-62	11	53	no	no	DET
gsrj-62	11	54	indications	indication	NOUN
gsrj-62	11	55	of	of	ADP
gsrj-62	11	56	any	any	DET
gsrj-62	11	57	gfp	gfp	PROPN
gsrj-62	11	58	-	-	PUNCT
gsrj-62	11	59	tagged	tag	VERB
gsrj-62	11	60	5	5	NUM
gsrj-62	11	61	-	-	PUNCT
gsrj-62	11	62	ht	ht	PROPN
gsrj-62	11	63	receptor	receptor	NOUN
gsrj-62	11	64	studies	study	NOUN
gsrj-62	11	65	looking	look	VERB
gsrj-62	11	66	at	at	ADP
gsrj-62	11	67	neuroanatomy	neuroanatomy	NOUN
gsrj-62	11	68	,	,	PUNCT
gsrj-62	11	69	which	which	PRON
gsrj-62	11	70	may	may	AUX
gsrj-62	11	71	be	be	AUX
gsrj-62	11	72	explained	explain	VERB
gsrj-62	11	73	by	by	ADP
gsrj-62	11	74	the	the	DET
gsrj-62	11	75	multitude	multitude	NOUN
gsrj-62	11	76	of	of	ADP
gsrj-62	11	77	differences	difference	NOUN
gsrj-62	11	78	in	in	ADP
gsrj-62	11	79	5	5	NUM
gsrj-62	11	80	-	-	PUNCT
gsrj-62	11	81	htr	htr	NOUN
gsrj-62	11	82	localization	localization	NOUN
gsrj-62	11	83	between	between	ADP
gsrj-62	11	84	model	model	NOUN
gsrj-62	11	85	species	specie	NOUN
gsrj-62	11	86	and	and	CCONJ
gsrj-62	11	87	humans	human	NOUN
gsrj-62	11	88	.	.	PUNCT
gsrj-62	12	1	the	the	DET
gsrj-62	12	2	first	first	ADJ
gsrj-62	12	3	use	use	NOUN
gsrj-62	12	4	for	for	ADP
gsrj-62	12	5	drugs	drug	NOUN
gsrj-62	12	6	targeting	target	VERB
gsrj-62	12	7	these	these	DET
gsrj-62	12	8	receptors	receptor	NOUN
gsrj-62	12	9	was	be	AUX
gsrj-62	12	10	recreational	recreational	ADJ
gsrj-62	12	11	,	,	PUNCT
gsrj-62	12	12	as	as	SCONJ
gsrj-62	12	13	most	most	ADJ
gsrj-62	12	14	were	be	AUX
gsrj-62	12	15	discovered	discover	VERB
gsrj-62	12	16	as	as	ADP
gsrj-62	12	17	psychedelics	psychedelic	NOUN
gsrj-62	12	18	or	or	CCONJ
gsrj-62	12	19	hallucinogens	hallucinogen	NOUN
gsrj-62	12	20	,	,	PUNCT
gsrj-62	12	21	producing	produce	VERB
gsrj-62	12	22	consciousness	consciousness	NOUN
gsrj-62	12	23	-	-	PUNCT
gsrj-62	12	24	altering	alter	VERB
gsrj-62	12	25	effects	effect	NOUN
gsrj-62	12	26	.	.	PUNCT
gsrj-62	13	1	the	the	DET
gsrj-62	13	2	most	most	ADV
gsrj-62	13	3	prominent	prominent	ADJ
gsrj-62	13	4	of	of	ADP
gsrj-62	13	5	these	these	PRON
gsrj-62	13	6	was	be	AUX
gsrj-62	13	7	lysergic	lysergic	ADJ
gsrj-62	13	8	acid	acid	NOUN
gsrj-62	13	9	diethylamide	diethylamide	NOUN
gsrj-62	13	10	,	,	PUNCT
gsrj-62	13	11	or	or	CCONJ
gsrj-62	13	12	lsd	lsd	NOUN
gsrj-62	13	13	,	,	PUNCT
gsrj-62	13	14	discovered	discover	VERB
gsrj-62	13	15	in	in	ADP
gsrj-62	13	16	the	the	DET
gsrj-62	13	17	1900s	1900	NOUN
gsrj-62	13	18	by	by	ADP
gsrj-62	13	19	swiss	swiss	ADJ
gsrj-62	13	20	chemist	chemist	NOUN
gsrj-62	13	21	20	20	NUM
gsrj-62	13	22	georgetown	georgetown	PROPN
gsrj-62	13	23	scientific	scientific	PROPN
gsrj-62	13	24	research	research	PROPN
gsrj-62	13	25	journal	journal	PROPN
gsrj-62	13	26	albert	albert	PROPN
gsrj-62	13	27	hoffman.3	hoffman.3	PROPN
gsrj-62	13	28	while	while	SCONJ
gsrj-62	13	29	not	not	PART
gsrj-62	13	30	as	as	ADV
gsrj-62	13	31	similar	similar	ADJ
gsrj-62	13	32	structurally	structurally	ADV
gsrj-62	13	33	to	to	ADP
gsrj-62	13	34	5	5	NUM
gsrj-62	13	35	-	-	PUNCT
gsrj-62	13	36	ht	ht	NOUN
gsrj-62	13	37	or	or	CCONJ
gsrj-62	13	38	psilocybin	psilocybin	NOUN
gsrj-62	13	39	,	,	PUNCT
gsrj-62	13	40	it	it	PRON
gsrj-62	13	41	still	still	ADV
gsrj-62	13	42	shares	share	VERB
gsrj-62	13	43	the	the	DET
gsrj-62	13	44	indole	indole	NOUN
gsrj-62	13	45	and	and	CCONJ
gsrj-62	13	46	similarly	similarly	ADV
gsrj-62	13	47	positioned	position	VERB
gsrj-62	13	48	nitrogen	nitrogen	NOUN
gsrj-62	13	49	that	that	PRON
gsrj-62	13	50	allows	allow	VERB
gsrj-62	13	51	binding	bind	VERB
gsrj-62	13	52	to	to	ADP
gsrj-62	13	53	the	the	DET
gsrj-62	13	54	5	5	NUM
gsrj-62	13	55	-	-	SYM
gsrj-62	13	56	ht2ar	ht2ar	NOUN
gsrj-62	13	57	,	,	PUNCT
gsrj-62	13	58	contributing	contribute	VERB
gsrj-62	13	59	to	to	ADP
gsrj-62	13	60	its	its	PRON
gsrj-62	13	61	similarity	similarity	NOUN
gsrj-62	13	62	in	in	ADP
gsrj-62	13	63	hallucinogenic	hallucinogenic	ADJ
gsrj-62	13	64	effect	effect	NOUN
gsrj-62	13	65	and	and	CCONJ
gsrj-62	13	66	usefulness	usefulness	NOUN
gsrj-62	13	67	in	in	ADP
gsrj-62	13	68	analogous	analogous	ADJ
gsrj-62	13	69	psilocybin	psilocybin	NOUN
gsrj-62	13	70	research	research	NOUN
gsrj-62	13	71	.	.	PUNCT
gsrj-62	14	1	ffiigguurree	ffiigguurree	NOUN
gsrj-62	14	2	11	11	NUM
gsrj-62	14	3	..	..	PUNCT
gsrj-62	14	4	ccoommppaarriissoonn	ccoommppaarriissoonn	VERB
gsrj-62	14	5	ooff	ooff	ADJ
gsrj-62	14	6	ssttrruuccttuurreess	ssttrruuccttuurreess	NOUN
gsrj-62	14	7	ooff	ooff	ADP
gsrj-62	14	8	sseerroottoonniinn	sseerroottoonniinn	NOUN
gsrj-62	14	9	,	,	PUNCT
gsrj-62	14	10	,	,	PUNCT
gsrj-62	14	11	ppssiillooccyybbiinn	ppssiillooccyybbiinn	PROPN
gsrj-62	14	12	,	,	PUNCT
gsrj-62	14	13	,	,	PUNCT
gsrj-62	14	14	ppssiilloocciinn	ppssiilloocciinn	NOUN
gsrj-62	14	15	,	,	PUNCT
gsrj-62	14	16	,	,	PUNCT
gsrj-62	14	17	aanndd	aanndd	NOUN
gsrj-62	14	18	llssdd	llssdd	PROPN
gsrj-62	14	19	..	..	PUNCT
gsrj-62	14	20	adapted	adapt	VERB
gsrj-62	14	21	from	from	ADP
gsrj-62	14	22	bauer	bauer	PROPN
gsrj-62	14	23	et	et	PROPN
gsrj-62	14	24	al	al	PROPN
gsrj-62	14	25	.	.	PROPN
gsrj-62	14	26	,	,	PUNCT
gsrj-62	14	27	2019.4	2019.4	NUM
gsrj-62	14	28	molecular	molecular	ADJ
gsrj-62	14	29	structure	structure	NOUN
gsrj-62	14	30	of	of	ADP
gsrj-62	14	31	serotonin	serotonin	NOUN
gsrj-62	14	32	,	,	PUNCT
gsrj-62	14	33	psilocybin	psilocybin	NOUN
gsrj-62	14	34	,	,	PUNCT
gsrj-62	14	35	its	its	PRON
gsrj-62	14	36	metabolite	metabolite	NOUN
gsrj-62	14	37	psilocin	psilocin	NOUN
gsrj-62	14	38	,	,	PUNCT
gsrj-62	14	39	and	and	CCONJ
gsrj-62	14	40	lsd	lsd	NOUN
gsrj-62	14	41	.	.	PUNCT
gsrj-62	15	1	psilocybin	psilocybin	NOUN
gsrj-62	15	2	(	(	PUNCT
gsrj-62	15	3	and	and	CCONJ
gsrj-62	15	4	its	its	PRON
gsrj-62	15	5	active	active	ADJ
gsrj-62	15	6	metabolite	metabolite	NOUN
gsrj-62	15	7	,	,	PUNCT
gsrj-62	15	8	psilocin	psilocin	PROPN
gsrj-62	15	9	)	)	PUNCT
gsrj-62	15	10	,	,	PUNCT
gsrj-62	15	11	however	however	ADV
gsrj-62	15	12	,	,	PUNCT
gsrj-62	15	13	is	be	AUX
gsrj-62	15	14	almost	almost	ADV
gsrj-62	15	15	identical	identical	ADJ
gsrj-62	15	16	to	to	ADP
gsrj-62	15	17	5	5	NUM
gsrj-62	15	18	-	-	SYM
gsrj-62	15	19	ht	ht	NOUN
gsrj-62	15	20	,	,	PUNCT
gsrj-62	15	21	featuring	feature	VERB
gsrj-62	15	22	the	the	DET
gsrj-62	15	23	same	same	ADJ
gsrj-62	15	24	indole	indole	NOUN
gsrj-62	15	25	and	and	CCONJ
gsrj-62	15	26	distant	distant	ADJ
gsrj-62	15	27	nh2	nh2	NOUN
gsrj-62	15	28	group	group	NOUN
gsrj-62	15	29	,	,	PUNCT
gsrj-62	15	30	with	with	ADP
gsrj-62	15	31	the	the	DET
gsrj-62	15	32	only	only	ADJ
gsrj-62	15	33	changes	change	NOUN
gsrj-62	15	34	being	be	AUX
gsrj-62	15	35	the	the	DET
gsrj-62	15	36	2	2	NUM
gsrj-62	15	37	additional	additional	ADJ
gsrj-62	15	38	n	n	CCONJ
gsrj-62	15	39	-	-	PUNCT
gsrj-62	15	40	methyl	methyl	NOUN
gsrj-62	15	41	groups	group	NOUN
gsrj-62	15	42	and	and	CCONJ
gsrj-62	15	43	the	the	DET
gsrj-62	15	44	electronegative	electronegative	ADJ
gsrj-62	15	45	hydroxyl	hydroxyl	NOUN
gsrj-62	15	46	group	group	NOUN
gsrj-62	15	47	shifting	shift	VERB
gsrj-62	15	48	over	over	ADP
gsrj-62	15	49	one	one	NUM
gsrj-62	15	50	carbon	carbon	NOUN
gsrj-62	15	51	on	on	ADP
gsrj-62	15	52	the	the	DET
gsrj-62	15	53	benzene	benzene	NOUN
gsrj-62	15	54	ring	ring	NOUN
gsrj-62	15	55	.	.	PUNCT
gsrj-62	16	1	research	research	NOUN
gsrj-62	16	2	into	into	ADP
gsrj-62	16	3	psilocybin	psilocybin	NOUN
gsrj-62	16	4	,	,	PUNCT
gsrj-62	16	5	like	like	ADP
gsrj-62	16	6	lsd	lsd	NOUN
gsrj-62	16	7	and	and	CCONJ
gsrj-62	16	8	other	other	ADJ
gsrj-62	16	9	hallucinogens	hallucinogen	NOUN
gsrj-62	16	10	,	,	PUNCT
gsrj-62	16	11	was	be	AUX
gsrj-62	16	12	hampered	hamper	VERB
gsrj-62	16	13	by	by	ADP
gsrj-62	16	14	its	its	PRON
gsrj-62	16	15	designation	designation	NOUN
gsrj-62	16	16	as	as	ADP
gsrj-62	16	17	a	a	DET
gsrj-62	16	18	schedule	schedule	NOUN
gsrj-62	16	19	1	1	NUM
gsrj-62	16	20	drug	drug	NOUN
gsrj-62	16	21	by	by	ADP
gsrj-62	16	22	the	the	DET
gsrj-62	16	23	us	us	PROPN
gsrj-62	16	24	government	government	NOUN
gsrj-62	16	25	,	,	PUNCT
gsrj-62	16	26	tightening	tighten	VERB
gsrj-62	16	27	regulations	regulation	NOUN
gsrj-62	16	28	,	,	PUNCT
gsrj-62	16	29	increasing	increase	VERB
gsrj-62	16	30	stigmas	stigma	NOUN
gsrj-62	16	31	,	,	PUNCT
gsrj-62	16	32	and	and	CCONJ
gsrj-62	16	33	overall	overall	ADV
gsrj-62	16	34	decreasing	decrease	VERB
gsrj-62	16	35	interest	interest	NOUN
gsrj-62	16	36	in	in	ADP
gsrj-62	16	37	researching	research	VERB
gsrj-62	16	38	its	its	PRON
gsrj-62	16	39	potential	potential	ADJ
gsrj-62	16	40	therapeutic	therapeutic	ADJ
gsrj-62	16	41	effects	effect	NOUN
gsrj-62	16	42	.	.	PUNCT
gsrj-62	17	1	however	however	ADV
gsrj-62	17	2	,	,	PUNCT
gsrj-62	17	3	after	after	ADP
gsrj-62	17	4	decades	decade	NOUN
gsrj-62	17	5	of	of	ADP
gsrj-62	17	6	mixed	mixed	ADJ
gsrj-62	17	7	opinions	opinion	NOUN
gsrj-62	17	8	from	from	ADP
gsrj-62	17	9	the	the	DET
gsrj-62	17	10	scientific	scientific	ADJ
gsrj-62	17	11	community	community	NOUN
gsrj-62	17	12	,	,	PUNCT
gsrj-62	17	13	hallucinogens	hallucinogen	NOUN
gsrj-62	17	14	are	be	AUX
gsrj-62	17	15	now	now	ADV
gsrj-62	17	16	widely	widely	ADV
gsrj-62	17	17	accepted	accept	VERB
gsrj-62	17	18	as	as	ADP
gsrj-62	17	19	potential	potential	ADJ
gsrj-62	17	20	therapies	therapy	NOUN
gsrj-62	17	21	for	for	ADP
gsrj-62	17	22	all	all	DET
gsrj-62	17	23	kinds	kind	NOUN
gsrj-62	17	24	of	of	ADP
gsrj-62	17	25	disorders	disorder	NOUN
gsrj-62	17	26	,	,	PUNCT
gsrj-62	17	27	including	include	VERB
gsrj-62	17	28	substance	substance	NOUN
gsrj-62	17	29	abuse	abuse	NOUN
gsrj-62	17	30	,	,	PUNCT
gsrj-62	17	31	anxiety	anxiety	NOUN
gsrj-62	17	32	,	,	PUNCT
gsrj-62	17	33	and	and	CCONJ
gsrj-62	17	34	depression	depression	NOUN
gsrj-62	17	35	,	,	PUNCT
gsrj-62	17	36	as	as	SCONJ
gsrj-62	17	37	will	will	AUX
gsrj-62	17	38	be	be	AUX
gsrj-62	17	39	discussed	discuss	VERB
gsrj-62	17	40	later.5	later.5	ADJ
gsrj-62	17	41	in	in	ADP
gsrj-62	17	42	2018	2018	NUM
gsrj-62	17	43	,	,	PUNCT
gsrj-62	17	44	the	the	DET
gsrj-62	17	45	fda	fda	PROPN
gsrj-62	17	46	granted	grant	VERB
gsrj-62	17	47	psilocybin	psilocybin	NOUN
gsrj-62	17	48	breakthrough	breakthrough	NOUN
gsrj-62	17	49	therapy	therapy	NOUN
gsrj-62	17	50	status	status	NOUN
gsrj-62	17	51	through	through	ADP
gsrj-62	17	52	compass	compass	NOUN
gsrj-62	17	53	pathways	pathway	NOUN
gsrj-62	17	54	’	'	PUNCT
gsrj-62	17	55	ongoing	ongoing	ADJ
gsrj-62	17	56	work	work	NOUN
gsrj-62	17	57	in	in	ADP
gsrj-62	17	58	phase	phase	NOUN
gsrj-62	17	59	2	2	NUM
gsrj-62	17	60	clinical	clinical	ADJ
gsrj-62	17	61	trials	trial	NOUN
gsrj-62	17	62	to	to	PART
gsrj-62	17	63	combat	combat	VERB
gsrj-62	17	64	treatment	treatment	NOUN
gsrj-62	17	65	resistant	resistant	ADJ
gsrj-62	17	66	depression.6,7	depression.6,7	PROPN
gsrj-62	17	67	in	in	ADP
gsrj-62	17	68	the	the	DET
gsrj-62	17	69	united	united	PROPN
gsrj-62	17	70	states	states	PROPN
gsrj-62	17	71	,	,	PUNCT
gsrj-62	17	72	treatment	treatment	NOUN
gsrj-62	17	73	resistant	resistant	ADJ
gsrj-62	17	74	depression	depression	NOUN
gsrj-62	17	75	creates	create	VERB
gsrj-62	17	76	an	an	DET
gsrj-62	17	77	annual	annual	ADJ
gsrj-62	17	78	burden	burden	NOUN
gsrj-62	17	79	of	of	ADP
gsrj-62	17	80	$	$	SYM
gsrj-62	17	81	43.8	43.8	NUM
gsrj-62	17	82	billion	billion	NUM
gsrj-62	17	83	dollars	dollar	NOUN
gsrj-62	17	84	,	,	PUNCT
gsrj-62	17	85	with	with	ADP
gsrj-62	17	86	an	an	DET
gsrj-62	17	87	estimated	estimate	VERB
gsrj-62	17	88	12	12	NUM
gsrj-62	17	89	-	-	PUNCT
gsrj-62	17	90	month	month	NOUN
gsrj-62	17	91	prevalence	prevalence	NOUN
gsrj-62	17	92	of	of	ADP
gsrj-62	17	93	2.8	2.8	NUM
gsrj-62	17	94	million	million	NUM
gsrj-62	17	95	in	in	ADP
gsrj-62	17	96	2021	2021	NUM
gsrj-62	17	97	.	.	PUNCT
gsrj-62	18	1	more	more	ADV
gsrj-62	18	2	recently	recently	ADV
gsrj-62	18	3	,	,	PUNCT
gsrj-62	18	4	the	the	DET
gsrj-62	18	5	fda	fda	PROPN
gsrj-62	18	6	also	also	ADV
gsrj-62	18	7	granted	grant	VERB
gsrj-62	18	8	breakthrough	breakthrough	ADJ
gsrj-62	18	9	status	status	NOUN
gsrj-62	18	10	to	to	ADP
gsrj-62	18	11	a	a	DET
gsrj-62	18	12	therapy	therapy	NOUN
gsrj-62	18	13	from	from	ADP
gsrj-62	18	14	the	the	DET
gsrj-62	18	15	usona	usona	PROPN
gsrj-62	18	16	institute	institute	PROPN
gsrj-62	18	17	in	in	ADP
gsrj-62	18	18	phase	phase	NOUN
gsrj-62	18	19	2	2	NUM
gsrj-62	18	20	trials	trial	NOUN
gsrj-62	18	21	to	to	PART
gsrj-62	18	22	treat	treat	VERB
gsrj-62	18	23	major	major	ADJ
gsrj-62	18	24	depressive	depressive	ADJ
gsrj-62	18	25	disorder	disorder	NOUN
gsrj-62	18	26	(	(	PUNCT
gsrj-62	18	27	mdd	mdd	PROPN
gsrj-62	18	28	)	)	PUNCT
gsrj-62	18	29	,	,	PUNCT
gsrj-62	18	30	expanding	expand	VERB
gsrj-62	18	31	patient	patient	ADJ
gsrj-62	18	32	scope	scope	NOUN
gsrj-62	18	33	by	by	ADP
gsrj-62	18	34	an	an	DET
gsrj-62	18	35	estimated	estimate	VERB
gsrj-62	18	36	3	3	NUM
gsrj-62	18	37	-	-	SYM
gsrj-62	18	38	10	10	NUM
gsrj-62	18	39	times	time	NOUN
gsrj-62	18	40	.	.	PUNCT
gsrj-62	19	1	medicationtreated	medicationtreate	VERB
gsrj-62	19	2	mdd	mdd	PROPN
gsrj-62	19	3	has	have	VERB
gsrj-62	19	4	a	a	DET
gsrj-62	19	5	12	12	NUM
gsrj-62	19	6	-	-	PUNCT
gsrj-62	19	7	month	month	NOUN
gsrj-62	19	8	prevalence	prevalence	NOUN
gsrj-62	19	9	in	in	ADP
gsrj-62	19	10	the	the	DET
gsrj-62	19	11	united	united	PROPN
gsrj-62	19	12	states	states	PROPN
gsrj-62	19	13	of	of	ADP
gsrj-62	19	14	8.9	8.9	NUM
gsrj-62	19	15	million	million	NUM
gsrj-62	19	16	adults	adult	NOUN
gsrj-62	19	17	,	,	PUNCT
gsrj-62	19	18	costing	cost	VERB
gsrj-62	19	19	$	$	SYM
gsrj-62	19	20	92.7	92.7	NUM
gsrj-62	19	21	billion	billion	NUM
gsrj-62	19	22	annually.6,8	annually.6,8	NOUN
gsrj-62	19	23	finding	find	VERB
gsrj-62	19	24	higher	high	ADJ
gsrj-62	19	25	quality	quality	NOUN
gsrj-62	19	26	and	and	CCONJ
gsrj-62	19	27	more	more	ADJ
gsrj-62	19	28	cost	cost	NOUN
gsrj-62	19	29	-	-	PUNCT
gsrj-62	19	30	effective	effective	ADJ
gsrj-62	19	31	treatments	treatment	NOUN
gsrj-62	19	32	for	for	ADP
gsrj-62	19	33	these	these	DET
gsrj-62	19	34	disorders	disorder	NOUN
gsrj-62	19	35	would	would	AUX
gsrj-62	19	36	help	help	VERB
gsrj-62	19	37	millions	million	NOUN
gsrj-62	19	38	of	of	ADP
gsrj-62	19	39	americans	americans	PROPN
gsrj-62	19	40	and	and	CCONJ
gsrj-62	19	41	potentially	potentially	ADV
gsrj-62	19	42	tens	ten	NOUN
gsrj-62	19	43	to	to	PART
gsrj-62	19	44	hundreds	hundred	NOUN
gsrj-62	19	45	of	of	ADP
gsrj-62	19	46	millions	million	NOUN
gsrj-62	19	47	of	of	ADP
gsrj-62	19	48	people	people	NOUN
gsrj-62	19	49	internationally	internationally	ADV
gsrj-62	19	50	,	,	PUNCT
gsrj-62	19	51	as	as	ADV
gsrj-62	19	52	well	well	ADV
gsrj-62	19	53	as	as	ADP
gsrj-62	19	54	alleviate	alleviate	VERB
gsrj-62	19	55	tens	ten	NOUN
gsrj-62	19	56	of	of	ADP
gsrj-62	19	57	billions	billion	NOUN
gsrj-62	19	58	of	of	ADP
gsrj-62	19	59	dollars	dollar	NOUN
gsrj-62	19	60	in	in	ADP
gsrj-62	19	61	medical	medical	ADJ
gsrj-62	19	62	burdens	burden	NOUN
gsrj-62	19	63	in	in	ADP
gsrj-62	19	64	the	the	DET
gsrj-62	19	65	us	us	PROPN
gsrj-62	19	66	alone	alone	ADV
gsrj-62	19	67	.	.	PUNCT
gsrj-62	20	1	22	22	NUM
gsrj-62	20	2	..	..	PUNCT
gsrj-62	20	3	rreelleevvaannccee	rreelleevvaannccee	VERB
gsrj-62	20	4	ttoo	ttoo	NOUN
gsrj-62	20	5	ddeepprreessssiioonn	ddeepprreessssiioonn	PROPN
gsrj-62	20	6	depressive	depressive	ADJ
gsrj-62	20	7	symptoms	symptom	NOUN
gsrj-62	20	8	have	have	AUX
gsrj-62	20	9	been	be	AUX
gsrj-62	20	10	linked	link	VERB
gsrj-62	20	11	to	to	ADP
gsrj-62	20	12	overactivity	overactivity	NOUN
gsrj-62	20	13	of	of	ADP
gsrj-62	20	14	the	the	DET
gsrj-62	20	15	brain	brain	NOUN
gsrj-62	20	16	network	network	NOUN
gsrj-62	20	17	responsible	responsible	ADJ
gsrj-62	20	18	for	for	ADP
gsrj-62	20	19	introspection	introspection	NOUN
gsrj-62	20	20	and	and	CCONJ
gsrj-62	20	21	self	self	NOUN
gsrj-62	20	22	-	-	PUNCT
gsrj-62	20	23	referential	referential	ADJ
gsrj-62	20	24	thinking	thinking	NOUN
gsrj-62	20	25	,	,	PUNCT
gsrj-62	20	26	called	call	VERB
gsrj-62	20	27	the	the	DET
gsrj-62	20	28	default	default	NOUN
gsrj-62	20	29	mode	mode	NOUN
gsrj-62	20	30	network	network	NOUN
gsrj-62	20	31	,	,	PUNCT
gsrj-62	20	32	which	which	PRON
gsrj-62	20	33	is	be	AUX
gsrj-62	20	34	localized	localize	VERB
gsrj-62	20	35	to	to	ADP
gsrj-62	20	36	the	the	DET
gsrj-62	20	37	medial	medial	ADJ
gsrj-62	20	38	prefrontal	prefrontal	ADJ
gsrj-62	20	39	cortex	cortex	NOUN
gsrj-62	20	40	,	,	PUNCT
gsrj-62	20	41	bilateral	bilateral	ADJ
gsrj-62	20	42	angular	angular	ADJ
gsrj-62	20	43	gyri	gyri	NOUN
gsrj-62	20	44	,	,	PUNCT
gsrj-62	20	45	and	and	CCONJ
gsrj-62	20	46	temporal	temporal	ADJ
gsrj-62	20	47	poles	pole	NOUN
gsrj-62	20	48	.	.	PUNCT
gsrj-62	21	1	depression	depression	NOUN
gsrj-62	21	2	is	be	AUX
gsrj-62	21	3	also	also	ADV
gsrj-62	21	4	found	find	VERB
gsrj-62	21	5	to	to	PART
gsrj-62	21	6	involve	involve	VERB
gsrj-62	21	7	an	an	DET
gsrj-62	21	8	impairment	impairment	NOUN
gsrj-62	21	9	of	of	ADP
gsrj-62	21	10	the	the	DET
gsrj-62	21	11	executive	executive	ADJ
gsrj-62	21	12	network	network	NOUN
gsrj-62	21	13	and	and	CCONJ
gsrj-62	21	14	salience	salience	NOUN
gsrj-62	21	15	network	network	NOUN
gsrj-62	21	16	,	,	PUNCT
gsrj-62	21	17	which	which	PRON
gsrj-62	21	18	are	be	AUX
gsrj-62	21	19	associated	associate	VERB
gsrj-62	21	20	with	with	ADP
gsrj-62	21	21	cognitive	cognitive	ADJ
gsrj-62	21	22	control	control	NOUN
gsrj-62	21	23	and	and	CCONJ
gsrj-62	21	24	switching	switch	VERB
gsrj-62	21	25	between	between	ADP
gsrj-62	21	26	internal	internal	ADJ
gsrj-62	21	27	and	and	CCONJ
gsrj-62	21	28	external	external	ADJ
gsrj-62	21	29	attention.9	attention.9	X
gsrj-62	21	30	the	the	DET
gsrj-62	21	31	binding	bind	VERB
gsrj-62	21	32	site	site	NOUN
gsrj-62	21	33	of	of	ADP
gsrj-62	21	34	psychedelics	psychedelic	NOUN
gsrj-62	21	35	such	such	ADJ
gsrj-62	21	36	as	as	ADP
gsrj-62	21	37	psilocybin	psilocybin	NOUN
gsrj-62	21	38	,	,	PUNCT
gsrj-62	21	39	5	5	NUM
gsrj-62	21	40	-	-	SYM
gsrj-62	21	41	ht2ar	ht2ar	NUM
gsrj-62	21	42	,	,	PUNCT
gsrj-62	21	43	has	have	AUX
gsrj-62	21	44	become	become	VERB
gsrj-62	21	45	an	an	DET
gsrj-62	21	46	important	important	ADJ
gsrj-62	21	47	focus	focus	NOUN
gsrj-62	21	48	in	in	ADP
gsrj-62	21	49	depression	depression	NOUN
gsrj-62	21	50	research	research	NOUN
gsrj-62	21	51	as	as	SCONJ
gsrj-62	21	52	this	this	DET
gsrj-62	21	53	receptor	receptor	NOUN
gsrj-62	21	54	is	be	AUX
gsrj-62	21	55	found	find	VERB
gsrj-62	21	56	most	most	ADV
gsrj-62	21	57	densely	densely	ADV
gsrj-62	21	58	in	in	ADP
gsrj-62	21	59	a	a	DET
gsrj-62	21	60	“	"	PUNCT
gsrj-62	21	61	broad	broad	ADJ
gsrj-62	21	62	pattern	pattern	NOUN
gsrj-62	21	63	of	of	ADP
gsrj-62	21	64	cortex	cortex	NOUN
gsrj-62	21	65	that	that	PRON
gsrj-62	21	66	closely	closely	ADV
gsrj-62	21	67	resembles	resemble	VERB
gsrj-62	21	68	a	a	DET
gsrj-62	21	69	conjunction	conjunction	NOUN
gsrj-62	21	70	map	map	NOUN
gsrj-62	21	71	of	of	ADP
gsrj-62	21	72	the	the	DET
gsrj-62	21	73	default	default	NOUN
gsrj-62	21	74	mode	mode	NOUN
gsrj-62	21	75	,	,	PUNCT
gsrj-62	21	76	executive	executive	NOUN
gsrj-62	21	77	and	and	CCONJ
gsrj-62	21	78	salience	salience	NOUN
gsrj-62	21	79	networks	network	NOUN
gsrj-62	21	80	.	.	PUNCT
gsrj-62	22	1	”10	”10	NOUN
gsrj-62	22	2	in	in	ADP
gsrj-62	22	3	a	a	DET
gsrj-62	22	4	clinical	clinical	ADJ
gsrj-62	22	5	trial	trial	NOUN
gsrj-62	22	6	in	in	ADP
gsrj-62	22	7	which	which	PRON
gsrj-62	22	8	patients	patient	NOUN
gsrj-62	22	9	with	with	ADP
gsrj-62	22	10	treatment	treatment	NOUN
gsrj-62	22	11	resistant	resistant	ADJ
gsrj-62	22	12	depression	depression	NOUN
gsrj-62	22	13	were	be	AUX
gsrj-62	22	14	given	give	VERB
gsrj-62	22	15	an	an	DET
gsrj-62	22	16	orally	orally	ADV
gsrj-62	22	17	administered	administer	VERB
gsrj-62	22	18	10	10	NUM
gsrj-62	22	19	mg	mg	NOUN
gsrj-62	22	20	dose	dose	NOUN
gsrj-62	22	21	of	of	ADP
gsrj-62	22	22	psilocybin	psilocybin	NOUN
gsrj-62	22	23	and	and	CCONJ
gsrj-62	22	24	then	then	ADV
gsrj-62	22	25	another	another	DET
gsrj-62	22	26	25	25	NUM
gsrj-62	22	27	mg	mg	PROPN
gsrj-62	22	28	dose	dose	VERB
gsrj-62	22	29	a	a	DET
gsrj-62	22	30	week	week	NOUN
gsrj-62	22	31	later	later	ADV
gsrj-62	22	32	,	,	PUNCT
gsrj-62	22	33	depression	depression	NOUN
gsrj-62	22	34	symptoms	symptom	NOUN
gsrj-62	22	35	as	as	SCONJ
gsrj-62	22	36	measured	measure	VERB
gsrj-62	22	37	by	by	ADP
gsrj-62	22	38	beck	beck	PROPN
gsrj-62	22	39	’s	’s	PART
gsrj-62	22	40	depression	depression	NOUN
gsrj-62	22	41	inventory	inventory	NOUN
gsrj-62	22	42	(	(	PUNCT
gsrj-62	22	43	bdi	bdi	PROPN
gsrj-62	22	44	)	)	PUNCT
gsrj-62	22	45	decreased	decrease	VERB
gsrj-62	22	46	significantly	significantly	ADV
gsrj-62	22	47	.	.	PUNCT
gsrj-62	23	1	starting	start	VERB
gsrj-62	23	2	from	from	ADP
gsrj-62	23	3	a	a	DET
gsrj-62	23	4	bdi	bdi	PROPN
gsrj-62	23	5	score	score	NOUN
gsrj-62	23	6	of	of	ADP
gsrj-62	23	7	34.81±	34.81±	NUM
gsrj-62	23	8	7.38	7.38	NUM
gsrj-62	23	9	,	,	PUNCT
gsrj-62	23	10	the	the	DET
gsrj-62	23	11	mean	mean	NOUN
gsrj-62	23	12	was	be	AUX
gsrj-62	23	13	reduced	reduce	VERB
gsrj-62	23	14	by	by	ADP
gsrj-62	23	15	21	21	NUM
gsrj-62	23	16	points	point	NOUN
gsrj-62	23	17	after	after	ADP
gsrj-62	23	18	one	one	NUM
gsrj-62	23	19	week	week	NOUN
gsrj-62	23	20	and	and	CCONJ
gsrj-62	23	21	remained	remain	VERB
gsrj-62	23	22	14.19	14.19	NUM
gsrj-62	23	23	points	point	NOUN
gsrj-62	23	24	lower	low	ADJ
gsrj-62	23	25	relative	relative	ADJ
gsrj-62	23	26	to	to	ADP
gsrj-62	23	27	the	the	DET
gsrj-62	23	28	baseline	baseline	NOUN
gsrj-62	23	29	at	at	ADP
gsrj-62	23	30	the	the	DET
gsrj-62	23	31	six	six	NUM
gsrj-62	23	32	-	-	PUNCT
gsrj-62	23	33	month	month	NOUN
gsrj-62	23	34	check	check	NOUN
gsrj-62	23	35	in	in	ADP
gsrj-62	23	36	.	.	PUNCT
gsrj-62	24	1	this	this	PRON
gsrj-62	24	2	was	be	AUX
gsrj-62	24	3	a	a	DET
gsrj-62	24	4	greater	great	ADJ
gsrj-62	24	5	decrease	decrease	NOUN
gsrj-62	24	6	than	than	ADP
gsrj-62	24	7	that	that	PRON
gsrj-62	24	8	observed	observe	VERB
gsrj-62	24	9	among	among	ADP
gsrj-62	24	10	those	those	PRON
gsrj-62	24	11	who	who	PRON
gsrj-62	24	12	were	be	AUX
gsrj-62	24	13	given	give	VERB
gsrj-62	24	14	the	the	DET
gsrj-62	24	15	selective	selective	ADJ
gsrj-62	24	16	serotonin	serotonin	NOUN
gsrj-62	24	17	reuptake	reuptake	NOUN
gsrj-62	24	18	inhibitor	inhibitor	NOUN
gsrj-62	24	19	(	(	PUNCT
gsrj-62	24	20	ssri	ssri	PROPN
gsrj-62	24	21	)	)	PUNCT
gsrj-62	24	22	escitalopram	escitalopram	PROPN
gsrj-62	24	23	daily	daily	PROPN
gsrj-62	24	24	for	for	ADP
gsrj-62	24	25	six	six	NUM
gsrj-62	24	26	weeks.10	weeks.10	PROPN
gsrj-62	24	27	another	another	DET
gsrj-62	24	28	study	study	NOUN
gsrj-62	24	29	which	which	PRON
gsrj-62	24	30	used	use	VERB
gsrj-62	24	31	the	the	DET
gsrj-62	24	32	quick	quick	ADJ
gsrj-62	24	33	inventory	inventory	NOUN
gsrj-62	24	34	of	of	ADP
gsrj-62	24	35	depressive	depressive	ADJ
gsrj-62	24	36	symptomatology	symptomatology	NOUN
gsrj-62	24	37	-self	-self	NOUN
gsrj-62	24	38	report	report	NOUN
gsrj-62	24	39	(	(	PUNCT
gsrj-62	24	40	qids	qid	NOUN
gsrj-62	24	41	sr	sr	PROPN
gsrj-62	24	42	16	16	NUM
gsrj-62	24	43	)	)	PUNCT
gsrj-62	24	44	showed	show	VERB
gsrj-62	24	45	no	no	DET
gsrj-62	24	46	significant	significant	ADJ
gsrj-62	24	47	difference	difference	NOUN
gsrj-62	24	48	between	between	ADP
gsrj-62	24	49	scores	score	NOUN
gsrj-62	24	50	of	of	ADP
gsrj-62	24	51	participants	participant	NOUN
gsrj-62	24	52	given	give	VERB
gsrj-62	24	53	psilocybin	psilocybin	NOUN
gsrj-62	24	54	versus	versus	ADP
gsrj-62	24	55	escitalopram	escitalopram	PROPN
gsrj-62	24	56	after	after	SCONJ
gsrj-62	24	57	six	six	NUM
gsrj-62	24	58	weeks.11	weeks.11	NOUN
gsrj-62	24	59	this	this	DET
gsrj-62	24	60	discrepancy	discrepancy	NOUN
gsrj-62	24	61	is	be	AUX
gsrj-62	24	62	most	most	ADV
gsrj-62	24	63	likely	likely	ADJ
gsrj-62	24	64	due	due	ADP
gsrj-62	24	65	to	to	ADP
gsrj-62	24	66	the	the	DET
gsrj-62	24	67	difference	difference	NOUN
gsrj-62	24	68	in	in	ADP
gsrj-62	24	69	timing	timing	NOUN
gsrj-62	24	70	between	between	ADP
gsrj-62	24	71	the	the	DET
gsrj-62	24	72	two	two	NUM
gsrj-62	24	73	21	21	NUM
gsrj-62	24	74	georgetown	georgetown	NOUN
gsrj-62	24	75	scientific	scientific	ADJ
gsrj-62	24	76	research	research	PROPN
gsrj-62	24	77	journal	journal	PROPN
gsrj-62	24	78	studies	study	NOUN
gsrj-62	24	79	'	'	PART
gsrj-62	24	80	assessments	assessment	NOUN
gsrj-62	24	81	and	and	CCONJ
gsrj-62	24	82	possible	possible	ADJ
gsrj-62	24	83	differences	difference	NOUN
gsrj-62	24	84	between	between	ADP
gsrj-62	24	85	the	the	DET
gsrj-62	24	86	two	two	NUM
gsrj-62	24	87	self	self	NOUN
gsrj-62	24	88	-	-	PUNCT
gsrj-62	24	89	reporting	reporting	NOUN
gsrj-62	24	90	scales	scale	NOUN
gsrj-62	24	91	for	for	ADP
gsrj-62	24	92	depression	depression	NOUN
gsrj-62	24	93	symptoms	symptom	NOUN
gsrj-62	24	94	.	.	PUNCT
gsrj-62	25	1	ffiigguurree	ffiigguurree	NOUN
gsrj-62	25	2	22	22	NUM
gsrj-62	25	3	..	..	PUNCT
gsrj-62	25	4	bbeecckk’’ss	bbeecckk’’s	NOUN
gsrj-62	25	5	ddeepprreessssiioonn	ddeepprreessssiioonn	PROPN
gsrj-62	25	6	iinnddeexx	iinnddeexx	PROPN
gsrj-62	25	7	ssccoorreess	ssccoorreess	PROPN
gsrj-62	25	8	aafftteerr	aafftteerr	PROPN
gsrj-62	25	9	ttrreeaattmmeenntt	ttrreeaattmmeenntt	PROPN
gsrj-62	25	10	wwiitthh	wwiitthh	ADJ
gsrj-62	25	11	ppssiillooccyybbiinn	ppssiillooccyybbiinn	PROPN
gsrj-62	25	12	aanndd	aanndd	NOUN
gsrj-62	25	13	eesscciittaalloopprraamm	eesscciittaalloopprraamm	PROPN
gsrj-62	25	14	.	.	PUNCT
gsrj-62	26	1	db	db	PROPN
gsrj-62	26	2	-	-	PUNCT
gsrj-62	26	3	rct	rct	PROPN
gsrj-62	26	4	bdi	bdi	PROPN
gsrj-62	26	5	scores	score	NOUN
gsrj-62	26	6	from	from	ADP
gsrj-62	26	7	each	each	DET
gsrj-62	26	8	study	study	NOUN
gsrj-62	26	9	arm	arm	NOUN
gsrj-62	26	10	and	and	CCONJ
gsrj-62	26	11	time	time	NOUN
gsrj-62	26	12	point	point	NOUN
gsrj-62	26	13	.	.	PUNCT
gsrj-62	27	1	adapted	adapt	VERB
gsrj-62	27	2	from	from	ADP
gsrj-62	27	3	daws	daws	PROPN
gsrj-62	27	4	et	et	PROPN
gsrj-62	27	5	al	al	PROPN
gsrj-62	27	6	.	.	PROPN
gsrj-62	27	7	,	,	PUNCT
gsrj-62	27	8	2022.10	2022.10	NUM
gsrj-62	27	9	in	in	ADP
gsrj-62	27	10	addition	addition	NOUN
gsrj-62	27	11	to	to	ADP
gsrj-62	27	12	having	have	VERB
gsrj-62	27	13	an	an	DET
gsrj-62	27	14	equal	equal	ADJ
gsrj-62	27	15	or	or	CCONJ
gsrj-62	27	16	greater	great	ADJ
gsrj-62	27	17	effect	effect	NOUN
gsrj-62	27	18	on	on	ADP
gsrj-62	27	19	self	self	NOUN
gsrj-62	27	20	-	-	PUNCT
gsrj-62	27	21	reported	report	VERB
gsrj-62	27	22	feelings	feeling	NOUN
gsrj-62	27	23	of	of	ADP
gsrj-62	27	24	depression	depression	NOUN
gsrj-62	27	25	,	,	PUNCT
gsrj-62	27	26	as	as	SCONJ
gsrj-62	27	27	measured	measure	VERB
gsrj-62	27	28	by	by	ADP
gsrj-62	27	29	bdi	bdi	PROPN
gsrj-62	27	30	or	or	CCONJ
gsrj-62	27	31	qids	qid	VERB
gsrj-62	27	32	sr	sr	PROPN
gsrj-62	27	33	16	16	NUM
gsrj-62	27	34	,	,	PUNCT
gsrj-62	27	35	than	than	ADP
gsrj-62	27	36	treatment	treatment	NOUN
gsrj-62	27	37	with	with	ADP
gsrj-62	27	38	the	the	DET
gsrj-62	27	39	ssri	ssri	PROPN
gsrj-62	27	40	escitalopram	escitalopram	PROPN
gsrj-62	27	41	,	,	PUNCT
gsrj-62	27	42	psilocybin	psilocybin	NOUN
gsrj-62	27	43	also	also	ADV
gsrj-62	27	44	decreased	decrease	VERB
gsrj-62	27	45	brain	brain	NOUN
gsrj-62	27	46	modularity	modularity	NOUN
gsrj-62	27	47	,	,	PUNCT
gsrj-62	27	48	a	a	DET
gsrj-62	27	49	measure	measure	NOUN
gsrj-62	27	50	of	of	ADP
gsrj-62	27	51	how	how	SCONJ
gsrj-62	27	52	segregated	segregated	ADJ
gsrj-62	27	53	brain	brain	NOUN
gsrj-62	27	54	networks	network	NOUN
gsrj-62	27	55	are	be	AUX
gsrj-62	27	56	from	from	ADP
gsrj-62	27	57	one	one	NUM
gsrj-62	27	58	another	another	DET
gsrj-62	27	59	.	.	PUNCT
gsrj-62	28	1	lower	low	ADJ
gsrj-62	28	2	modularity	modularity	NOUN
gsrj-62	28	3	means	mean	VERB
gsrj-62	28	4	more	more	ADV
gsrj-62	28	5	functional	functional	ADJ
gsrj-62	28	6	connectivity	connectivity	NOUN
gsrj-62	28	7	between	between	ADP
gsrj-62	28	8	networks	network	NOUN
gsrj-62	28	9	and	and	CCONJ
gsrj-62	28	10	a	a	DET
gsrj-62	28	11	reduction	reduction	NOUN
gsrj-62	28	12	of	of	ADP
gsrj-62	28	13	within	within	ADP
gsrj-62	28	14	-	-	PUNCT
gsrj-62	28	15	network	network	NOUN
gsrj-62	28	16	connectivity	connectivity	NOUN
gsrj-62	28	17	.	.	PUNCT
gsrj-62	29	1	after	after	ADP
gsrj-62	29	2	treatment	treatment	NOUN
gsrj-62	29	3	with	with	ADP
gsrj-62	29	4	psilocybin	psilocybin	NOUN
gsrj-62	29	5	,	,	PUNCT
gsrj-62	29	6	there	there	PRON
gsrj-62	29	7	was	be	VERB
gsrj-62	29	8	a	a	DET
gsrj-62	29	9	significant	significant	ADJ
gsrj-62	29	10	decrease	decrease	NOUN
gsrj-62	29	11	in	in	ADP
gsrj-62	29	12	the	the	DET
gsrj-62	29	13	hyperconnectivity	hyperconnectivity	NOUN
gsrj-62	29	14	within	within	ADP
gsrj-62	29	15	the	the	DET
gsrj-62	29	16	default	default	NOUN
gsrj-62	29	17	mode	mode	NOUN
gsrj-62	29	18	network	network	NOUN
gsrj-62	29	19	that	that	PRON
gsrj-62	29	20	characterizes	characterize	VERB
gsrj-62	29	21	depression	depression	NOUN
gsrj-62	29	22	.	.	PUNCT
gsrj-62	30	1	there	there	PRON
gsrj-62	30	2	was	be	VERB
gsrj-62	30	3	also	also	ADV
gsrj-62	30	4	a	a	DET
gsrj-62	30	5	significant	significant	ADJ
gsrj-62	30	6	increase	increase	NOUN
gsrj-62	30	7	in	in	ADP
gsrj-62	30	8	connectivity	connectivity	NOUN
gsrj-62	30	9	between	between	ADP
gsrj-62	30	10	the	the	DET
gsrj-62	30	11	default	default	NOUN
gsrj-62	30	12	mode	mode	NOUN
gsrj-62	30	13	and	and	CCONJ
gsrj-62	30	14	executive	executive	ADJ
gsrj-62	30	15	networks	network	NOUN
gsrj-62	30	16	as	as	ADV
gsrj-62	30	17	well	well	ADV
gsrj-62	30	18	as	as	ADP
gsrj-62	30	19	the	the	DET
gsrj-62	30	20	default	default	NOUN
gsrj-62	30	21	mode	mode	NOUN
gsrj-62	30	22	and	and	CCONJ
gsrj-62	30	23	the	the	DET
gsrj-62	30	24	salience	salience	NOUN
gsrj-62	30	25	networks	network	NOUN
gsrj-62	30	26	.	.	PUNCT
gsrj-62	31	1	the	the	DET
gsrj-62	31	2	researchers	researcher	NOUN
gsrj-62	31	3	hypothesized	hypothesize	VERB
gsrj-62	31	4	that	that	SCONJ
gsrj-62	31	5	this	this	DET
gsrj-62	31	6	increase	increase	NOUN
gsrj-62	31	7	of	of	ADP
gsrj-62	31	8	integration	integration	NOUN
gsrj-62	31	9	among	among	ADP
gsrj-62	31	10	brain	brain	NOUN
gsrj-62	31	11	networks	network	NOUN
gsrj-62	31	12	was	be	AUX
gsrj-62	31	13	responsible	responsible	ADJ
gsrj-62	31	14	for	for	ADP
gsrj-62	31	15	the	the	DET
gsrj-62	31	16	antidepressant	antidepressant	ADJ
gsrj-62	31	17	effect	effect	NOUN
gsrj-62	31	18	of	of	ADP
gsrj-62	31	19	psilocybin	psilocybin	NOUN
gsrj-62	31	20	,	,	PUNCT
gsrj-62	31	21	so	so	SCONJ
gsrj-62	31	22	they	they	PRON
gsrj-62	31	23	compared	compare	VERB
gsrj-62	31	24	brain	brain	NOUN
gsrj-62	31	25	modulation	modulation	NOUN
gsrj-62	31	26	,	,	PUNCT
gsrj-62	31	27	measured	measure	VERB
gsrj-62	31	28	by	by	ADP
gsrj-62	31	29	fmri	fmri	PROPN
gsrj-62	31	30	,	,	PUNCT
gsrj-62	31	31	and	and	CCONJ
gsrj-62	31	32	bdi	bdi	PROPN
gsrj-62	31	33	scores	score	NOUN
gsrj-62	31	34	of	of	ADP
gsrj-62	31	35	each	each	DET
gsrj-62	31	36	patient	patient	NOUN
gsrj-62	31	37	and	and	CCONJ
gsrj-62	31	38	found	find	VERB
gsrj-62	31	39	that	that	SCONJ
gsrj-62	31	40	they	they	PRON
gsrj-62	31	41	were	be	AUX
gsrj-62	31	42	significantly	significantly	ADV
gsrj-62	31	43	correlated	correlate	VERB
gsrj-62	31	44	at	at	ADP
gsrj-62	31	45	the	the	DET
gsrj-62	31	46	six	six	NUM
gsrj-62	31	47	-	-	PUNCT
gsrj-62	31	48	month	month	NOUN
gsrj-62	31	49	point.10	point.10	NOUN
gsrj-62	31	50	similarly	similarly	ADV
gsrj-62	31	51	,	,	PUNCT
gsrj-62	31	52	it	it	PRON
gsrj-62	31	53	has	have	AUX
gsrj-62	31	54	recently	recently	ADV
gsrj-62	31	55	been	be	AUX
gsrj-62	31	56	shown	show	VERB
gsrj-62	31	57	that	that	SCONJ
gsrj-62	31	58	lsd	lsd	NOUN
gsrj-62	31	59	,	,	PUNCT
gsrj-62	31	60	a	a	DET
gsrj-62	31	61	hallucinogenic	hallucinogenic	NOUN
gsrj-62	31	62	with	with	ADP
gsrj-62	31	63	a	a	DET
gsrj-62	31	64	similar	similar	ADJ
gsrj-62	31	65	mechanism	mechanism	NOUN
gsrj-62	31	66	of	of	ADP
gsrj-62	31	67	action	action	NOUN
gsrj-62	31	68	to	to	ADP
gsrj-62	31	69	psilocybin	psilocybin	NOUN
gsrj-62	31	70	,	,	PUNCT
gsrj-62	31	71	is	be	AUX
gsrj-62	31	72	associated	associate	VERB
gsrj-62	31	73	with	with	ADP
gsrj-62	31	74	a	a	DET
gsrj-62	31	75	decrease	decrease	NOUN
gsrj-62	31	76	in	in	ADP
gsrj-62	31	77	functional	functional	ADJ
gsrj-62	31	78	connectivity	connectivity	NOUN
gsrj-62	31	79	within	within	ADP
gsrj-62	31	80	the	the	DET
gsrj-62	31	81	default	default	NOUN
gsrj-62	31	82	mode	mode	NOUN
gsrj-62	31	83	network	network	NOUN
gsrj-62	31	84	and	and	CCONJ
gsrj-62	31	85	an	an	DET
gsrj-62	31	86	increase	increase	NOUN
gsrj-62	31	87	of	of	ADP
gsrj-62	31	88	functional	functional	ADJ
gsrj-62	31	89	connectivity	connectivity	NOUN
gsrj-62	31	90	between	between	ADP
gsrj-62	31	91	the	the	DET
gsrj-62	31	92	default	default	NOUN
gsrj-62	31	93	mode	mode	NOUN
gsrj-62	31	94	network	network	NOUN
gsrj-62	31	95	and	and	CCONJ
gsrj-62	31	96	the	the	DET
gsrj-62	31	97	executive	executive	NOUN
gsrj-62	31	98	network.12	network.12	PROPN
gsrj-62	31	99	33	33	NUM
gsrj-62	31	100	..	..	PUNCT
gsrj-62	31	101	mmoolleeccuullaarr	mmoolleeccuullaarr	PROPN
gsrj-62	31	102	mmeecchhaanniissmmss	mmeecchhaanniissmmss	PROPN
gsrj-62	31	103	ooff	ooff	PROPN
gsrj-62	31	104	hhaalllluucciinnooggeennss	hhaalllluucciinnooggeenns	NOUN
gsrj-62	31	105	3.1	3.1	NUM
gsrj-62	31	106	interactions	interaction	NOUN
gsrj-62	31	107	with	with	ADP
gsrj-62	31	108	the	the	DET
gsrj-62	31	109	5	5	NUM
gsrj-62	31	110	-	-	PUNCT
gsrj-62	31	111	ht2a	ht2a	NOUN
gsrj-62	31	112	receptor	receptor	NOUN
gsrj-62	31	113	the	the	DET
gsrj-62	31	114	clinical	clinical	ADJ
gsrj-62	31	115	application	application	NOUN
gsrj-62	31	116	of	of	ADP
gsrj-62	31	117	psilocybin	psilocybin	NOUN
gsrj-62	31	118	as	as	ADP
gsrj-62	31	119	a	a	DET
gsrj-62	31	120	treatment	treatment	NOUN
gsrj-62	31	121	for	for	ADP
gsrj-62	31	122	depression	depression	NOUN
gsrj-62	31	123	is	be	AUX
gsrj-62	31	124	promising	promise	VERB
gsrj-62	31	125	and	and	CCONJ
gsrj-62	31	126	has	have	AUX
gsrj-62	31	127	spurred	spur	VERB
gsrj-62	31	128	investigations	investigation	NOUN
gsrj-62	31	129	into	into	ADP
gsrj-62	31	130	how	how	SCONJ
gsrj-62	31	131	similar	similar	ADJ
gsrj-62	31	132	drugs	drug	NOUN
gsrj-62	31	133	function	function	VERB
gsrj-62	31	134	on	on	ADP
gsrj-62	31	135	a	a	DET
gsrj-62	31	136	molecular	molecular	ADJ
gsrj-62	31	137	level	level	NOUN
gsrj-62	31	138	.	.	PUNCT
gsrj-62	32	1	primarily	primarily	ADV
gsrj-62	32	2	,	,	PUNCT
gsrj-62	32	3	psilocybin	psilocybin	NOUN
gsrj-62	32	4	and	and	CCONJ
gsrj-62	32	5	other	other	ADJ
gsrj-62	32	6	hallucinogenic	hallucinogenic	ADJ
gsrj-62	32	7	compounds	compound	NOUN
gsrj-62	32	8	function	function	VERB
gsrj-62	32	9	through	through	ADP
gsrj-62	32	10	their	their	PRON
gsrj-62	32	11	interactions	interaction	NOUN
gsrj-62	32	12	with	with	ADP
gsrj-62	32	13	the	the	DET
gsrj-62	32	14	5	5	NUM
gsrj-62	32	15	-	-	PUNCT
gsrj-62	32	16	ht2a	ht2a	NOUN
gsrj-62	32	17	receptor	receptor	NOUN
gsrj-62	32	18	.	.	PUNCT
gsrj-62	33	1	psilocybin	psilocybin	NOUN
gsrj-62	33	2	acts	act	VERB
gsrj-62	33	3	as	as	ADP
gsrj-62	33	4	a	a	DET
gsrj-62	33	5	5	5	NUM
gsrj-62	33	6	-	-	PUNCT
gsrj-62	33	7	ht2a	ht2a	NOUN
gsrj-62	33	8	receptor	receptor	NOUN
gsrj-62	33	9	agonist	agonist	NOUN
gsrj-62	33	10	,	,	PUNCT
gsrj-62	33	11	and	and	CCONJ
gsrj-62	33	12	the	the	DET
gsrj-62	33	13	activation	activation	NOUN
gsrj-62	33	14	of	of	ADP
gsrj-62	33	15	this	this	DET
gsrj-62	33	16	receptor	receptor	NOUN
gsrj-62	33	17	can	can	AUX
gsrj-62	33	18	lead	lead	VERB
gsrj-62	33	19	to	to	ADP
gsrj-62	33	20	hallucinogenesis	hallucinogenesis	NOUN
gsrj-62	33	21	in	in	ADP
gsrj-62	33	22	humans	human	NOUN
gsrj-62	33	23	and	and	CCONJ
gsrj-62	33	24	experimental	experimental	ADJ
gsrj-62	33	25	animals.13	animals.13	PROPN
gsrj-62	34	1	although	although	SCONJ
gsrj-62	34	2	there	there	PRON
gsrj-62	34	3	are	be	VERB
gsrj-62	34	4	other	other	ADJ
gsrj-62	34	5	5	5	NUM
gsrj-62	34	6	-	-	PUNCT
gsrj-62	34	7	ht2a	ht2a	PROPN
gsrj-62	34	8	receptor	receptor	NOUN
gsrj-62	34	9	agonists	agonist	NOUN
gsrj-62	34	10	,	,	PUNCT
gsrj-62	34	11	many	many	ADJ
gsrj-62	34	12	do	do	AUX
gsrj-62	34	13	not	not	PART
gsrj-62	34	14	produce	produce	VERB
gsrj-62	34	15	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	16	effects	effect	NOUN
gsrj-62	34	17	(	(	PUNCT
gsrj-62	34	18	non	non	ADJ
gsrj-62	34	19	-	-	ADJ
gsrj-62	34	20	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	21	compounds	compound	NOUN
gsrj-62	34	22	)	)	PUNCT
gsrj-62	34	23	indicating	indicate	VERB
gsrj-62	34	24	that	that	SCONJ
gsrj-62	34	25	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	26	effects	effect	NOUN
gsrj-62	34	27	are	be	AUX
gsrj-62	34	28	caused	cause	VERB
gsrj-62	34	29	by	by	ADP
gsrj-62	34	30	a	a	DET
gsrj-62	34	31	specific	specific	ADJ
gsrj-62	34	32	signaling	signal	VERB
gsrj-62	34	33	pathway.13	pathway.13	NOUN
gsrj-62	34	34	both	both	CCONJ
gsrj-62	34	35	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	36	and	and	CCONJ
gsrj-62	34	37	non	non	ADJ
gsrj-62	34	38	-	-	ADJ
gsrj-62	34	39	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	40	compounds	compound	NOUN
gsrj-62	34	41	activate	activate	VERB
gsrj-62	34	42	phospholipase	phospholipase	NOUN
gsrj-62	34	43	c	c	PROPN
gsrj-62	34	44	-	-	PUNCT
gsrj-62	34	45	β	β	NOUN
gsrj-62	34	46	,	,	PUNCT
gsrj-62	34	47	but	but	CCONJ
gsrj-62	34	48	research	research	NOUN
gsrj-62	34	49	conducted	conduct	VERB
gsrj-62	34	50	by	by	ADP
gsrj-62	34	51	gonzález	gonzález	PROPN
gsrj-62	34	52	-	-	PUNCT
gsrj-62	34	53	maeso	maeso	NOUN
gsrj-62	34	54	et	et	PROPN
gsrj-62	34	55	al	al	PROPN
gsrj-62	34	56	.	.	PROPN
gsrj-62	34	57	indicates	indicate	VERB
gsrj-62	34	58	that	that	SCONJ
gsrj-62	34	59	the	the	DET
gsrj-62	34	60	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	61	pathway	pathway	NOUN
gsrj-62	34	62	is	be	AUX
gsrj-62	34	63	unique	unique	ADJ
gsrj-62	34	64	due	due	ADJ
gsrj-62	34	65	to	to	ADP
gsrj-62	34	66	co	co	NOUN
gsrj-62	34	67	-	-	NOUN
gsrj-62	34	68	activation	activation	NOUN
gsrj-62	34	69	of	of	ADP
gsrj-62	34	70	heterotrimeric	heterotrimeric	ADJ
gsrj-62	34	71	gq/11	gq/11	PROPN
gsrj-62	34	72	and	and	CCONJ
gsrj-62	34	73	pertussis	pertussis	VERB
gsrj-62	34	74	toxin	toxin	NOUN
gsrj-62	34	75	-	-	PUNCT
gsrj-62	34	76	sensitive	sensitive	ADJ
gsrj-62	34	77	gi	gi	PROPN
gsrj-62	34	78	/	/	SYM
gsrj-62	34	79	o	o	NOUN
gsrj-62	34	80	proteins.13	proteins.13	NOUN
gsrj-62	34	81	furthermore	furthermore	ADV
gsrj-62	34	82	,	,	PUNCT
gsrj-62	34	83	expression	expression	NOUN
gsrj-62	34	84	of	of	ADP
gsrj-62	34	85	c	c	NOUN
gsrj-62	34	86	-	-	PUNCT
gsrj-62	34	87	fos	fos	NOUN
gsrj-62	34	88	,	,	PUNCT
gsrj-62	34	89	egr-2	egr-2	ADV
gsrj-62	34	90	,	,	PUNCT
gsrj-62	34	91	and	and	CCONJ
gsrj-62	34	92	egr-1	egr-1	NUM
gsrj-62	34	93	is	be	AUX
gsrj-62	34	94	elevated	elevate	VERB
gsrj-62	34	95	by	by	ADP
gsrj-62	34	96	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	97	compounds	compound	NOUN
gsrj-62	34	98	while	while	SCONJ
gsrj-62	34	99	non	non	ADJ
gsrj-62	34	100	-	-	ADJ
gsrj-62	34	101	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	102	compounds	compound	NOUN
gsrj-62	34	103	only	only	ADV
gsrj-62	34	104	show	show	VERB
gsrj-62	34	105	c	c	NOUN
gsrj-62	34	106	-	-	PUNCT
gsrj-62	34	107	fos	fos	NOUN
gsrj-62	34	108	elevation	elevation	NOUN
gsrj-62	34	109	,	,	PUNCT
gsrj-62	34	110	allowing	allow	VERB
gsrj-62	34	111	erg-2	erg-2	ADV
gsrj-62	34	112	and	and	CCONJ
gsrj-62	34	113	erg-1	erg-1	ADP
gsrj-62	34	114	to	to	PART
gsrj-62	34	115	be	be	AUX
gsrj-62	34	116	used	use	VERB
gsrj-62	34	117	as	as	ADP
gsrj-62	34	118	a	a	DET
gsrj-62	34	119	marker	marker	NOUN
gsrj-62	34	120	unique	unique	ADJ
gsrj-62	34	121	to	to	ADP
gsrj-62	34	122	5	5	NUM
gsrj-62	34	123	-	-	SYM
gsrj-62	34	124	ht2ar	ht2ar	NUM
gsrj-62	34	125	hallucinogens.14	hallucinogens.14	NOUN
gsrj-62	34	126	using	use	VERB
gsrj-62	34	127	the	the	DET
gsrj-62	34	128	characteristic	characteristic	ADJ
gsrj-62	34	129	gene	gene	NOUN
gsrj-62	34	130	responses	response	NOUN
gsrj-62	34	131	of	of	ADP
gsrj-62	34	132	c	c	NOUN
gsrj-62	34	133	-	-	PUNCT
gsrj-62	34	134	fos	fos	NOUN
gsrj-62	34	135	and	and	CCONJ
gsrj-62	34	136	egr-1/2	egr-1/2	PROPN
gsrj-62	34	137	,	,	PUNCT
gsrj-62	34	138	gonzález	gonzález	PROPN
gsrj-62	34	139	-	-	PUNCT
gsrj-62	34	140	maeso	maeso	NOUN
gsrj-62	34	141	et	et	PROPN
gsrj-62	34	142	al	al	PROPN
gsrj-62	34	143	.	.	PROPN
gsrj-62	34	144	investigated	investigate	VERB
gsrj-62	34	145	how	how	SCONJ
gsrj-62	34	146	this	this	DET
gsrj-62	34	147	hallucinogenic	hallucinogenic	ADJ
gsrj-62	34	148	pathway	pathway	NOUN
gsrj-62	34	149	worked	work	VERB
gsrj-62	34	150	.	.	PUNCT
gsrj-62	35	1	they	they	PRON
gsrj-62	35	2	found	find	VERB
gsrj-62	35	3	that	that	SCONJ
gsrj-62	35	4	when	when	SCONJ
gsrj-62	35	5	phospholipase	phospholipase	PROPN
gsrj-62	35	6	c	c	NOUN
gsrj-62	35	7	-	-	PUNCT
gsrj-62	35	8	β	β	PROPN
gsrj-62	35	9	was	be	AUX
gsrj-62	35	10	inhibited	inhibit	VERB
gsrj-62	35	11	by	by	ADP
gsrj-62	35	12	u73122	u73122	PROPN
gsrj-62	35	13	,	,	PUNCT
gsrj-62	35	14	a	a	DET
gsrj-62	35	15	gene	gene	NOUN
gsrj-62	35	16	response	response	NOUN
gsrj-62	35	17	was	be	AUX
gsrj-62	35	18	not	not	PART
gsrj-62	35	19	obtained	obtain	VERB
gsrj-62	35	20	by	by	ADP
gsrj-62	35	21	lsd	lsd	NOUN
gsrj-62	35	22	or	or	CCONJ
gsrj-62	35	23	r	r	NOUN
gsrj-62	35	24	-	-	PUNCT
gsrj-62	35	25	lisuride	lisuride	PROPN
gsrj-62	35	26	,	,	PUNCT
gsrj-62	35	27	a	a	DET
gsrj-62	35	28	non	non	ADJ
gsrj-62	35	29	-	-	ADJ
gsrj-62	35	30	hallucinogenic	hallucinogenic	ADJ
gsrj-62	35	31	closely	closely	ADV
gsrj-62	35	32	related	relate	VERB
gsrj-62	35	33	to	to	ADP
gsrj-62	35	34	lsd	lsd	NOUN
gsrj-62	35	35	(	(	PUNCT
gsrj-62	35	36	figure	figure	NOUN
gsrj-62	35	37	3a	3a	NUM
gsrj-62	35	38	)	)	PUNCT
gsrj-62	35	39	.	.	PUNCT
gsrj-62	36	1	similarly	similarly	ADV
gsrj-62	36	2	,	,	PUNCT
gsrj-62	36	3	inhibition	inhibition	NOUN
gsrj-62	36	4	of	of	ADP
gsrj-62	36	5	gi	gi	NOUN
gsrj-62	36	6	/	/	SYM
gsrj-62	36	7	o	o	NOUN
gsrj-62	36	8	protein	protein	NOUN
gsrj-62	36	9	with	with	ADP
gsrj-62	36	10	pertussis	pertussis	NOUN
gsrj-62	36	11	toxin	toxin	NOUN
gsrj-62	36	12	and	and	CCONJ
gsrj-62	36	13	inhibition	inhibition	NOUN
gsrj-62	36	14	of	of	ADP
gsrj-62	36	15	src	src	NOUN
gsrj-62	36	16	attenuated	attenuate	VERB
gsrj-62	36	17	the	the	DET
gsrj-62	36	18	gene	gene	NOUN
gsrj-62	36	19	response	response	NOUN
gsrj-62	36	20	to	to	ADP
gsrj-62	36	21	lsd	lsd	NOUN
gsrj-62	36	22	(	(	PUNCT
gsrj-62	36	23	figure	figure	NOUN
gsrj-62	36	24	3b	3b	NUM
gsrj-62	36	25	)	)	PUNCT
gsrj-62	36	26	.	.	PUNCT
gsrj-62	37	1	this	this	PRON
gsrj-62	37	2	indicates	indicate	VERB
gsrj-62	37	3	the	the	DET
gsrj-62	37	4	importance	importance	NOUN
gsrj-62	37	5	of	of	ADP
gsrj-62	37	6	specific	specific	ADJ
gsrj-62	37	7	regulation	regulation	NOUN
gsrj-62	37	8	of	of	ADP
gsrj-62	37	9	gi	gi	NOUN
gsrj-62	37	10	/	/	SYM
gsrj-62	37	11	o	o	NOUN
gsrj-62	37	12	protein	protein	NOUN
gsrj-62	37	13	and	and	CCONJ
gsrj-62	37	14	src	src	NOUN
gsrj-62	37	15	in	in	ADP
gsrj-62	37	16	response	response	NOUN
gsrj-62	37	17	to	to	ADP
gsrj-62	37	18	hallucinogenic	hallucinogenic	ADJ
gsrj-62	37	19	compounds	compound	NOUN
gsrj-62	37	20	like	like	ADP
gsrj-62	37	21	lsd	lsd	NOUN
gsrj-62	37	22	,	,	PUNCT
gsrj-62	37	23	emphasizing	emphasize	VERB
gsrj-62	37	24	their	their	PRON
gsrj-62	37	25	role	role	NOUN
gsrj-62	37	26	in	in	ADP
gsrj-62	37	27	hallucinogenesis	hallucinogenesis	NOUN
gsrj-62	37	28	as	as	ADP
gsrj-62	37	29	a	a	DET
gsrj-62	37	30	22	22	NUM
gsrj-62	37	31	georgetown	georgetown	NOUN
gsrj-62	37	32	scientific	scientific	ADJ
gsrj-62	37	33	research	research	NOUN
gsrj-62	37	34	journal	journal	PROPN
gsrj-62	37	35	result	result	NOUN
gsrj-62	37	36	of	of	ADP
gsrj-62	37	37	partial	partial	ADJ
gsrj-62	37	38	or	or	CCONJ
gsrj-62	37	39	complete	complete	ADJ
gsrj-62	37	40	agonism	agonism	NOUN
gsrj-62	37	41	of	of	ADP
gsrj-62	37	42	the	the	DET
gsrj-62	37	43	5ht2a	5ht2a	NUM
gsrj-62	37	44	receptor	receptor	NOUN
gsrj-62	37	45	.	.	PUNCT
gsrj-62	38	1	ffiigguurree	ffiigguurree	NOUN
gsrj-62	38	2	33	33	NUM
gsrj-62	38	3	..	..	PUNCT
gsrj-62	38	4	llssdd	llssdd	ADJ
gsrj-62	38	5	--	--	PUNCT
gsrj-62	38	6	ssppeecciiffiicc	ssppeecciiffiicc	NOUN
gsrj-62	38	7	ssiiggnnaalliinngg	ssiiggnnaalliinngg	VERB
gsrj-62	38	8	iinn	iinn	ADJ
gsrj-62	38	9	pprriimmaarryy	pprriimmaarryy	NOUN
gsrj-62	38	10	ccoorrttiiccaall	ccoorrttiiccaall	NOUN
gsrj-62	38	11	nneeuurroonnss	nneeuurroonns	NOUN
gsrj-62	38	12	.	.	PUNCT
gsrj-62	39	1	a	a	DET
gsrj-62	39	2	)	)	PUNCT
gsrj-62	39	3	cortical	cortical	ADJ
gsrj-62	39	4	neurons	neuron	NOUN
gsrj-62	39	5	treated	treat	VERB
gsrj-62	39	6	with	with	ADP
gsrj-62	39	7	u73122	u73122	PROPN
gsrj-62	39	8	,	,	PUNCT
gsrj-62	39	9	a	a	DET
gsrj-62	39	10	plc	plc	PROPN
gsrj-62	39	11	-	-	PUNCT
gsrj-62	39	12	β	β	NOUN
gsrj-62	39	13	inhibitor	inhibitor	NOUN
gsrj-62	39	14	,	,	PUNCT
gsrj-62	39	15	results	result	VERB
gsrj-62	39	16	in	in	ADP
gsrj-62	39	17	inhibition	inhibition	NOUN
gsrj-62	39	18	of	of	ADP
gsrj-62	39	19	gene	gene	NOUN
gsrj-62	39	20	expression	expression	NOUN
gsrj-62	39	21	in	in	ADP
gsrj-62	39	22	response	response	NOUN
gsrj-62	39	23	to	to	ADP
gsrj-62	39	24	lsd	lsd	NOUN
gsrj-62	39	25	.	.	PUNCT
gsrj-62	40	1	b	b	X
gsrj-62	40	2	)	)	PUNCT
gsrj-62	40	3	gene	gene	NOUN
gsrj-62	40	4	induction	induction	NOUN
gsrj-62	40	5	pattern	pattern	NOUN
gsrj-62	40	6	in	in	ADP
gsrj-62	40	7	response	response	NOUN
gsrj-62	40	8	to	to	ADP
gsrj-62	40	9	lsd	lsd	NOUN
gsrj-62	40	10	is	be	AUX
gsrj-62	40	11	attenuated	attenuate	VERB
gsrj-62	40	12	by	by	ADP
gsrj-62	40	13	inhibition	inhibition	NOUN
gsrj-62	40	14	of	of	ADP
gsrj-62	40	15	gi	gi	NOUN
gsrj-62	40	16	/	/	SYM
gsrj-62	40	17	o	o	NOUN
gsrj-62	40	18	protein	protein	NOUN
gsrj-62	40	19	with	with	ADP
gsrj-62	40	20	pertussis	pertussis	NOUN
gsrj-62	40	21	toxin	toxin	NOUN
gsrj-62	40	22	and	and	CCONJ
gsrj-62	40	23	not	not	PART
gsrj-62	40	24	affected	affect	VERB
gsrj-62	40	25	by	by	ADP
gsrj-62	40	26	inhibition	inhibition	NOUN
gsrj-62	40	27	of	of	ADP
gsrj-62	40	28	pi3	pi3	NOUN
gsrj-62	40	29	-	-	PUNCT
gsrj-62	40	30	k	k	NOUN
gsrj-62	40	31	with	with	ADP
gsrj-62	40	32	ly294002	ly294002	PROPN
gsrj-62	40	33	.	.	PUNCT
gsrj-62	41	1	lsd	lsd	NOUN
gsrj-62	41	2	and	and	CCONJ
gsrj-62	41	3	r	r	NOUN
gsrj-62	41	4	-	-	PUNCT
gsrj-62	41	5	lisuride	lisuride	ADJ
gsrj-62	41	6	are	be	AUX
gsrj-62	41	7	identical	identical	ADJ
gsrj-62	41	8	in	in	ADP
gsrj-62	41	9	the	the	DET
gsrj-62	41	10	absence	absence	NOUN
gsrj-62	41	11	of	of	ADP
gsrj-62	41	12	src	src	NOUN
gsrj-62	41	13	activity	activity	NOUN
gsrj-62	41	14	via	via	ADP
gsrj-62	41	15	inhibition	inhibition	NOUN
gsrj-62	41	16	with	with	ADP
gsrj-62	41	17	pp2	pp2	PROPN
gsrj-62	41	18	.	.	PROPN
gsrj-62	41	19	adapted	adapt	VERB
gsrj-62	41	20	from	from	ADP
gsrj-62	41	21	gonzálezmaeso	gonzálezmaeso	PROPN
gsrj-62	41	22	et	et	PROPN
gsrj-62	41	23	al	al	PROPN
gsrj-62	41	24	.	.	PROPN
gsrj-62	41	25	,	,	PUNCT
gsrj-62	41	26	2007.13	2007.13	NUM
gsrj-62	41	27	based	base	VERB
gsrj-62	41	28	on	on	ADP
gsrj-62	41	29	their	their	PRON
gsrj-62	41	30	research	research	NOUN
gsrj-62	41	31	,	,	PUNCT
gsrj-62	41	32	gonzález	gonzález	PROPN
gsrj-62	41	33	-	-	PUNCT
gsrj-62	41	34	maeso	maeso	NOUN
gsrj-62	41	35	et	et	PROPN
gsrj-62	41	36	al	al	PROPN
gsrj-62	41	37	.	.	PROPN
gsrj-62	41	38	proposed	propose	VERB
gsrj-62	41	39	a	a	DET
gsrj-62	41	40	model	model	NOUN
gsrj-62	41	41	that	that	PRON
gsrj-62	41	42	elucidates	elucidate	VERB
gsrj-62	41	43	the	the	DET
gsrj-62	41	44	molecular	molecular	ADJ
gsrj-62	41	45	mechanism	mechanism	NOUN
gsrj-62	41	46	that	that	PRON
gsrj-62	41	47	results	result	VERB
gsrj-62	41	48	in	in	ADP
gsrj-62	41	49	the	the	DET
gsrj-62	41	50	hallucinogenic	hallucinogenic	ADJ
gsrj-62	41	51	response	response	NOUN
gsrj-62	41	52	seen	see	VERB
gsrj-62	41	53	in	in	ADP
gsrj-62	41	54	psychedelics	psychedelic	NOUN
gsrj-62	41	55	including	include	VERB
gsrj-62	41	56	lsd	lsd	NOUN
gsrj-62	41	57	,	,	PUNCT
gsrj-62	41	58	psilocybin	psilocybin	NOUN
gsrj-62	41	59	,	,	PUNCT
gsrj-62	41	60	and	and	CCONJ
gsrj-62	41	61	doi	doi	NOUN
gsrj-62	41	62	.	.	PUNCT
gsrj-62	42	1	although	although	SCONJ
gsrj-62	42	2	hallucinogenic	hallucinogenic	ADJ
gsrj-62	42	3	and	and	CCONJ
gsrj-62	42	4	non	non	ADJ
gsrj-62	42	5	-	-	ADJ
gsrj-62	42	6	hallucinogenic	hallucinogenic	ADJ
gsrj-62	42	7	compounds	compound	NOUN
gsrj-62	42	8	both	both	PRON
gsrj-62	42	9	interact	interact	VERB
gsrj-62	42	10	with	with	ADP
gsrj-62	42	11	the	the	DET
gsrj-62	42	12	5	5	NUM
gsrj-62	42	13	-	-	PUNCT
gsrj-62	42	14	ht2a	ht2a	NOUN
gsrj-62	42	15	receptor	receptor	NOUN
gsrj-62	42	16	,	,	PUNCT
gsrj-62	42	17	the	the	DET
gsrj-62	42	18	conformation	conformation	NOUN
gsrj-62	42	19	stabilized	stabilize	VERB
gsrj-62	42	20	by	by	ADP
gsrj-62	42	21	hallucinogens	hallucinogen	NOUN
gsrj-62	42	22	like	like	ADP
gsrj-62	42	23	lsd	lsd	NOUN
gsrj-62	42	24	is	be	AUX
gsrj-62	42	25	unique	unique	ADJ
gsrj-62	42	26	and	and	CCONJ
gsrj-62	42	27	leads	lead	VERB
gsrj-62	42	28	to	to	ADP
gsrj-62	42	29	a	a	DET
gsrj-62	42	30	different	different	ADJ
gsrj-62	42	31	pattern	pattern	NOUN
gsrj-62	42	32	of	of	ADP
gsrj-62	42	33	cellular	cellular	ADJ
gsrj-62	42	34	signaling	signaling	NOUN
gsrj-62	42	35	.	.	PUNCT
gsrj-62	43	1	in	in	ADP
gsrj-62	43	2	this	this	DET
gsrj-62	43	3	research	research	NOUN
gsrj-62	43	4	,	,	PUNCT
gsrj-62	43	5	they	they	PRON
gsrj-62	43	6	also	also	ADV
gsrj-62	43	7	assessed	assess	VERB
gsrj-62	43	8	how	how	SCONJ
gsrj-62	43	9	recovery	recovery	NOUN
gsrj-62	43	10	of	of	ADP
gsrj-62	43	11	the	the	DET
gsrj-62	43	12	5	5	NUM
gsrj-62	43	13	-	-	PUNCT
gsrj-62	43	14	ht2a	ht2a	NOUN
gsrj-62	43	15	receptor	receptor	NOUN
gsrj-62	43	16	in	in	ADP
gsrj-62	43	17	specific	specific	ADJ
gsrj-62	43	18	neuron	neuron	NOUN
gsrj-62	43	19	populations	population	NOUN
gsrj-62	43	20	recovered	recover	VERB
gsrj-62	43	21	the	the	DET
gsrj-62	43	22	hallucinogenic	hallucinogenic	ADJ
gsrj-62	43	23	response	response	NOUN
gsrj-62	43	24	.	.	PUNCT
gsrj-62	44	1	using	use	VERB
gsrj-62	44	2	htr2a−/−	htr2a−/−	ADJ
gsrj-62	44	3	mice	mouse	NOUN
gsrj-62	44	4	,	,	PUNCT
gsrj-62	44	5	they	they	PRON
gsrj-62	44	6	discovered	discover	VERB
gsrj-62	44	7	that	that	SCONJ
gsrj-62	44	8	signaling	signal	VERB
gsrj-62	44	9	and	and	CCONJ
gsrj-62	44	10	behavioral	behavioral	ADJ
gsrj-62	44	11	responses	response	NOUN
gsrj-62	44	12	to	to	ADP
gsrj-62	44	13	hallucinogenic	hallucinogenic	ADJ
gsrj-62	44	14	compounds	compound	NOUN
gsrj-62	44	15	were	be	AUX
gsrj-62	44	16	established	establish	VERB
gsrj-62	44	17	when	when	SCONJ
gsrj-62	44	18	5	5	NUM
gsrj-62	44	19	-	-	PUNCT
gsrj-62	44	20	ht2a	ht2a	NUM
gsrj-62	44	21	receptors	receptor	NOUN
gsrj-62	44	22	were	be	AUX
gsrj-62	44	23	restored	restore	VERB
gsrj-62	44	24	within	within	ADP
gsrj-62	44	25	the	the	DET
gsrj-62	44	26	cortical	cortical	ADJ
gsrj-62	44	27	neurons	neuron	NOUN
gsrj-62	44	28	.	.	PUNCT
gsrj-62	45	1	they	they	PRON
gsrj-62	45	2	did	do	AUX
gsrj-62	45	3	not	not	PART
gsrj-62	45	4	find	find	VERB
gsrj-62	45	5	that	that	SCONJ
gsrj-62	45	6	restoration	restoration	NOUN
gsrj-62	45	7	in	in	ADP
gsrj-62	45	8	the	the	DET
gsrj-62	45	9	thalamus	thalamus	NOUN
gsrj-62	45	10	or	or	CCONJ
gsrj-62	45	11	subcortical	subcortical	ADJ
gsrj-62	45	12	brain	brain	NOUN
gsrj-62	45	13	region	region	NOUN
gsrj-62	45	14	were	be	AUX
gsrj-62	45	15	sufficient	sufficient	ADJ
gsrj-62	45	16	in	in	ADP
gsrj-62	45	17	re	re	VERB
gsrj-62	45	18	-	-	VERB
gsrj-62	45	19	establishing	establish	VERB
gsrj-62	45	20	normal	normal	ADJ
gsrj-62	45	21	hallucinogenic	hallucinogenic	ADJ
gsrj-62	45	22	responses	response	NOUN
gsrj-62	45	23	,	,	PUNCT
gsrj-62	45	24	indicating	indicate	VERB
gsrj-62	45	25	that	that	SCONJ
gsrj-62	45	26	these	these	DET
gsrj-62	45	27	areas	area	NOUN
gsrj-62	45	28	are	be	AUX
gsrj-62	45	29	not	not	PART
gsrj-62	45	30	required	require	VERB
gsrj-62	45	31	for	for	ADP
gsrj-62	45	32	hallucinogenic	hallucinogenic	ADJ
gsrj-62	45	33	activity	activity	NOUN
gsrj-62	45	34	,	,	PUNCT
gsrj-62	45	35	but	but	CCONJ
gsrj-62	45	36	that	that	SCONJ
gsrj-62	45	37	the	the	DET
gsrj-62	45	38	cortex	cortex	NOUN
gsrj-62	45	39	is.13	is.13	NOUN
gsrj-62	45	40	overall	overall	ADV
gsrj-62	45	41	,	,	PUNCT
gsrj-62	45	42	this	this	PRON
gsrj-62	45	43	outlines	outline	VERB
gsrj-62	45	44	the	the	DET
gsrj-62	45	45	molecular	molecular	ADJ
gsrj-62	45	46	interactions	interaction	NOUN
gsrj-62	45	47	with	with	ADP
gsrj-62	45	48	the	the	DET
gsrj-62	45	49	5	5	NUM
gsrj-62	45	50	-	-	SYM
gsrj-62	45	51	ht2ar	ht2ar	NOUN
gsrj-62	45	52	typical	typical	ADJ
gsrj-62	45	53	of	of	ADP
gsrj-62	45	54	hallucinogenic	hallucinogenic	ADJ
gsrj-62	45	55	drugs	drug	NOUN
gsrj-62	45	56	like	like	ADP
gsrj-62	45	57	psilocybin	psilocybin	NOUN
gsrj-62	45	58	,	,	PUNCT
gsrj-62	45	59	dependent	dependent	ADJ
gsrj-62	45	60	on	on	ADP
gsrj-62	45	61	gi	gi	NOUN
gsrj-62	45	62	/	/	SYM
gsrj-62	45	63	o	o	NOUN
gsrj-62	45	64	proteins	protein	NOUN
gsrj-62	45	65	,	,	PUNCT
gsrj-62	45	66	gq/11	gq/11	PROPN
gsrj-62	45	67	proteins	protein	NOUN
gsrj-62	45	68	,	,	PUNCT
gsrj-62	45	69	and	and	CCONJ
gsrj-62	45	70	src	src	NOUN
gsrj-62	45	71	.	.	PROPN
gsrj-62	45	72	3.2	3.2	NUM
gsrj-62	45	73	5	5	NUM
gsrj-62	45	74	-	-	SYM
gsrj-62	45	75	ht2ar	ht2ar	NUM
gsrj-62	45	76	and	and	CCONJ
gsrj-62	45	77	mglur2	mglur2	VERB
gsrj-62	45	78	complex	complex	ADJ
gsrj-62	45	79	formation	formation	NOUN
gsrj-62	45	80	although	although	SCONJ
gsrj-62	45	81	5	5	NUM
gsrj-62	45	82	-	-	SYM
gsrj-62	45	83	ht2ar	ht2ar	NUM
gsrj-62	45	84	activation	activation	NOUN
gsrj-62	45	85	is	be	AUX
gsrj-62	45	86	an	an	DET
gsrj-62	45	87	essential	essential	ADJ
gsrj-62	45	88	part	part	NOUN
gsrj-62	45	89	of	of	ADP
gsrj-62	45	90	classical	classical	ADJ
gsrj-62	45	91	hallucinogenic	hallucinogenic	ADJ
gsrj-62	45	92	function	function	NOUN
gsrj-62	45	93	,	,	PUNCT
gsrj-62	45	94	discussion	discussion	NOUN
gsrj-62	45	95	of	of	ADP
gsrj-62	45	96	the	the	DET
gsrj-62	45	97	psychedelic	psychedelic	ADJ
gsrj-62	45	98	mechanism	mechanism	NOUN
gsrj-62	45	99	would	would	AUX
gsrj-62	45	100	be	be	AUX
gsrj-62	45	101	incomplete	incomplete	ADJ
gsrj-62	45	102	without	without	ADP
gsrj-62	45	103	mentioning	mention	VERB
gsrj-62	45	104	metabotropic	metabotropic	NOUN
gsrj-62	45	105	glutamate	glutamate	NOUN
gsrj-62	45	106	receptors	receptor	NOUN
gsrj-62	45	107	.	.	PUNCT
gsrj-62	46	1	these	these	DET
gsrj-62	46	2	serotonergic	serotonergic	ADJ
gsrj-62	46	3	receptors	receptor	NOUN
gsrj-62	46	4	,	,	PUNCT
gsrj-62	46	5	5	5	NUM
gsrj-62	46	6	-	-	SYM
gsrj-62	46	7	ht2ar	ht2ar	NUM
gsrj-62	46	8	,	,	PUNCT
gsrj-62	46	9	and	and	CCONJ
gsrj-62	46	10	mglurs	mglur	NOUN
gsrj-62	46	11	are	be	AUX
gsrj-62	46	12	co	co	ADJ
gsrj-62	46	13	-	-	VERB
gsrj-62	46	14	localized	localized	ADJ
gsrj-62	46	15	throughout	throughout	ADP
gsrj-62	46	16	the	the	DET
gsrj-62	46	17	brain	brain	NOUN
gsrj-62	46	18	,	,	PUNCT
gsrj-62	46	19	specifically	specifically	ADV
gsrj-62	46	20	5	5	NUM
gsrj-62	46	21	-	-	SYM
gsrj-62	46	22	ht2ar	ht2ar	NOUN
gsrj-62	46	23	and	and	CCONJ
gsrj-62	46	24	mglur2.15	mglur2.15	ADP
gsrj-62	46	25	moreno	moreno	PROPN
gsrj-62	46	26	et	et	PROPN
gsrj-62	46	27	al	al	PROPN
gsrj-62	46	28	.	.	PROPN
gsrj-62	46	29	found	find	VERB
gsrj-62	46	30	that	that	DET
gsrj-62	46	31	mglur2	mglur2	NOUN
gsrj-62	46	32	was	be	AUX
gsrj-62	46	33	essential	essential	ADJ
gsrj-62	46	34	to	to	ADP
gsrj-62	46	35	the	the	DET
gsrj-62	46	36	hallucinogenic	hallucinogenic	ADJ
gsrj-62	46	37	effects	effect	NOUN
gsrj-62	46	38	caused	cause	VERB
gsrj-62	46	39	by	by	ADP
gsrj-62	46	40	5ht2ar	5ht2ar	NUM
gsrj-62	46	41	agonists	agonist	NOUN
gsrj-62	46	42	.	.	PUNCT
gsrj-62	47	1	in	in	ADP
gsrj-62	47	2	this	this	DET
gsrj-62	47	3	study	study	NOUN
gsrj-62	47	4	,	,	PUNCT
gsrj-62	47	5	they	they	PRON
gsrj-62	47	6	injected	inject	VERB
gsrj-62	47	7	(	(	PUNCT
gsrj-62	47	8	±)1(2,5	±)1(2,5	NOUN
gsrj-62	47	9	-	-	PUNCT
gsrj-62	47	10	dimethoxy-4	dimethoxy-4	NOUN
gsrj-62	47	11	-	-	PUNCT
gsrj-62	47	12	iodophenyl)-2	iodophenyl)-2	NOUN
gsrj-62	47	13	-	-	PUNCT
gsrj-62	47	14	aminopropane	aminopropane	NOUN
gsrj-62	47	15	(	(	PUNCT
gsrj-62	47	16	doi	doi	NOUN
gsrj-62	47	17	)	)	PUNCT
gsrj-62	47	18	and	and	CCONJ
gsrj-62	47	19	lysergic	lysergic	NOUN
gsrj-62	47	20	acid	acid	NOUN
gsrj-62	47	21	diethylamide	diethylamide	NOUN
gsrj-62	47	22	(	(	PUNCT
gsrj-62	47	23	lsd	lsd	NOUN
gsrj-62	47	24	)	)	PUNCT
gsrj-62	47	25	(	(	PUNCT
gsrj-62	47	26	both	both	PRON
gsrj-62	47	27	of	of	ADP
gsrj-62	47	28	which	which	PRON
gsrj-62	47	29	are	be	AUX
gsrj-62	47	30	functionally	functionally	ADV
gsrj-62	47	31	similar	similar	ADJ
gsrj-62	47	32	to	to	ADP
gsrj-62	47	33	psilocybin	psilocybin	NOUN
gsrj-62	47	34	in	in	ADP
gsrj-62	47	35	their	their	PRON
gsrj-62	47	36	hallucinogenic	hallucinogenic	ADJ
gsrj-62	47	37	effects	effect	NOUN
gsrj-62	47	38	)	)	PUNCT
gsrj-62	47	39	into	into	ADP
gsrj-62	47	40	mglur2	mglur2	NOUN
gsrj-62	47	41	knockout	knockout	NOUN
gsrj-62	47	42	(	(	PUNCT
gsrj-62	47	43	ko	ko	NOUN
gsrj-62	47	44	)	)	PUNCT
gsrj-62	47	45	mice	mouse	NOUN
gsrj-62	47	46	.	.	PUNCT
gsrj-62	48	1	they	they	PRON
gsrj-62	48	2	found	find	VERB
gsrj-62	48	3	that	that	SCONJ
gsrj-62	48	4	the	the	DET
gsrj-62	48	5	ko	ko	PROPN
gsrj-62	48	6	mice	mouse	NOUN
gsrj-62	48	7	had	have	VERB
gsrj-62	48	8	a	a	DET
gsrj-62	48	9	significantly	significantly	ADV
gsrj-62	48	10	reduced	reduce	VERB
gsrj-62	48	11	head	head	NOUN
gsrj-62	48	12	twitch	twitch	ADJ
gsrj-62	48	13	response	response	NOUN
gsrj-62	48	14	(	(	PUNCT
gsrj-62	48	15	a	a	DET
gsrj-62	48	16	common	common	ADJ
gsrj-62	48	17	behavioral	behavioral	ADJ
gsrj-62	48	18	assay	assay	NOUN
gsrj-62	48	19	indicating	indicate	VERB
gsrj-62	48	20	hallucinogenic	hallucinogenic	ADJ
gsrj-62	48	21	response	response	NOUN
gsrj-62	48	22	upon	upon	SCONJ
gsrj-62	48	23	5	5	NUM
gsrj-62	48	24	-	-	PUNCT
gsrj-62	48	25	ht2ar	ht2ar	NUM
gsrj-62	48	26	activation	activation	NOUN
gsrj-62	48	27	)	)	PUNCT
gsrj-62	48	28	in	in	ADP
gsrj-62	48	29	a	a	DET
gsrj-62	48	30	30	30	NUM
gsrj-62	48	31	minute	minute	NOUN
gsrj-62	48	32	window	window	NOUN
gsrj-62	48	33	compared	compare	VERB
gsrj-62	48	34	to	to	ADP
gsrj-62	48	35	wild	wild	ADJ
gsrj-62	48	36	type	type	NOUN
gsrj-62	48	37	mice	mouse	NOUN
gsrj-62	48	38	as	as	SCONJ
gsrj-62	48	39	seen	see	VERB
gsrj-62	48	40	in	in	ADP
gsrj-62	48	41	figure	figure	NOUN
gsrj-62	48	42	4	4	NUM
gsrj-62	48	43	,	,	PUNCT
gsrj-62	48	44	indicating	indicate	VERB
gsrj-62	48	45	mglur2	mglur2	NOUN
gsrj-62	48	46	was	be	AUX
gsrj-62	48	47	necessary	necessary	ADJ
gsrj-62	48	48	for	for	ADP
gsrj-62	48	49	hallucinogenic	hallucinogenic	ADJ
gsrj-62	48	50	specific	specific	ADJ
gsrj-62	48	51	response	response	NOUN
gsrj-62	48	52	within	within	ADP
gsrj-62	48	53	the	the	DET
gsrj-62	48	54	mice.16,17	mice.16,17	NOUN
gsrj-62	48	55	in	in	ADP
gsrj-62	48	56	a	a	DET
gsrj-62	48	57	more	more	ADV
gsrj-62	48	58	recent	recent	ADJ
gsrj-62	48	59	study	study	NOUN
gsrj-62	48	60	by	by	ADP
gsrj-62	48	61	benvenga	benvenga	NOUN
gsrj-62	48	62	et	et	PROPN
gsrj-62	48	63	al	al	PROPN
gsrj-62	48	64	.	.	PROPN
gsrj-62	48	65	,	,	PUNCT
gsrj-62	48	66	doi	doi	PROPN
gsrj-62	48	67	administered	administer	VERB
gsrj-62	48	68	to	to	PART
gsrj-62	48	69	mglur2	mglur2	VERB
gsrj-62	48	70	ko	ko	PROPN
gsrj-62	48	71	mice	mouse	NOUN
gsrj-62	48	72	failed	fail	VERB
gsrj-62	48	73	to	to	PART
gsrj-62	48	74	produce	produce	VERB
gsrj-62	48	75	a	a	DET
gsrj-62	48	76	significant	significant	ADJ
gsrj-62	48	77	number	number	NOUN
gsrj-62	48	78	of	of	ADP
gsrj-62	48	79	head	head	NOUN
gsrj-62	48	80	twitches	twitch	VERB
gsrj-62	48	81	even	even	ADV
gsrj-62	48	82	at	at	ADP
gsrj-62	48	83	a	a	DET
gsrj-62	48	84	dose	dose	NOUN
gsrj-62	48	85	tenfold	tenfold	ADV
gsrj-62	48	86	higher	high	ADJ
gsrj-62	48	87	than	than	ADP
gsrj-62	48	88	the	the	DET
gsrj-62	48	89	normal	normal	ADJ
gsrj-62	48	90	,	,	PUNCT
gsrj-62	48	91	peak	peak	ADJ
gsrj-62	48	92	effective	effective	ADJ
gsrj-62	48	93	dose	dose	NOUN
gsrj-62	48	94	that	that	PRON
gsrj-62	48	95	produced	produce	VERB
gsrj-62	48	96	head	head	NOUN
gsrj-62	48	97	twitches	twitch	NOUN
gsrj-62	48	98	in	in	ADP
gsrj-62	48	99	wild	wild	ADJ
gsrj-62	48	100	type	type	NOUN
gsrj-62	48	101	or	or	CCONJ
gsrj-62	48	102	mglur3	mglur3	NOUN
gsrj-62	48	103	ko	ko	PROPN
gsrj-62	48	104	mice	mouse	NOUN
gsrj-62	48	105	supporting	support	VERB
gsrj-62	48	106	moreno	moreno	PROPN
gsrj-62	48	107	’s	’s	PROPN
gsrj-62	48	108	findings.18	findings.18	PROPN
gsrj-62	48	109	23	23	NUM
gsrj-62	48	110	georgetown	georgetown	PROPN
gsrj-62	48	111	scientific	scientific	PROPN
gsrj-62	48	112	research	research	PROPN
gsrj-62	48	113	journal	journal	PROPN
gsrj-62	48	114	ffiigguurree	ffiigguurree	NOUN
gsrj-62	48	115	44	44	NUM
gsrj-62	48	116	..	..	PUNCT
gsrj-62	48	117	bbeehhaavviioorraall	bbeehhaavviioorraall	PRON
gsrj-62	48	118	rreessppoonnssee	rreessppoonnssee	VERB
gsrj-62	48	119	ttoo	ttoo	PROPN
gsrj-62	48	120	hhaalllluucciinnooggeennss	hhaalllluucciinnooggeennss	PROPN
gsrj-62	48	121	ddooii	ddooii	PROPN
gsrj-62	48	122	aanndd	aanndd	NOUN
gsrj-62	48	123	llssdd	llssdd	PROPN
gsrj-62	48	124	..	..	PUNCT
gsrj-62	48	125	wild	wild	ADJ
gsrj-62	48	126	type	type	NOUN
gsrj-62	48	127	and	and	CCONJ
gsrj-62	48	128	mglur2	mglur2	NOUN
gsrj-62	48	129	-	-	PUNCT
gsrj-62	48	130	ko	ko	NOUN
gsrj-62	48	131	mice	mouse	NOUN
gsrj-62	48	132	(	(	PUNCT
gsrj-62	48	133	n	n	NOUN
gsrj-62	48	134	=	=	SYM
gsrj-62	48	135	4–5	4–5	PROPN
gsrj-62	48	136	per	per	ADP
gsrj-62	48	137	treatment	treatment	NOUN
gsrj-62	48	138	group	group	NOUN
gsrj-62	48	139	)	)	PUNCT
gsrj-62	48	140	were	be	AUX
gsrj-62	48	141	injected	inject	VERB
gsrj-62	48	142	with	with	ADP
gsrj-62	48	143	vehicle	vehicle	NOUN
gsrj-62	48	144	,	,	PUNCT
gsrj-62	48	145	doi	doi	X
gsrj-62	48	146	(	(	PUNCT
gsrj-62	48	147	2	2	NUM
gsrj-62	48	148	mg	mg	PROPN
gsrj-62	48	149	/	/	SYM
gsrj-62	48	150	kg	kg	NOUN
gsrj-62	48	151	)	)	PUNCT
gsrj-62	48	152	or	or	CCONJ
gsrj-62	48	153	lsd	lsd	NOUN
gsrj-62	48	154	(	(	PUNCT
gsrj-62	48	155	0.24	0.24	NUM
gsrj-62	48	156	mg	mg	PROPN
gsrj-62	48	157	/	/	SYM
gsrj-62	48	158	kg	kg	PROPN
gsrj-62	48	159	)	)	PUNCT
gsrj-62	48	160	,	,	PUNCT
gsrj-62	48	161	and	and	CCONJ
gsrj-62	48	162	the	the	DET
gsrj-62	48	163	head	head	NOUN
gsrj-62	48	164	-	-	PUNCT
gsrj-62	48	165	twitch	twitch	NOUN
gsrj-62	48	166	response	response	NOUN
gsrj-62	48	167	was	be	AUX
gsrj-62	48	168	scored	score	VERB
gsrj-62	48	169	15	15	NUM
gsrj-62	48	170	min	min	NOUN
gsrj-62	48	171	after	after	ADP
gsrj-62	48	172	injection	injection	NOUN
gsrj-62	48	173	for	for	ADP
gsrj-62	48	174	30	30	NUM
gsrj-62	48	175	min	min	NOUN
gsrj-62	48	176	.	.	PUNCT
gsrj-62	49	1	*	*	PUNCT
gsrj-62	49	2	*	*	PUNCT
gsrj-62	49	3	*	*	PUNCT
gsrj-62	49	4	p	p	X
gsrj-62	49	5	<	<	X
gsrj-62	49	6	0.001	0.001	NUM
gsrj-62	49	7	;	;	PUNCT
gsrj-62	49	8	bonferroni	bonferroni	NOUN
gsrj-62	49	9	's	's	PART
gsrj-62	49	10	post	post	X
gsrj-62	49	11	hoc	hoc	X
gsrj-62	49	12	test	test	NOUN
gsrj-62	49	13	of	of	ADP
gsrj-62	49	14	two	two	NUM
gsrj-62	49	15	-	-	PUNCT
gsrj-62	49	16	way	way	NOUN
gsrj-62	49	17	anova	anova	PROPN
gsrj-62	49	18	.	.	PUNCT
gsrj-62	50	1	data	datum	NOUN
gsrj-62	50	2	are	be	AUX
gsrj-62	50	3	means	mean	VERB
gsrj-62	50	4	±	±	NUM
gsrj-62	50	5	s.e.m	s.e.m	NOUN
gsrj-62	50	6	.	.	PROPN
gsrj-62	50	7	adapted	adapt	VERB
gsrj-62	50	8	from	from	ADP
gsrj-62	50	9	moreno	moreno	PROPN
gsrj-62	50	10	et	et	PROPN
gsrj-62	50	11	al	al	PROPN
gsrj-62	50	12	.	.	PROPN
gsrj-62	50	13	,	,	PUNCT
gsrj-62	50	14	2011.16	2011.16	NUM
gsrj-62	50	15	these	these	DET
gsrj-62	50	16	findings	finding	NOUN
gsrj-62	50	17	suggested	suggest	VERB
gsrj-62	50	18	that	that	SCONJ
gsrj-62	50	19	5	5	NUM
gsrj-62	50	20	-	-	SYM
gsrj-62	50	21	ht2ar	ht2ar	NOUN
gsrj-62	50	22	relies	rely	VERB
gsrj-62	50	23	on	on	ADP
gsrj-62	50	24	mglur2	mglur2	NOUN
gsrj-62	50	25	for	for	ADP
gsrj-62	50	26	its	its	PRON
gsrj-62	50	27	downstream	downstream	ADJ
gsrj-62	50	28	effects	effect	NOUN
gsrj-62	50	29	upon	upon	SCONJ
gsrj-62	50	30	activation	activation	NOUN
gsrj-62	50	31	.	.	PUNCT
gsrj-62	51	1	per	per	ADP
gsrj-62	51	2	multiple	multiple	ADJ
gsrj-62	51	3	co	co	NOUN
gsrj-62	51	4	-	-	ADJ
gsrj-62	51	5	immunoprecipitation	immunoprecipitation	ADJ
gsrj-62	51	6	based	base	VERB
gsrj-62	51	7	studies	study	NOUN
gsrj-62	51	8	,	,	PUNCT
gsrj-62	51	9	it	it	PRON
gsrj-62	51	10	has	have	AUX
gsrj-62	51	11	been	be	AUX
gsrj-62	51	12	found	find	VERB
gsrj-62	51	13	that	that	SCONJ
gsrj-62	51	14	the	the	DET
gsrj-62	51	15	two	two	NUM
gsrj-62	51	16	receptors	receptor	NOUN
gsrj-62	51	17	form	form	VERB
gsrj-62	51	18	a	a	DET
gsrj-62	51	19	heterocomplex.19	heterocomplex.19	NOUN
gsrj-62	51	20	more	more	ADV
gsrj-62	51	21	specifically	specifically	ADV
gsrj-62	51	22	,	,	PUNCT
gsrj-62	51	23	phosphorylation	phosphorylation	NOUN
gsrj-62	51	24	at	at	ADP
gsrj-62	51	25	serine	serine	NOUN
gsrj-62	51	26	843	843	NUM
gsrj-62	51	27	,	,	PUNCT
gsrj-62	51	28	an	an	DET
gsrj-62	51	29	event	event	NOUN
gsrj-62	51	30	dependent	dependent	ADJ
gsrj-62	51	31	on	on	ADP
gsrj-62	51	32	5	5	NUM
gsrj-62	51	33	-	-	PUNCT
gsrj-62	51	34	ht2ar	ht2ar	NUM
gsrj-62	51	35	activation	activation	NOUN
gsrj-62	51	36	,	,	PUNCT
gsrj-62	51	37	is	be	AUX
gsrj-62	51	38	a	a	DET
gsrj-62	51	39	key	key	ADJ
gsrj-62	51	40	modulator	modulator	NOUN
gsrj-62	51	41	in	in	ADP
gsrj-62	51	42	mglur2	mglur2	PROPN
gsrj-62	51	43	’s	’s	PART
gsrj-62	51	44	functioning	function	VERB
gsrj-62	51	45	in	in	ADP
gsrj-62	51	46	gi	gi	PROPN
gsrj-62	51	47	/	/	SYM
gsrj-62	51	48	o	o	PROPN
gsrj-62	51	49	and	and	CCONJ
gsrj-62	51	50	gq/11	gq/11	PROPN
gsrj-62	51	51	protein	protein	NOUN
gsrj-62	51	52	activation	activation	NOUN
gsrj-62	51	53	and	and	CCONJ
gsrj-62	51	54	subsequent	subsequent	ADJ
gsrj-62	51	55	signaling.20,21	signaling.20,21	NOUN
gsrj-62	51	56	gq/11	gq/11	PROPN
gsrj-62	51	57	activation	activation	NOUN
gsrj-62	51	58	leads	lead	VERB
gsrj-62	51	59	to	to	ADP
gsrj-62	51	60	phosphatidylinositol	phosphatidylinositol	NOUN
gsrj-62	51	61	4,5	4,5	NUM
gsrj-62	51	62	-	-	PUNCT
gsrj-62	51	63	biphosphate	biphosphate	NOUN
gsrj-62	51	64	hydrolysis	hydrolysis	NOUN
gsrj-62	51	65	and	and	CCONJ
gsrj-62	51	66	calcium	calcium	NOUN
gsrj-62	51	67	release	release	NOUN
gsrj-62	51	68	that	that	PRON
gsrj-62	51	69	promotes	promote	VERB
gsrj-62	51	70	excitatory	excitatory	ADJ
gsrj-62	51	71	transmitter	transmitter	NOUN
gsrj-62	51	72	release	release	NOUN
gsrj-62	51	73	.	.	PUNCT
gsrj-62	52	1	for	for	ADP
gsrj-62	52	2	example	example	NOUN
gsrj-62	52	3	,	,	PUNCT
gsrj-62	52	4	extracellular	extracellular	ADJ
gsrj-62	52	5	glutamate	glutamate	NOUN
gsrj-62	52	6	levels	level	NOUN
gsrj-62	52	7	in	in	ADP
gsrj-62	52	8	the	the	DET
gsrj-62	52	9	somatosensory	somatosensory	NOUN
gsrj-62	52	10	cortex	cortex	NOUN
gsrj-62	52	11	of	of	ADP
gsrj-62	52	12	rats	rat	NOUN
gsrj-62	52	13	increases	increase	VERB
gsrj-62	52	14	upon	upon	SCONJ
gsrj-62	52	15	intracortical	intracortical	ADJ
gsrj-62	52	16	administration	administration	NOUN
gsrj-62	52	17	of	of	ADP
gsrj-62	52	18	doi	doi	NOUN
gsrj-62	52	19	without	without	ADP
gsrj-62	52	20	any	any	DET
gsrj-62	52	21	effect	effect	NOUN
gsrj-62	52	22	on	on	ADP
gsrj-62	52	23	gaba	gaba	PROPN
gsrj-62	52	24	or	or	CCONJ
gsrj-62	52	25	glycine	glycine	NOUN
gsrj-62	52	26	levels	level	NOUN
gsrj-62	52	27	,	,	PUNCT
gsrj-62	52	28	thus	thus	ADV
gsrj-62	52	29	increasing	increase	VERB
gsrj-62	52	30	excitatory	excitatory	ADJ
gsrj-62	52	31	neurotransmission	neurotransmission	NOUN
gsrj-62	52	32	and	and	CCONJ
gsrj-62	52	33	activating	activate	VERB
gsrj-62	52	34	nmda	nmda	ADJ
gsrj-62	52	35	receptors	receptor	NOUN
gsrj-62	52	36	and	and	CCONJ
gsrj-62	52	37	ampa	ampa	NOUN
gsrj-62	52	38	receptors	receptor	NOUN
gsrj-62	52	39	downstream	downstream	ADJ
gsrj-62	52	40	(	(	PUNCT
gsrj-62	52	41	figure	figure	VERB
gsrj-62	52	42	5).22	5).22	NOUN
gsrj-62	52	43	however	however	ADV
gsrj-62	52	44	,	,	PUNCT
gsrj-62	52	45	this	this	DET
gsrj-62	52	46	activation	activation	NOUN
gsrj-62	52	47	is	be	AUX
gsrj-62	52	48	not	not	PART
gsrj-62	52	49	only	only	ADV
gsrj-62	52	50	linked	link	VERB
gsrj-62	52	51	to	to	ADP
gsrj-62	52	52	hallucinogenic	hallucinogenic	ADJ
gsrj-62	52	53	“	"	PUNCT
gsrj-62	52	54	behavioral	behavioral	ADJ
gsrj-62	52	55	”	"	PUNCT
gsrj-62	52	56	effects	effect	NOUN
gsrj-62	52	57	(	(	PUNCT
gsrj-62	52	58	such	such	ADJ
gsrj-62	52	59	as	as	ADP
gsrj-62	52	60	head	head	NOUN
gsrj-62	52	61	twitching	twitch	VERB
gsrj-62	52	62	in	in	ADP
gsrj-62	52	63	rats	rat	NOUN
gsrj-62	52	64	and	and	CCONJ
gsrj-62	52	65	mice	mouse	NOUN
gsrj-62	52	66	)	)	PUNCT
gsrj-62	52	67	,	,	PUNCT
gsrj-62	52	68	but	but	CCONJ
gsrj-62	52	69	also	also	ADV
gsrj-62	52	70	,	,	PUNCT
gsrj-62	52	71	as	as	SCONJ
gsrj-62	52	72	mentioned	mention	VERB
gsrj-62	52	73	earlier	early	ADV
gsrj-62	52	74	,	,	PUNCT
gsrj-62	52	75	to	to	ADP
gsrj-62	52	76	the	the	DET
gsrj-62	52	77	release	release	NOUN
gsrj-62	52	78	of	of	ADP
gsrj-62	52	79	the	the	DET
gsrj-62	52	80	transcription	transcription	NOUN
gsrj-62	52	81	factor	factor	NOUN
gsrj-62	52	82	c	c	NOUN
gsrj-62	52	83	-	-	PUNCT
gsrj-62	52	84	fos	fos	NOUN
gsrj-62	52	85	and	and	CCONJ
gsrj-62	52	86	brain	brain	NOUN
gsrj-62	52	87	-	-	PUNCT
gsrj-62	52	88	derived	derive	VERB
gsrj-62	52	89	neurotrophic	neurotrophic	ADJ
gsrj-62	52	90	factor	factor	NOUN
gsrj-62	52	91	(	(	PUNCT
gsrj-62	52	92	bdnf).16,23	bdnf).16,23	PROPN
gsrj-62	52	93	gi	gi	NOUN
gsrj-62	52	94	/	/	SYM
gsrj-62	52	95	o	o	NOUN
gsrj-62	52	96	’s	’s	PART
gsrj-62	52	97	activation	activation	NOUN
gsrj-62	52	98	is	be	AUX
gsrj-62	52	99	linked	link	VERB
gsrj-62	52	100	to	to	PART
gsrj-62	52	101	increased	increase	VERB
gsrj-62	52	102	egr-2	egr-2	PRON
gsrj-62	52	103	expression	expression	NOUN
gsrj-62	52	104	,	,	PUNCT
gsrj-62	52	105	a	a	DET
gsrj-62	52	106	transcription	transcription	NOUN
gsrj-62	52	107	regulatory	regulatory	ADJ
gsrj-62	52	108	factor	factor	NOUN
gsrj-62	52	109	highly	highly	ADV
gsrj-62	52	110	expressed	express	VERB
gsrj-62	52	111	in	in	ADP
gsrj-62	52	112	migrating	migrate	VERB
gsrj-62	52	113	neural	neural	ADJ
gsrj-62	52	114	crest	crest	NOUN
gsrj-62	52	115	cells	cell	NOUN
gsrj-62	52	116	,	,	PUNCT
gsrj-62	52	117	and	and	CCONJ
gsrj-62	52	118	is	be	AUX
gsrj-62	52	119	essential	essential	ADJ
gsrj-62	52	120	for	for	ADP
gsrj-62	52	121	normal	normal	ADJ
gsrj-62	52	122	differentiation	differentiation	NOUN
gsrj-62	52	123	and	and	CCONJ
gsrj-62	52	124	maintenance	maintenance	NOUN
gsrj-62	52	125	of	of	ADP
gsrj-62	52	126	myelinating	myelinate	VERB
gsrj-62	52	127	schwann	schwann	PROPN
gsrj-62	52	128	cells	cell	NOUN
gsrj-62	52	129	,	,	PUNCT
gsrj-62	52	130	which	which	PRON
gsrj-62	52	131	have	have	AUX
gsrj-62	52	132	been	be	AUX
gsrj-62	52	133	found	find	VERB
gsrj-62	52	134	to	to	PART
gsrj-62	52	135	remyelinate	remyelinate	VERB
gsrj-62	52	136	in	in	ADP
gsrj-62	52	137	the	the	DET
gsrj-62	52	138	cns	cns	NOUN
gsrj-62	52	139	under	under	ADP
gsrj-62	52	140	certain	certain	ADJ
gsrj-62	52	141	conditions.24,25	conditions.24,25	NOUN
gsrj-62	52	142	the	the	DET
gsrj-62	52	143	increased	increase	VERB
gsrj-62	52	144	expression	expression	NOUN
gsrj-62	52	145	upon	upon	SCONJ
gsrj-62	52	146	heterocomplex	heterocomplex	ADJ
gsrj-62	52	147	formation	formation	NOUN
gsrj-62	52	148	may	may	AUX
gsrj-62	52	149	be	be	AUX
gsrj-62	52	150	what	what	PRON
gsrj-62	52	151	underlies	underlie	VERB
gsrj-62	52	152	the	the	DET
gsrj-62	52	153	increased	increase	VERB
gsrj-62	52	154	synaptogenesis	synaptogenesis	NOUN
gsrj-62	52	155	seen	see	VERB
gsrj-62	52	156	upon	upon	SCONJ
gsrj-62	52	157	psilocybin	psilocybin	NOUN
gsrj-62	52	158	administration	administration	NOUN
gsrj-62	52	159	in	in	ADP
gsrj-62	52	160	rats	rat	NOUN
gsrj-62	52	161	.	.	PUNCT
gsrj-62	53	1	ffiigguurree	ffiigguurree	NOUN
gsrj-62	53	2	55	55	NUM
gsrj-62	53	3	..	..	PUNCT
gsrj-62	54	1	the	the	DET
gsrj-62	54	2	figure	figure	NOUN
gsrj-62	54	3	shows	show	VERB
gsrj-62	54	4	a	a	DET
gsrj-62	54	5	model	model	NOUN
gsrj-62	54	6	in	in	ADP
gsrj-62	54	7	which	which	PRON
gsrj-62	54	8	hallucinogens	hallucinogen	NOUN
gsrj-62	54	9	,	,	PUNCT
gsrj-62	54	10	such	such	ADJ
gsrj-62	54	11	as	as	ADP
gsrj-62	54	12	psilocin	psilocin	NOUN
gsrj-62	54	13	,	,	PUNCT
gsrj-62	54	14	lysergic	lysergic	NOUN
gsrj-62	54	15	acid	acid	NOUN
gsrj-62	54	16	diethylamide	diethylamide	NOUN
gsrj-62	54	17	(	(	PUNCT
gsrj-62	54	18	lsd	lsd	NOUN
gsrj-62	54	19	)	)	PUNCT
gsrj-62	54	20	and	and	CCONJ
gsrj-62	54	21	dimethyltryptamine	dimethyltryptamine	NOUN
gsrj-62	54	22	(	(	PUNCT
gsrj-62	54	23	dmt	dmt	PROPN
gsrj-62	54	24	)	)	PUNCT
gsrj-62	54	25	,	,	PUNCT
gsrj-62	54	26	increase	increase	VERB
gsrj-62	54	27	extracellular	extracellular	ADJ
gsrj-62	54	28	glutamate	glutamate	NOUN
gsrj-62	54	29	levels	level	NOUN
gsrj-62	54	30	in	in	ADP
gsrj-62	54	31	the	the	DET
gsrj-62	54	32	prefrontal	prefrontal	ADJ
gsrj-62	54	33	cortex	cortex	NOUN
gsrj-62	54	34	through	through	ADP
gsrj-62	54	35	stimulation	stimulation	NOUN
gsrj-62	54	36	of	of	ADP
gsrj-62	54	37	postsynaptic	postsynaptic	ADJ
gsrj-62	54	38	5	5	NUM
gsrj-62	54	39	-	-	PUNCT
gsrj-62	54	40	ht2a	ht2a	NUM
gsrj-62	54	41	receptors	receptor	NOUN
gsrj-62	54	42	that	that	PRON
gsrj-62	54	43	are	be	AUX
gsrj-62	54	44	located	locate	VERB
gsrj-62	54	45	on	on	ADP
gsrj-62	54	46	large	large	ADJ
gsrj-62	54	47	glutamatergic	glutamatergic	ADJ
gsrj-62	54	48	pyramidal	pyramidal	ADJ
gsrj-62	54	49	cells	cell	NOUN
gsrj-62	54	50	in	in	ADP
gsrj-62	54	51	deep	deep	ADJ
gsrj-62	54	52	cortical	cortical	ADJ
gsrj-62	54	53	layers	layer	NOUN
gsrj-62	54	54	(	(	PUNCT
gsrj-62	54	55	v	v	NOUN
gsrj-62	54	56	and	and	CCONJ
gsrj-62	54	57	vi	vi	NOUN
gsrj-62	54	58	)	)	PUNCT
gsrj-62	54	59	projecting	project	VERB
gsrj-62	54	60	to	to	ADP
gsrj-62	54	61	layer	layer	NOUN
gsrj-62	54	62	v	v	NOUN
gsrj-62	54	63	pyramidal	pyramidal	ADJ
gsrj-62	54	64	neurons	neuron	NOUN
gsrj-62	54	65	.	.	PUNCT
gsrj-62	55	1	this	this	DET
gsrj-62	55	2	glutamate	glutamate	ADJ
gsrj-62	55	3	release	release	NOUN
gsrj-62	55	4	leads	lead	VERB
gsrj-62	55	5	to	to	ADP
gsrj-62	55	6	an	an	DET
gsrj-62	55	7	activation	activation	NOUN
gsrj-62	55	8	of	of	ADP
gsrj-62	55	9	ampa	ampa	NOUN
gsrj-62	55	10	(	(	PUNCT
gsrj-62	55	11	α	α	NOUN
gsrj-62	55	12	-	-	PUNCT
gsrj-62	55	13	amino-3	amino-3	NOUN
gsrj-62	55	14	-	-	PUNCT
gsrj-62	55	15	hydroxy-5methyl-4	hydroxy-5methyl-4	ADP
gsrj-62	55	16	-	-	PUNCT
gsrj-62	55	17	isoxazole	isoxazole	NOUN
gsrj-62	55	18	propionic	propionic	ADJ
gsrj-62	55	19	acid	acid	NOUN
gsrj-62	55	20	)	)	PUNCT
gsrj-62	55	21	and	and	CCONJ
gsrj-62	55	22	nmda	nmda	ADJ
gsrj-62	55	23	(	(	PUNCT
gsrj-62	55	24	n	n	CCONJ
gsrj-62	55	25	-	-	PUNCT
gsrj-62	55	26	methyl	methyl	NOUN
gsrj-62	55	27	-	-	PUNCT
gsrj-62	55	28	d	d	NOUN
gsrj-62	55	29	-	-	PUNCT
gsrj-62	55	30	aspartate	aspartate	ADJ
gsrj-62	55	31	)	)	PUNCT
gsrj-62	55	32	receptors	receptor	NOUN
gsrj-62	55	33	on	on	ADP
gsrj-62	55	34	cortical	cortical	ADJ
gsrj-62	55	35	pyramidal	pyramidal	ADJ
gsrj-62	55	36	neurons	neuron	NOUN
gsrj-62	55	37	.	.	PUNCT
gsrj-62	56	1	in	in	ADP
gsrj-62	56	2	addition	addition	NOUN
gsrj-62	56	3	,	,	PUNCT
gsrj-62	56	4	hallucinogens	hallucinogen	NOUN
gsrj-62	56	5	directly	directly	ADV
gsrj-62	56	6	activate	activate	VERB
gsrj-62	56	7	5	5	NUM
gsrj-62	56	8	-	-	PUNCT
gsrj-62	56	9	ht2a	ht2a	NUM
gsrj-62	56	10	receptors	receptor	NOUN
gsrj-62	56	11	located	locate	VERB
gsrj-62	56	12	on	on	ADP
gsrj-62	56	13	cortical	cortical	ADJ
gsrj-62	56	14	pyramidal	pyramidal	ADJ
gsrj-62	56	15	neurons	neuron	NOUN
gsrj-62	56	16	.	.	PUNCT
gsrj-62	57	1	this	this	DET
gsrj-62	57	2	activation	activation	NOUN
gsrj-62	57	3	is	be	AUX
gsrj-62	57	4	thought	think	VERB
gsrj-62	57	5	to	to	PART
gsrj-62	57	6	ultimately	ultimately	ADV
gsrj-62	57	7	lead	lead	VERB
gsrj-62	57	8	to	to	ADP
gsrj-62	57	9	increased	increase	VERB
gsrj-62	57	10	expression	expression	NOUN
gsrj-62	57	11	of	of	ADP
gsrj-62	57	12	bdnf	bdnf	PROPN
gsrj-62	57	13	.	.	PROPN
gsrj-62	58	1	adapted	adapt	VERB
gsrj-62	58	2	from	from	ADP
gsrj-62	58	3	vollenweider	vollenweider	ADV
gsrj-62	58	4	et	et	PROPN
gsrj-62	58	5	al	al	PROPN
gsrj-62	58	6	.	.	PROPN
gsrj-62	58	7	,	,	PUNCT
gsrj-62	58	8	2010.26	2010.26	NUM
gsrj-62	58	9	24	24	NUM
gsrj-62	58	10	georgetown	georgetown	NOUN
gsrj-62	58	11	scientific	scientific	ADJ
gsrj-62	58	12	research	research	NOUN
gsrj-62	58	13	journal	journal	PROPN
gsrj-62	58	14	44	44	NUM
gsrj-62	58	15	..	..	PUNCT
gsrj-62	58	16	ssyynnaappttooggeenneessiiss	ssyynnaappttooggeenneessiiss	PROPN
gsrj-62	58	17	aanndd	aanndd	NOUN
gsrj-62	58	18	ppssiillooccyybbiinn	ppssiillooccyybbiinn	PROPN
gsrj-62	58	19	4.1	4.1	NUM
gsrj-62	58	20	synaptogenesis	synaptogenesis	NOUN
gsrj-62	58	21	in	in	ADP
gsrj-62	58	22	the	the	DET
gsrj-62	58	23	pre	pre	ADJ
gsrj-62	58	24	-	-	ADJ
gsrj-62	58	25	frontal	frontal	ADJ
gsrj-62	58	26	cortex	cortex	NOUN
gsrj-62	58	27	upon	upon	SCONJ
gsrj-62	58	28	psilocybin	psilocybin	NOUN
gsrj-62	58	29	administration	administration	NOUN
gsrj-62	58	30	depression	depression	NOUN
gsrj-62	58	31	is	be	AUX
gsrj-62	58	32	associated	associate	VERB
gsrj-62	58	33	with	with	ADP
gsrj-62	58	34	synaptic	synaptic	ADJ
gsrj-62	58	35	atrophy	atrophy	NOUN
gsrj-62	58	36	of	of	ADP
gsrj-62	58	37	the	the	DET
gsrj-62	58	38	pre	pre	ADJ
gsrj-62	58	39	-	-	ADJ
gsrj-62	58	40	frontal	frontal	ADJ
gsrj-62	58	41	cortex	cortex	NOUN
gsrj-62	58	42	;	;	PUNCT
gsrj-62	58	43	however	however	ADV
gsrj-62	58	44	,	,	PUNCT
gsrj-62	58	45	psilocybin	psilocybin	NOUN
gsrj-62	58	46	may	may	AUX
gsrj-62	58	47	provide	provide	VERB
gsrj-62	58	48	a	a	DET
gsrj-62	58	49	fix	fix	NOUN
gsrj-62	58	50	to	to	ADP
gsrj-62	58	51	such	such	ADJ
gsrj-62	58	52	atrophy.27	atrophy.27	PROPN
gsrj-62	58	53	shao	shao	PROPN
gsrj-62	58	54	et	et	PROPN
gsrj-62	58	55	al	al	PROPN
gsrj-62	58	56	.	.	PROPN
gsrj-62	58	57	investigated	investigate	VERB
gsrj-62	58	58	how	how	SCONJ
gsrj-62	58	59	a	a	DET
gsrj-62	58	60	single	single	ADJ
gsrj-62	58	61	dose	dose	NOUN
gsrj-62	58	62	of	of	ADP
gsrj-62	58	63	psilocybin	psilocybin	NOUN
gsrj-62	58	64	can	can	AUX
gsrj-62	58	65	lead	lead	VERB
gsrj-62	58	66	to	to	ADP
gsrj-62	58	67	rapid	rapid	ADJ
gsrj-62	58	68	and	and	CCONJ
gsrj-62	58	69	persistent	persistent	ADJ
gsrj-62	58	70	growth	growth	NOUN
gsrj-62	58	71	of	of	ADP
gsrj-62	58	72	dendritic	dendritic	ADJ
gsrj-62	58	73	spines	spine	NOUN
gsrj-62	58	74	in	in	ADP
gsrj-62	58	75	the	the	DET
gsrj-62	58	76	frontal	frontal	ADJ
gsrj-62	58	77	cortex	cortex	NOUN
gsrj-62	58	78	of	of	ADP
gsrj-62	58	79	mice	mouse	NOUN
gsrj-62	58	80	(	(	PUNCT
gsrj-62	58	81	cg1	cg1	NOUN
gsrj-62	58	82	/	/	SYM
gsrj-62	58	83	m2	m2	PROPN
gsrj-62	58	84	)	)	PUNCT
gsrj-62	58	85	,	,	PUNCT
gsrj-62	58	86	possibly	possibly	ADV
gsrj-62	58	87	reversing	reverse	VERB
gsrj-62	58	88	the	the	DET
gsrj-62	58	89	synaptic	synaptic	ADJ
gsrj-62	58	90	atrophy	atrophy	NOUN
gsrj-62	58	91	associated	associate	VERB
gsrj-62	58	92	with	with	ADP
gsrj-62	58	93	depression.28	depression.28	NOUN
gsrj-62	58	94	dendritic	dendritic	ADJ
gsrj-62	58	95	spines	spine	NOUN
gsrj-62	58	96	are	be	AUX
gsrj-62	58	97	small	small	ADJ
gsrj-62	58	98	protrusions	protrusion	NOUN
gsrj-62	58	99	from	from	ADP
gsrj-62	58	100	neuronal	neuronal	ADJ
gsrj-62	58	101	dendrites	dendrite	NOUN
gsrj-62	58	102	that	that	PRON
gsrj-62	58	103	receive	receive	VERB
gsrj-62	58	104	input	input	NOUN
gsrj-62	58	105	from	from	ADP
gsrj-62	58	106	an	an	DET
gsrj-62	58	107	axon	axon	NOUN
gsrj-62	58	108	at	at	ADP
gsrj-62	58	109	the	the	DET
gsrj-62	58	110	synapse	synapse	NOUN
gsrj-62	58	111	.	.	PUNCT
gsrj-62	59	1	they	they	PRON
gsrj-62	59	2	are	be	AUX
gsrj-62	59	3	the	the	DET
gsrj-62	59	4	primary	primary	ADJ
gsrj-62	59	5	site	site	NOUN
gsrj-62	59	6	of	of	ADP
gsrj-62	59	7	glutamatergic	glutamatergic	ADJ
gsrj-62	59	8	and	and	CCONJ
gsrj-62	59	9	excitatory	excitatory	ADJ
gsrj-62	59	10	neurotransmission	neurotransmission	NOUN
gsrj-62	59	11	in	in	ADP
gsrj-62	59	12	the	the	DET
gsrj-62	59	13	brain	brain	NOUN
gsrj-62	59	14	and	and	CCONJ
gsrj-62	59	15	serve	serve	VERB
gsrj-62	59	16	to	to	PART
gsrj-62	59	17	maximize	maximize	VERB
gsrj-62	59	18	contact	contact	NOUN
gsrj-62	59	19	between	between	ADP
gsrj-62	59	20	neurons	neuron	NOUN
gsrj-62	59	21	.	.	PUNCT
gsrj-62	60	1	researchers	researcher	NOUN
gsrj-62	60	2	dosed	dose	VERB
gsrj-62	60	3	mice	mouse	NOUN
gsrj-62	60	4	with	with	ADP
gsrj-62	60	5	1mg	1mg	PROPN
gsrj-62	60	6	/	/	SYM
gsrj-62	60	7	kg	kg	PROPN
gsrj-62	60	8	of	of	ADP
gsrj-62	60	9	psilocybin	psilocybin	NOUN
gsrj-62	60	10	and	and	CCONJ
gsrj-62	60	11	analyzed	analyze	VERB
gsrj-62	60	12	the	the	DET
gsrj-62	60	13	turnover	turnover	NOUN
gsrj-62	60	14	of	of	ADP
gsrj-62	60	15	dendritic	dendritic	ADJ
gsrj-62	60	16	spines	spine	NOUN
gsrj-62	60	17	.	.	PUNCT
gsrj-62	61	1	interestingly	interestingly	ADV
gsrj-62	61	2	,	,	PUNCT
gsrj-62	61	3	dendritic	dendritic	ADJ
gsrj-62	61	4	spine	spine	ADJ
gsrj-62	61	5	formation	formation	NOUN
gsrj-62	61	6	increased	increase	VERB
gsrj-62	61	7	significantly	significantly	ADV
gsrj-62	61	8	in	in	ADP
gsrj-62	61	9	both	both	DET
gsrj-62	61	10	males	male	NOUN
gsrj-62	61	11	and	and	CCONJ
gsrj-62	61	12	females	female	NOUN
gsrj-62	61	13	,	,	PUNCT
gsrj-62	61	14	but	but	CCONJ
gsrj-62	61	15	the	the	DET
gsrj-62	61	16	spine	spine	ADJ
gsrj-62	61	17	formation	formation	NOUN
gsrj-62	61	18	of	of	ADP
gsrj-62	61	19	females	female	NOUN
gsrj-62	61	20	increased	increase	VERB
gsrj-62	61	21	by	by	ADP
gsrj-62	61	22	nearly	nearly	ADV
gsrj-62	61	23	double	double	DET
gsrj-62	61	24	that	that	PRON
gsrj-62	61	25	of	of	ADP
gsrj-62	61	26	males’.28	males’.28	NOUN
gsrj-62	61	27	additionally	additionally	ADV
gsrj-62	61	28	,	,	PUNCT
gsrj-62	61	29	there	there	PRON
gsrj-62	61	30	was	be	VERB
gsrj-62	61	31	no	no	DET
gsrj-62	61	32	significant	significant	ADJ
gsrj-62	61	33	change	change	NOUN
gsrj-62	61	34	in	in	ADP
gsrj-62	61	35	the	the	DET
gsrj-62	61	36	rate	rate	NOUN
gsrj-62	61	37	of	of	ADP
gsrj-62	61	38	spine	spine	ADJ
gsrj-62	61	39	elimination	elimination	NOUN
gsrj-62	61	40	,	,	PUNCT
gsrj-62	61	41	suggesting	suggest	VERB
gsrj-62	61	42	a	a	DET
gsrj-62	61	43	net	net	ADJ
gsrj-62	61	44	-	-	PUNCT
gsrj-62	61	45	positive	positive	ADJ
gsrj-62	61	46	growth	growth	NOUN
gsrj-62	61	47	rate	rate	NOUN
gsrj-62	61	48	in	in	ADP
gsrj-62	61	49	both	both	DET
gsrj-62	61	50	males	male	NOUN
gsrj-62	61	51	and	and	CCONJ
gsrj-62	61	52	females	female	NOUN
gsrj-62	61	53	.	.	PUNCT
gsrj-62	62	1	due	due	ADP
gsrj-62	62	2	to	to	ADP
gsrj-62	62	3	the	the	DET
gsrj-62	62	4	deficit	deficit	NOUN
gsrj-62	62	5	of	of	ADP
gsrj-62	62	6	synapses	synapsis	NOUN
gsrj-62	62	7	in	in	ADP
gsrj-62	62	8	the	the	DET
gsrj-62	62	9	pre	pre	ADJ
gsrj-62	62	10	-	-	ADJ
gsrj-62	62	11	frontal	frontal	ADJ
gsrj-62	62	12	cortex	cortex	NOUN
gsrj-62	62	13	,	,	PUNCT
gsrj-62	62	14	spine	spine	ADJ
gsrj-62	62	15	formation	formation	NOUN
gsrj-62	62	16	could	could	AUX
gsrj-62	62	17	lead	lead	VERB
gsrj-62	62	18	to	to	ADP
gsrj-62	62	19	new	new	ADJ
gsrj-62	62	20	neural	neural	ADJ
gsrj-62	62	21	connections	connection	NOUN
gsrj-62	62	22	that	that	PRON
gsrj-62	62	23	may	may	AUX
gsrj-62	62	24	alleviate	alleviate	VERB
gsrj-62	62	25	symptoms	symptom	NOUN
gsrj-62	62	26	of	of	ADP
gsrj-62	62	27	depression	depression	NOUN
gsrj-62	62	28	.	.	PUNCT
gsrj-62	63	1	this	this	PRON
gsrj-62	63	2	is	be	AUX
gsrj-62	63	3	significant	significant	ADJ
gsrj-62	63	4	because	because	SCONJ
gsrj-62	63	5	if	if	SCONJ
gsrj-62	63	6	these	these	DET
gsrj-62	63	7	results	result	NOUN
gsrj-62	63	8	can	can	AUX
gsrj-62	63	9	be	be	AUX
gsrj-62	63	10	replicated	replicate	VERB
gsrj-62	63	11	in	in	ADP
gsrj-62	63	12	humans	human	NOUN
gsrj-62	63	13	,	,	PUNCT
gsrj-62	63	14	it	it	PRON
gsrj-62	63	15	could	could	AUX
gsrj-62	63	16	provide	provide	VERB
gsrj-62	63	17	a	a	DET
gsrj-62	63	18	possible	possible	ADJ
gsrj-62	63	19	molecular	molecular	ADJ
gsrj-62	63	20	explanation	explanation	NOUN
gsrj-62	63	21	to	to	ADP
gsrj-62	63	22	the	the	DET
gsrj-62	63	23	alleviation	alleviation	NOUN
gsrj-62	63	24	of	of	ADP
gsrj-62	63	25	depressive	depressive	ADJ
gsrj-62	63	26	symptoms	symptom	NOUN
gsrj-62	63	27	commonly	commonly	ADV
gsrj-62	63	28	associated	associate	VERB
gsrj-62	63	29	with	with	ADP
gsrj-62	63	30	hallucinogenics	hallucinogenic	NOUN
gsrj-62	63	31	.	.	PUNCT
gsrj-62	64	1	the	the	DET
gsrj-62	64	2	highest	high	ADJ
gsrj-62	64	3	rate	rate	NOUN
gsrj-62	64	4	of	of	ADP
gsrj-62	64	5	dendritic	dendritic	ADJ
gsrj-62	64	6	spine	spine	ADJ
gsrj-62	64	7	formation	formation	NOUN
gsrj-62	64	8	occurred	occur	VERB
gsrj-62	64	9	a	a	DET
gsrj-62	64	10	day	day	NOUN
gsrj-62	64	11	after	after	ADP
gsrj-62	64	12	administration	administration	NOUN
gsrj-62	64	13	;	;	PUNCT
gsrj-62	64	14	however	however	ADV
gsrj-62	64	15	,	,	PUNCT
gsrj-62	64	16	spine	spine	ADJ
gsrj-62	64	17	formation	formation	NOUN
gsrj-62	64	18	increased	increase	VERB
gsrj-62	64	19	up	up	ADP
gsrj-62	64	20	to	to	PART
gsrj-62	64	21	7	7	NUM
gsrj-62	64	22	days	day	NOUN
gsrj-62	64	23	after	after	ADP
gsrj-62	64	24	administration	administration	NOUN
gsrj-62	64	25	suggesting	suggest	VERB
gsrj-62	64	26	that	that	SCONJ
gsrj-62	64	27	psilocybin	psilocybin	NOUN
gsrj-62	64	28	has	have	VERB
gsrj-62	64	29	an	an	DET
gsrj-62	64	30	extended	extended	ADJ
gsrj-62	64	31	ability	ability	NOUN
gsrj-62	64	32	to	to	PART
gsrj-62	64	33	increase	increase	VERB
gsrj-62	64	34	spine	spine	ADJ
gsrj-62	64	35	formation	formation	NOUN
gsrj-62	64	36	postadministration	postadministration	NOUN
gsrj-62	64	37	.	.	PUNCT
gsrj-62	65	1	to	to	PART
gsrj-62	65	2	further	far	ADV
gsrj-62	65	3	investigate	investigate	VERB
gsrj-62	65	4	,	,	PUNCT
gsrj-62	65	5	researchers	researcher	NOUN
gsrj-62	65	6	imaged	image	VERB
gsrj-62	65	7	the	the	DET
gsrj-62	65	8	new	new	ADJ
gsrj-62	65	9	spines	spine	NOUN
gsrj-62	65	10	that	that	PRON
gsrj-62	65	11	formed	form	VERB
gsrj-62	65	12	34	34	NUM
gsrj-62	65	13	days	day	NOUN
gsrj-62	65	14	later	later	ADV
gsrj-62	65	15	and	and	CCONJ
gsrj-62	65	16	found	find	VERB
gsrj-62	65	17	approximately	approximately	ADV
gsrj-62	65	18	a	a	DET
gsrj-62	65	19	third	third	NOUN
gsrj-62	65	20	of	of	ADP
gsrj-62	65	21	psilocybinprovoked	psilocybinprovoke	VERB
gsrj-62	65	22	new	new	ADJ
gsrj-62	65	23	spines	spine	NOUN
gsrj-62	65	24	persisted	persist	VERB
gsrj-62	65	25	in	in	ADP
gsrj-62	65	26	growth	growth	NOUN
gsrj-62	65	27	(	(	PUNCT
gsrj-62	65	28	34	34	NUM
gsrj-62	65	29	%	%	NOUN
gsrj-62	65	30	±	±	NUM
gsrj-62	65	31	10	10	NUM
gsrj-62	65	32	%	%	NOUN
gsrj-62	65	33	for	for	ADP
gsrj-62	65	34	females	female	NOUN
gsrj-62	65	35	and	and	CCONJ
gsrj-62	65	36	37	37	NUM
gsrj-62	65	37	%	%	NOUN
gsrj-62	65	38	±	±	NUM
gsrj-62	65	39	12	12	NUM
gsrj-62	65	40	%	%	NOUN
gsrj-62	65	41	for	for	ADP
gsrj-62	65	42	males).28	males).28	NOUN
gsrj-62	65	43	these	these	DET
gsrj-62	65	44	findings	finding	NOUN
gsrj-62	65	45	are	be	AUX
gsrj-62	65	46	novel	novel	ADJ
gsrj-62	65	47	and	and	CCONJ
gsrj-62	65	48	significant	significant	ADJ
gsrj-62	65	49	,	,	PUNCT
gsrj-62	65	50	considering	consider	VERB
gsrj-62	65	51	there	there	PRON
gsrj-62	65	52	has	have	AUX
gsrj-62	65	53	been	be	AUX
gsrj-62	65	54	no	no	DET
gsrj-62	65	55	direct	direct	ADJ
gsrj-62	65	56	demonstration	demonstration	NOUN
gsrj-62	65	57	in	in	ADP
gsrj-62	65	58	the	the	DET
gsrj-62	65	59	past	past	NOUN
gsrj-62	65	60	of	of	ADP
gsrj-62	65	61	psilocybin	psilocybin	NOUN
gsrj-62	65	62	-	-	PUNCT
gsrj-62	65	63	induced	induce	VERB
gsrj-62	65	64	structural	structural	ADJ
gsrj-62	65	65	plasticity	plasticity	NOUN
gsrj-62	65	66	observed	observe	VERB
gsrj-62	65	67	at	at	ADP
gsrj-62	65	68	the	the	DET
gsrj-62	65	69	cellular	cellular	ADJ
gsrj-62	65	70	level	level	NOUN
gsrj-62	65	71	in	in	ADP
gsrj-62	65	72	mammalian	mammalian	ADJ
gsrj-62	65	73	brains	brain	NOUN
gsrj-62	65	74	.	.	PUNCT
gsrj-62	66	1	ffiigguurree	ffiigguurree	NOUN
gsrj-62	66	2	66	66	NUM
gsrj-62	66	3	..	..	PUNCT
gsrj-62	66	4	ddeennddrriittiicc	ddeennddrriittiicc	NOUN
gsrj-62	66	5	ssppiinnee	ssppiinnee	NOUN
gsrj-62	66	6	ffoorrmmaattiioonn	ffoorrmmaattiioonn	NOUN
gsrj-62	66	7	rraattee	rraattee	PROPN
gsrj-62	66	8	ppeerrssiissttss	ppeerrssiissttss	NOUN
gsrj-62	66	9	ffoorr	ffoorr	PROPN
gsrj-62	66	10	uupp	uupp	PROPN
gsrj-62	66	11	ttoo	ttoo	PROPN
gsrj-62	66	12	77	77	NUM
gsrj-62	66	13	ddaayyss	ddaayyss	NOUN
gsrj-62	66	14	aafftteerr	aafftteerr	PROPN
gsrj-62	66	15	ttrreeaattmmeenntt	ttrreeaattmmeenntt	PROPN
gsrj-62	66	16	wwiitthh	wwiitthh	ADJ
gsrj-62	66	17	nnoo	nnoo	PROPN
gsrj-62	66	18	ssiiggnniiffiiccaanntt	ssiiggnniiffiiccaanntt	PROPN
gsrj-62	66	19	nneett	nneett	PROPN
gsrj-62	66	20	cchhaannggee	cchhaannggee	PROPN
gsrj-62	66	21	iinn	iinn	PROPN
gsrj-62	66	22	ssppiinnee	ssppiinnee	PROPN
gsrj-62	66	23	eelliimmiinnaattiioonn	eelliimmiinnaattiioonn	PROPN
gsrj-62	66	24	rraattee	rraattee	NOUN
gsrj-62	66	25	.	.	PUNCT
gsrj-62	67	1	mice	mouse	NOUN
gsrj-62	67	2	(	(	PUNCT
gsrj-62	67	3	cg1	cg1	NOUN
gsrj-62	67	4	/	/	SYM
gsrj-62	67	5	m2	m2	PROPN
gsrj-62	67	6	)	)	PUNCT
gsrj-62	67	7	were	be	AUX
gsrj-62	67	8	dosed	dose	VERB
gsrj-62	67	9	with	with	ADP
gsrj-62	67	10	1mg	1mg	PROPN
gsrj-62	67	11	/	/	SYM
gsrj-62	67	12	kg	kg	PROPN
gsrj-62	67	13	of	of	ADP
gsrj-62	67	14	psilocybin	psilocybin	NOUN
gsrj-62	67	15	.	.	PUNCT
gsrj-62	68	1	after	after	SCONJ
gsrj-62	68	2	7	7	NUM
gsrj-62	68	3	days	day	NOUN
gsrj-62	68	4	spine	spine	ADJ
gsrj-62	68	5	formation	formation	NOUN
gsrj-62	68	6	rate	rate	NOUN
gsrj-62	68	7	was	be	AUX
gsrj-62	68	8	greater	great	ADJ
gsrj-62	68	9	in	in	ADP
gsrj-62	68	10	dosed	dose	VERB
gsrj-62	68	11	mice	mouse	NOUN
gsrj-62	68	12	compared	compare	VERB
gsrj-62	68	13	to	to	AUX
gsrj-62	68	14	control	control	VERB
gsrj-62	68	15	mice	mouse	NOUN
gsrj-62	68	16	.	.	PUNCT
gsrj-62	69	1	spine	spine	ADJ
gsrj-62	69	2	formation	formation	NOUN
gsrj-62	69	3	rate	rate	NOUN
gsrj-62	69	4	was	be	AUX
gsrj-62	69	5	nearly	nearly	ADV
gsrj-62	69	6	double	double	ADJ
gsrj-62	69	7	in	in	ADP
gsrj-62	69	8	females	female	NOUN
gsrj-62	69	9	compared	compare	VERB
gsrj-62	69	10	to	to	ADP
gsrj-62	69	11	males	male	NOUN
gsrj-62	69	12	.	.	PUNCT
gsrj-62	70	1	additionally	additionally	ADV
gsrj-62	70	2	,	,	PUNCT
gsrj-62	70	3	spine	spine	ADJ
gsrj-62	70	4	elimination	elimination	NOUN
gsrj-62	70	5	rate	rate	NOUN
gsrj-62	70	6	did	do	AUX
gsrj-62	70	7	not	not	PART
gsrj-62	70	8	significantly	significantly	ADV
gsrj-62	70	9	change	change	VERB
gsrj-62	70	10	.	.	PUNCT
gsrj-62	71	1	adapted	adapt	VERB
gsrj-62	71	2	from	from	ADP
gsrj-62	71	3	shao	shao	PROPN
gsrj-62	71	4	et	et	PROPN
gsrj-62	71	5	al	al	PROPN
gsrj-62	71	6	.	.	PROPN
gsrj-62	71	7	,	,	PUNCT
gsrj-62	71	8	2021.28	2021.28	NUM
gsrj-62	71	9	then	then	ADV
gsrj-62	71	10	,	,	PUNCT
gsrj-62	71	11	researchers	researcher	NOUN
gsrj-62	71	12	attempted	attempt	VERB
gsrj-62	71	13	to	to	PART
gsrj-62	71	14	replicate	replicate	VERB
gsrj-62	71	15	the	the	DET
gsrj-62	71	16	above	above	ADJ
gsrj-62	71	17	findings	finding	NOUN
gsrj-62	71	18	in	in	ADP
gsrj-62	71	19	a	a	DET
gsrj-62	71	20	separate	separate	ADJ
gsrj-62	71	21	cohort	cohort	NOUN
gsrj-62	71	22	of	of	ADP
gsrj-62	71	23	mice	mouse	NOUN
gsrj-62	71	24	(	(	PUNCT
gsrj-62	71	25	thyg1	thyg1	NOUN
gsrj-62	71	26	mouse	mouse	NOUN
gsrj-62	71	27	)	)	PUNCT
gsrj-62	71	28	and	and	CCONJ
gsrj-62	71	29	found	find	VERB
gsrj-62	71	30	similar	similar	ADJ
gsrj-62	71	31	results	result	NOUN
gsrj-62	71	32	.	.	PUNCT
gsrj-62	72	1	by	by	ADP
gsrj-62	72	2	integrating	integrate	VERB
gsrj-62	72	3	data	datum	NOUN
gsrj-62	72	4	from	from	ADP
gsrj-62	72	5	these	these	DET
gsrj-62	72	6	two	two	NUM
gsrj-62	72	7	cohorts	cohort	NOUN
gsrj-62	72	8	,	,	PUNCT
gsrj-62	72	9	researchers	researcher	NOUN
gsrj-62	72	10	were	be	AUX
gsrj-62	72	11	able	able	ADJ
gsrj-62	72	12	to	to	PART
gsrj-62	72	13	conclude	conclude	VERB
gsrj-62	72	14	that	that	SCONJ
gsrj-62	72	15	a	a	DET
gsrj-62	72	16	single	single	ADJ
gsrj-62	72	17	dose	dose	NOUN
gsrj-62	72	18	of	of	ADP
gsrj-62	72	19	psilocybin	psilocybin	NOUN
gsrj-62	72	20	initiated	initiate	VERB
gsrj-62	72	21	dendritic	dendritic	ADJ
gsrj-62	72	22	spine	spine	ADJ
gsrj-62	72	23	growth	growth	NOUN
gsrj-62	72	24	in	in	ADP
gsrj-62	72	25	the	the	DET
gsrj-62	72	26	medial	medial	ADJ
gsrj-62	72	27	frontal	frontal	ADJ
gsrj-62	72	28	cortex	cortex	NOUN
gsrj-62	72	29	of	of	ADP
gsrj-62	72	30	the	the	DET
gsrj-62	72	31	mouse.28	mouse.28	NOUN
gsrj-62	72	32	given	give	VERB
gsrj-62	72	33	that	that	DET
gsrj-62	72	34	synaptic	synaptic	ADJ
gsrj-62	72	35	atrophy	atrophy	NOUN
gsrj-62	72	36	is	be	AUX
gsrj-62	72	37	associated	associate	VERB
gsrj-62	72	38	with	with	ADP
gsrj-62	72	39	depression	depression	NOUN
gsrj-62	72	40	,	,	PUNCT
gsrj-62	72	41	these	these	DET
gsrj-62	72	42	results	result	NOUN
gsrj-62	72	43	have	have	VERB
gsrj-62	72	44	potential	potential	NOUN
gsrj-62	72	45	to	to	PART
gsrj-62	72	46	revolutionize	revolutionize	VERB
gsrj-62	72	47	psilocybin	psilocybin	NOUN
gsrj-62	72	48	’s	’s	PART
gsrj-62	72	49	use	use	NOUN
gsrj-62	72	50	as	as	ADP
gsrj-62	72	51	an	an	DET
gsrj-62	72	52	antidepressant	antidepressant	NOUN
gsrj-62	72	53	.	.	PUNCT
gsrj-62	73	1	however	however	ADV
gsrj-62	73	2	,	,	PUNCT
gsrj-62	73	3	many	many	ADJ
gsrj-62	73	4	questions	question	NOUN
gsrj-62	73	5	remain	remain	VERB
gsrj-62	73	6	before	before	SCONJ
gsrj-62	73	7	psilocybin	psilocybin	NOUN
gsrj-62	73	8	can	can	AUX
gsrj-62	73	9	become	become	VERB
gsrj-62	73	10	an	an	DET
gsrj-62	73	11	approved	approve	VERB
gsrj-62	73	12	treatment	treatment	NOUN
gsrj-62	73	13	for	for	ADP
gsrj-62	73	14	depression	depression	NOUN
gsrj-62	73	15	.	.	PUNCT
gsrj-62	74	1	for	for	ADP
gsrj-62	74	2	example	example	NOUN
gsrj-62	74	3	,	,	PUNCT
gsrj-62	74	4	female	female	ADJ
gsrj-62	74	5	mice	mouse	NOUN
gsrj-62	74	6	experienced	experience	VERB
gsrj-62	74	7	a	a	DET
gsrj-62	74	8	much	much	ADV
gsrj-62	74	9	higher	high	ADJ
gsrj-62	74	10	spine	spine	ADJ
gsrj-62	74	11	formation	formation	NOUN
gsrj-62	74	12	than	than	ADP
gsrj-62	74	13	male	male	ADJ
gsrj-62	74	14	mice	mouse	NOUN
gsrj-62	74	15	in	in	ADP
gsrj-62	74	16	this	this	DET
gsrj-62	74	17	experiment	experiment	NOUN
gsrj-62	74	18	.	.	PUNCT
gsrj-62	75	1	perhaps	perhaps	ADV
gsrj-62	75	2	biological	biological	ADJ
gsrj-62	75	3	sex	sex	NOUN
gsrj-62	75	4	plays	play	VERB
gsrj-62	75	5	a	a	DET
gsrj-62	75	6	role	role	NOUN
gsrj-62	75	7	in	in	ADP
gsrj-62	75	8	the	the	DET
gsrj-62	75	9	effectiveness	effectiveness	NOUN
gsrj-62	75	10	of	of	ADP
gsrj-62	75	11	psilocybin	psilocybin	NOUN
gsrj-62	75	12	on	on	ADP
gsrj-62	75	13	spine	spine	ADJ
gsrj-62	75	14	formation	formation	NOUN
gsrj-62	75	15	.	.	PUNCT
gsrj-62	76	1	research	research	NOUN
gsrj-62	76	2	on	on	ADP
gsrj-62	76	3	human	human	ADJ
gsrj-62	76	4	models	model	NOUN
gsrj-62	76	5	is	be	AUX
gsrj-62	76	6	essential	essential	ADJ
gsrj-62	76	7	to	to	ADP
gsrj-62	76	8	further	further	ADJ
gsrj-62	76	9	understanding	understanding	NOUN
gsrj-62	76	10	of	of	ADP
gsrj-62	76	11	how	how	SCONJ
gsrj-62	76	12	psilocybin	psilocybin	NOUN
gsrj-62	76	13	affects	affect	VERB
gsrj-62	76	14	depression	depression	NOUN
gsrj-62	76	15	at	at	ADP
gsrj-62	76	16	the	the	DET
gsrj-62	76	17	molecular	molecular	ADJ
gsrj-62	76	18	level	level	NOUN
gsrj-62	76	19	and	and	CCONJ
gsrj-62	76	20	its	its	PRON
gsrj-62	76	21	potential	potential	ADJ
gsrj-62	76	22	effects	effect	NOUN
gsrj-62	76	23	as	as	ADP
gsrj-62	76	24	a	a	DET
gsrj-62	76	25	depression	depression	NOUN
gsrj-62	76	26	treatment	treatment	NOUN
gsrj-62	76	27	.	.	PUNCT
gsrj-62	77	1	25	25	NUM
gsrj-62	77	2	georgetown	georgetown	PROPN
gsrj-62	77	3	scientific	scientific	ADJ
gsrj-62	77	4	research	research	NOUN
gsrj-62	77	5	journal	journal	PROPN
gsrj-62	77	6	4.2	4.2	NUM
gsrj-62	77	7	hypothesis	hypothesis	NOUN
gsrj-62	77	8	to	to	PART
gsrj-62	77	9	synaptogenesis	synaptogenesis	NOUN
gsrj-62	77	10	caused	cause	VERB
gsrj-62	77	11	by	by	ADP
gsrj-62	77	12	psilocybin	psilocybin	NOUN
gsrj-62	77	13	as	as	ADP
gsrj-62	77	14	previously	previously	ADV
gsrj-62	77	15	mentioned	mention	VERB
gsrj-62	77	16	,	,	PUNCT
gsrj-62	77	17	major	major	ADJ
gsrj-62	77	18	depressive	depressive	ADJ
gsrj-62	77	19	disorder	disorder	NOUN
gsrj-62	77	20	has	have	AUX
gsrj-62	77	21	been	be	AUX
gsrj-62	77	22	linked	link	VERB
gsrj-62	77	23	to	to	PART
gsrj-62	77	24	synaptogenesis	synaptogenesis	VERB
gsrj-62	77	25	disruption	disruption	NOUN
gsrj-62	77	26	including	include	VERB
gsrj-62	77	27	loss	loss	NOUN
gsrj-62	77	28	of	of	ADP
gsrj-62	77	29	neurotrophic	neurotrophic	ADJ
gsrj-62	77	30	factor	factor	NOUN
gsrj-62	77	31	support.29	support.29	NOUN
gsrj-62	77	32	antidepressants	antidepressant	NOUN
gsrj-62	77	33	have	have	AUX
gsrj-62	77	34	shown	show	VERB
gsrj-62	77	35	to	to	PART
gsrj-62	77	36	increase	increase	VERB
gsrj-62	77	37	synaptogenesis	synaptogenesis	NOUN
gsrj-62	77	38	and	and	CCONJ
gsrj-62	77	39	plasticity	plasticity	NOUN
gsrj-62	77	40	;	;	PUNCT
gsrj-62	77	41	however	however	ADV
gsrj-62	77	42	,	,	PUNCT
gsrj-62	77	43	the	the	DET
gsrj-62	77	44	underlying	underlie	VERB
gsrj-62	77	45	mechanisms	mechanism	NOUN
gsrj-62	77	46	by	by	ADP
gsrj-62	77	47	which	which	PRON
gsrj-62	77	48	this	this	PRON
gsrj-62	77	49	occurs	occur	VERB
gsrj-62	77	50	has	have	AUX
gsrj-62	77	51	not	not	PART
gsrj-62	77	52	been	be	AUX
gsrj-62	77	53	investigated	investigate	VERB
gsrj-62	77	54	,	,	PUNCT
gsrj-62	77	55	likely	likely	ADJ
gsrj-62	77	56	because	because	SCONJ
gsrj-62	77	57	it	it	PRON
gsrj-62	77	58	is	be	AUX
gsrj-62	77	59	a	a	DET
gsrj-62	77	60	combination	combination	NOUN
gsrj-62	77	61	of	of	ADP
gsrj-62	77	62	complex	complex	ADJ
gsrj-62	77	63	and	and	CCONJ
gsrj-62	77	64	interconnected	interconnected	ADJ
gsrj-62	77	65	mechanisms	mechanism	NOUN
gsrj-62	77	66	.	.	PUNCT
gsrj-62	78	1	psilocybin	psilocybin	PROPN
gsrj-62	78	2	’s	’s	PART
gsrj-62	78	3	analogous	analogous	ADJ
gsrj-62	78	4	effect	effect	NOUN
gsrj-62	78	5	to	to	ADP
gsrj-62	78	6	antidepressants	antidepressant	NOUN
gsrj-62	78	7	provides	provide	VERB
gsrj-62	78	8	a	a	DET
gsrj-62	78	9	new	new	ADJ
gsrj-62	78	10	avenue	avenue	NOUN
gsrj-62	78	11	to	to	PART
gsrj-62	78	12	investigate	investigate	VERB
gsrj-62	78	13	the	the	DET
gsrj-62	78	14	mechanisms	mechanism	NOUN
gsrj-62	78	15	that	that	PRON
gsrj-62	78	16	underlie	underlie	VERB
gsrj-62	78	17	synaptogenesis	synaptogenesis	NOUN
gsrj-62	78	18	and	and	CCONJ
gsrj-62	78	19	plasticity	plasticity	NOUN
gsrj-62	78	20	upon	upon	SCONJ
gsrj-62	78	21	serotonin	serotonin	NOUN
gsrj-62	78	22	receptor	receptor	NOUN
gsrj-62	78	23	activation	activation	NOUN
gsrj-62	78	24	.	.	PUNCT
gsrj-62	79	1	one	one	NUM
gsrj-62	79	2	such	such	ADJ
gsrj-62	79	3	factor	factor	NOUN
gsrj-62	79	4	that	that	PRON
gsrj-62	79	5	may	may	AUX
gsrj-62	79	6	be	be	AUX
gsrj-62	79	7	involved	involve	VERB
gsrj-62	79	8	is	be	AUX
gsrj-62	79	9	egr-2	egr-2	X
gsrj-62	79	10	,	,	PUNCT
gsrj-62	79	11	specifically	specifically	ADV
gsrj-62	79	12	in	in	ADP
gsrj-62	79	13	its	its	PRON
gsrj-62	79	14	relation	relation	NOUN
gsrj-62	79	15	to	to	ADP
gsrj-62	79	16	hallucinogen	hallucinogen	NOUN
gsrj-62	79	17	generated	generate	VERB
gsrj-62	79	18	synaptogenesis	synaptogenesis	NOUN
gsrj-62	79	19	and	and	CCONJ
gsrj-62	79	20	plasticity	plasticity	NOUN
gsrj-62	79	21	.	.	PUNCT
gsrj-62	80	1	moreno	moreno	PROPN
gsrj-62	80	2	et	et	PROPN
gsrj-62	80	3	.	.	PUNCT
gsrj-62	81	1	al	al	PROPN
gsrj-62	81	2	.	.	PROPN
gsrj-62	81	3	showed	show	VERB
gsrj-62	81	4	that	that	DET
gsrj-62	81	5	mglur2	mglur2	NOUN
gsrj-62	81	6	ko	ko	NOUN
gsrj-62	81	7	mice	mouse	NOUN
gsrj-62	81	8	did	do	AUX
gsrj-62	81	9	not	not	PART
gsrj-62	81	10	express	express	VERB
gsrj-62	81	11	egr-2	egr-2	ADV
gsrj-62	81	12	,	,	PUNCT
gsrj-62	81	13	indicating	indicate	VERB
gsrj-62	81	14	that	that	SCONJ
gsrj-62	81	15	this	this	DET
gsrj-62	81	16	transcription	transcription	NOUN
gsrj-62	81	17	factor	factor	NOUN
gsrj-62	81	18	relies	rely	VERB
gsrj-62	81	19	on	on	ADP
gsrj-62	81	20	mglur2	mglur2	NOUN
gsrj-62	81	21	complex	complex	ADJ
gsrj-62	81	22	formation.16	formation.16	PROPN
gsrj-62	81	23	very	very	ADV
gsrj-62	81	24	little	little	ADJ
gsrj-62	81	25	research	research	NOUN
gsrj-62	81	26	has	have	AUX
gsrj-62	81	27	been	be	AUX
gsrj-62	81	28	done	do	VERB
gsrj-62	81	29	on	on	ADP
gsrj-62	81	30	egr-2	egr-2	PUNCT
gsrj-62	81	31	as	as	SCONJ
gsrj-62	81	32	more	more	ADJ
gsrj-62	81	33	focus	focus	NOUN
gsrj-62	81	34	has	have	AUX
gsrj-62	81	35	been	be	AUX
gsrj-62	81	36	given	give	VERB
gsrj-62	81	37	to	to	ADP
gsrj-62	81	38	its	its	PRON
gsrj-62	81	39	other	other	ADJ
gsrj-62	81	40	gene	gene	NOUN
gsrj-62	81	41	family	family	NOUN
gsrj-62	81	42	members	member	NOUN
gsrj-62	81	43	.	.	PUNCT
gsrj-62	82	1	these	these	DET
gsrj-62	82	2	family	family	NOUN
gsrj-62	82	3	members	member	NOUN
gsrj-62	82	4	include	include	VERB
gsrj-62	82	5	egr-1	egr-1	NUM
gsrj-62	82	6	which	which	PRON
gsrj-62	82	7	is	be	AUX
gsrj-62	82	8	implicated	implicate	VERB
gsrj-62	82	9	in	in	ADP
gsrj-62	82	10	synaptic	synaptic	ADJ
gsrj-62	82	11	homeostasis	homeostasis	NOUN
gsrj-62	82	12	and	and	CCONJ
gsrj-62	82	13	plasticity	plasticity	NOUN
gsrj-62	82	14	and	and	CCONJ
gsrj-62	82	15	egr-4	egr-4	ADP
gsrj-62	82	16	which	which	PRON
gsrj-62	82	17	has	have	AUX
gsrj-62	82	18	been	be	AUX
gsrj-62	82	19	found	find	VERB
gsrj-62	82	20	to	to	PART
gsrj-62	82	21	modulate	modulate	VERB
gsrj-62	82	22	bdnf	bdnf	ADJ
gsrj-62	82	23	induction	induction	NOUN
gsrj-62	82	24	of	of	ADP
gsrj-62	82	25	potassium	potassium	NOUN
gsrj-62	82	26	chloride	chloride	NOUN
gsrj-62	82	27	cotransporter.30,31	cotransporter.30,31	NOUN
gsrj-62	82	28	however	however	ADV
gsrj-62	82	29	,	,	PUNCT
gsrj-62	82	30	one	one	NUM
gsrj-62	82	31	group	group	NOUN
gsrj-62	82	32	found	find	VERB
gsrj-62	82	33	that	that	SCONJ
gsrj-62	82	34	mutations	mutation	NOUN
gsrj-62	82	35	in	in	ADP
gsrj-62	82	36	the	the	DET
gsrj-62	82	37	egr-2	egr-2	NUM
gsrj-62	82	38	gene	gene	NOUN
gsrj-62	82	39	are	be	AUX
gsrj-62	82	40	associated	associate	VERB
gsrj-62	82	41	with	with	ADP
gsrj-62	82	42	hereditary	hereditary	ADJ
gsrj-62	82	43	myelinopathies.32	myelinopathies.32	VERB
gsrj-62	82	44	although	although	SCONJ
gsrj-62	82	45	egr-2	egr-2	PRON
gsrj-62	82	46	has	have	AUX
gsrj-62	82	47	been	be	AUX
gsrj-62	82	48	found	find	VERB
gsrj-62	82	49	to	to	PART
gsrj-62	82	50	be	be	AUX
gsrj-62	82	51	involved	involve	VERB
gsrj-62	82	52	in	in	ADP
gsrj-62	82	53	the	the	DET
gsrj-62	82	54	onset	onset	NOUN
gsrj-62	82	55	of	of	ADP
gsrj-62	82	56	myelination	myelination	NOUN
gsrj-62	82	57	,	,	PUNCT
gsrj-62	82	58	its	its	PRON
gsrj-62	82	59	expression	expression	NOUN
gsrj-62	82	60	and	and	CCONJ
gsrj-62	82	61	effect	effect	NOUN
gsrj-62	82	62	on	on	ADP
gsrj-62	82	63	disrupted	disrupt	VERB
gsrj-62	82	64	or	or	CCONJ
gsrj-62	82	65	damaged	damage	VERB
gsrj-62	82	66	synapses	synapsis	NOUN
gsrj-62	82	67	had	have	AUX
gsrj-62	82	68	not	not	PART
gsrj-62	82	69	been	be	AUX
gsrj-62	82	70	investigated	investigate	VERB
gsrj-62	82	71	,	,	PUNCT
gsrj-62	82	72	especially	especially	ADV
gsrj-62	82	73	in	in	ADP
gsrj-62	82	74	its	its	PRON
gsrj-62	82	75	connection	connection	NOUN
gsrj-62	82	76	with	with	ADP
gsrj-62	82	77	hallucinogens	hallucinogen	NOUN
gsrj-62	82	78	or	or	CCONJ
gsrj-62	82	79	depression	depression	NOUN
gsrj-62	82	80	.	.	PUNCT
gsrj-62	83	1	along	along	ADP
gsrj-62	83	2	with	with	ADP
gsrj-62	83	3	egr-2	egr-2	PRON
gsrj-62	83	4	expression	expression	NOUN
gsrj-62	83	5	being	be	AUX
gsrj-62	83	6	increased	increase	VERB
gsrj-62	83	7	upon	upon	SCONJ
gsrj-62	83	8	mglur2	mglur2	NOUN
gsrj-62	83	9	complex	complex	ADJ
gsrj-62	83	10	activation	activation	NOUN
gsrj-62	83	11	,	,	PUNCT
gsrj-62	83	12	c	c	X
gsrj-62	83	13	-	-	PUNCT
gsrj-62	83	14	fos	fos	NOUN
gsrj-62	83	15	expression	expression	NOUN
gsrj-62	83	16	was	be	AUX
gsrj-62	83	17	also	also	ADV
gsrj-62	83	18	increased	increase	VERB
gsrj-62	83	19	.	.	PUNCT
gsrj-62	84	1	an	an	DET
gsrj-62	84	2	important	important	ADJ
gsrj-62	84	3	early	early	ADJ
gsrj-62	84	4	response	response	NOUN
gsrj-62	84	5	gene	gene	NOUN
gsrj-62	84	6	highly	highly	ADV
gsrj-62	84	7	expressed	express	VERB
gsrj-62	84	8	within	within	ADP
gsrj-62	84	9	the	the	DET
gsrj-62	84	10	prefrontal	prefrontal	ADJ
gsrj-62	84	11	cortex	cortex	NOUN
gsrj-62	84	12	,	,	PUNCT
gsrj-62	84	13	c	c	X
gsrj-62	84	14	-	-	PUNCT
gsrj-62	84	15	fos	fos	NOUN
gsrj-62	84	16	has	have	AUX
gsrj-62	84	17	been	be	AUX
gsrj-62	84	18	implicated	implicate	VERB
gsrj-62	84	19	in	in	ADP
gsrj-62	84	20	multiple	multiple	ADJ
gsrj-62	84	21	important	important	ADJ
gsrj-62	84	22	functions	function	NOUN
gsrj-62	84	23	.	.	PUNCT
gsrj-62	85	1	for	for	ADP
gsrj-62	85	2	example	example	NOUN
gsrj-62	85	3	,	,	PUNCT
gsrj-62	85	4	c	c	X
gsrj-62	85	5	-	-	PUNCT
gsrj-62	85	6	fos	fos	NOUN
gsrj-62	85	7	is	be	AUX
gsrj-62	85	8	essential	essential	ADJ
gsrj-62	85	9	for	for	ADP
gsrj-62	85	10	cell	cell	NOUN
gsrj-62	85	11	proliferation	proliferation	NOUN
gsrj-62	85	12	and	and	CCONJ
gsrj-62	85	13	differentiation	differentiation	NOUN
gsrj-62	85	14	,	,	PUNCT
gsrj-62	85	15	it	it	PRON
gsrj-62	85	16	is	be	AUX
gsrj-62	85	17	an	an	DET
gsrj-62	85	18	activator	activator	NOUN
gsrj-62	85	19	of	of	ADP
gsrj-62	85	20	phospholipid	phospholipid	NOUN
gsrj-62	85	21	synthesis	synthesis	NOUN
gsrj-62	85	22	during	during	ADP
gsrj-62	85	23	events	event	NOUN
gsrj-62	85	24	that	that	PRON
gsrj-62	85	25	require	require	VERB
gsrj-62	85	26	biogenesis	biogenesis	NOUN
gsrj-62	85	27	,	,	PUNCT
gsrj-62	85	28	and	and	CCONJ
gsrj-62	85	29	it	it	PRON
gsrj-62	85	30	modulates	modulate	VERB
gsrj-62	85	31	bdnf	bdnf	ADJ
gsrj-62	85	32	.	.	PUNCT
gsrj-62	86	1	in	in	ADP
gsrj-62	86	2	rats	rat	NOUN
gsrj-62	86	3	,	,	PUNCT
gsrj-62	86	4	c	c	X
gsrj-62	86	5	-	-	PUNCT
gsrj-62	86	6	fos	fos	NOUN
gsrj-62	86	7	and	and	CCONJ
gsrj-62	86	8	bdnf	bdnf	ADJ
gsrj-62	86	9	expression	expression	NOUN
gsrj-62	86	10	was	be	AUX
gsrj-62	86	11	found	find	VERB
gsrj-62	86	12	to	to	PART
gsrj-62	86	13	be	be	AUX
gsrj-62	86	14	upregulated	upregulate	VERB
gsrj-62	86	15	when	when	SCONJ
gsrj-62	86	16	administered	administer	VERB
gsrj-62	86	17	antidepressants	antidepressant	NOUN
gsrj-62	86	18	.	.	PUNCT
gsrj-62	87	1	no	no	DET
gsrj-62	87	2	one	one	NOUN
gsrj-62	87	3	has	have	AUX
gsrj-62	87	4	investigated	investigate	VERB
gsrj-62	87	5	bdnf	bdnf	PROPN
gsrj-62	87	6	’s	’s	PART
gsrj-62	87	7	expression	expression	NOUN
gsrj-62	87	8	upon	upon	SCONJ
gsrj-62	87	9	mglur2	mglur2	NOUN
gsrj-62	87	10	complex	complex	ADJ
gsrj-62	87	11	activation	activation	NOUN
gsrj-62	87	12	despite	despite	SCONJ
gsrj-62	87	13	the	the	DET
gsrj-62	87	14	fact	fact	NOUN
gsrj-62	87	15	bdnf	bdnf	NOUN
gsrj-62	87	16	has	have	AUX
gsrj-62	87	17	been	be	AUX
gsrj-62	87	18	shown	show	VERB
gsrj-62	87	19	to	to	PART
gsrj-62	87	20	encourage	encourage	VERB
gsrj-62	87	21	development	development	NOUN
gsrj-62	87	22	and	and	CCONJ
gsrj-62	87	23	growth	growth	NOUN
gsrj-62	87	24	of	of	ADP
gsrj-62	87	25	new	new	ADJ
gsrj-62	87	26	and	and	CCONJ
gsrj-62	87	27	existing	exist	VERB
gsrj-62	87	28	neurons.33	neurons.33	NOUN
gsrj-62	87	29	bdnf	bdnf	NOUN
gsrj-62	87	30	potently	potently	ADV
gsrj-62	87	31	binds	bind	VERB
gsrj-62	87	32	to	to	ADP
gsrj-62	87	33	trkb	trkb	NOUN
gsrj-62	87	34	,	,	PUNCT
gsrj-62	87	35	creating	create	VERB
gsrj-62	87	36	a	a	DET
gsrj-62	87	37	bdnf	bdnf	ADJ
gsrj-62	87	38	-	-	PUNCT
gsrj-62	87	39	trkb	trkb	NOUN
gsrj-62	87	40	signaling	signal	VERB
gsrj-62	87	41	pathway	pathway	NOUN
gsrj-62	87	42	.	.	PUNCT
gsrj-62	88	1	the	the	DET
gsrj-62	88	2	trkb	trkb	NOUN
gsrj-62	88	3	gene	gene	NOUN
gsrj-62	88	4	contains	contain	VERB
gsrj-62	88	5	at	at	ADV
gsrj-62	88	6	least	least	ADV
gsrj-62	88	7	three	three	NUM
gsrj-62	88	8	different	different	ADJ
gsrj-62	88	9	receptor	receptor	NOUN
gsrj-62	88	10	subtypes	subtype	NOUN
gsrj-62	88	11	:	:	PUNCT
gsrj-62	88	12	tk+	tk+	NOUN
gsrj-62	88	13	,	,	PUNCT
gsrj-62	88	14	t1	t1	NOUN
gsrj-62	88	15	,	,	PUNCT
gsrj-62	88	16	and	and	CCONJ
gsrj-62	88	17	t2.34	t2.34	VERB
gsrj-62	88	18	trkb	trkb	NOUN
gsrj-62	88	19	-	-	PUNCT
gsrj-62	88	20	t1	t1	NOUN
gsrj-62	88	21	overexpression	overexpression	NOUN
gsrj-62	88	22	induces	induce	NOUN
gsrj-62	88	23	has	have	AUX
gsrj-62	88	24	been	be	AUX
gsrj-62	88	25	shown	show	VERB
gsrj-62	88	26	to	to	PART
gsrj-62	88	27	promote	promote	VERB
gsrj-62	88	28	elongation	elongation	NOUN
gsrj-62	88	29	and	and	CCONJ
gsrj-62	88	30	an	an	DET
gsrj-62	88	31	increase	increase	NOUN
gsrj-62	88	32	in	in	ADP
gsrj-62	88	33	the	the	DET
gsrj-62	88	34	branch	branch	NOUN
gsrj-62	88	35	number	number	NOUN
gsrj-62	88	36	of	of	ADP
gsrj-62	88	37	distal	distal	ADJ
gsrj-62	88	38	dendrites	dendrite	NOUN
gsrj-62	88	39	of	of	ADP
gsrj-62	88	40	cortical	cortical	ADJ
gsrj-62	88	41	pyramidal	pyramidal	ADJ
gsrj-62	88	42	neurons	neuron	NOUN
gsrj-62	88	43	in	in	ADP
gsrj-62	88	44	slices.35	slices.35	PROPN
gsrj-62	88	45	moreover	moreover	ADV
gsrj-62	88	46	,	,	PUNCT
gsrj-62	88	47	research	research	NOUN
gsrj-62	88	48	has	have	AUX
gsrj-62	88	49	implicated	implicate	VERB
gsrj-62	88	50	the	the	DET
gsrj-62	88	51	bdnf	bdnf	ADJ
gsrj-62	88	52	-	-	PUNCT
gsrj-62	88	53	trkb	trkb	NOUN
gsrj-62	88	54	pathway	pathway	NOUN
gsrj-62	88	55	as	as	ADP
gsrj-62	88	56	playing	play	VERB
gsrj-62	88	57	a	a	DET
gsrj-62	88	58	role	role	NOUN
gsrj-62	88	59	in	in	ADP
gsrj-62	88	60	cell	cell	NOUN
gsrj-62	88	61	migration	migration	NOUN
gsrj-62	88	62	,	,	PUNCT
gsrj-62	88	63	outgrowth	outgrowth	NOUN
gsrj-62	88	64	of	of	ADP
gsrj-62	88	65	neurites	neurite	NOUN
gsrj-62	88	66	,	,	PUNCT
gsrj-62	88	67	synaptogenesis	synaptogenesis	NOUN
gsrj-62	88	68	,	,	PUNCT
gsrj-62	88	69	cell	cell	NOUN
gsrj-62	88	70	survival	survival	NOUN
gsrj-62	88	71	and	and	CCONJ
gsrj-62	88	72	death	death	NOUN
gsrj-62	88	73	,	,	PUNCT
gsrj-62	88	74	neuronal	neuronal	ADJ
gsrj-62	88	75	transmission	transmission	NOUN
gsrj-62	88	76	,	,	PUNCT
gsrj-62	88	77	and	and	CCONJ
gsrj-62	88	78	synaptic	synaptic	ADJ
gsrj-62	88	79	plasticity	plasticity	NOUN
gsrj-62	88	80	in	in	ADP
gsrj-62	88	81	the	the	DET
gsrj-62	88	82	cns.36	cns.36	NOUN
gsrj-62	88	83	referring	refer	VERB
gsrj-62	88	84	back	back	ADV
gsrj-62	88	85	to	to	ADP
gsrj-62	88	86	shao	shao	PROPN
gsrj-62	88	87	et	et	PROPN
gsrj-62	88	88	al	al	PROPN
gsrj-62	88	89	.	.	PROPN
gsrj-62	88	90	,	,	PUNCT
gsrj-62	88	91	(	(	PUNCT
gsrj-62	88	92	see	see	VERB
gsrj-62	88	93	under	under	ADP
gsrj-62	88	94	“	"	PUNCT
gsrj-62	88	95	synaptogenesis	synaptogenesis	VERB
gsrj-62	88	96	in	in	ADP
gsrj-62	88	97	the	the	DET
gsrj-62	88	98	pfc	pfc	NOUN
gsrj-62	88	99	”	"	PUNCT
gsrj-62	88	100	)	)	PUNCT
gsrj-62	88	101	researchers	researcher	NOUN
gsrj-62	88	102	observed	observe	VERB
gsrj-62	88	103	“	"	PUNCT
gsrj-62	88	104	rapid	rapid	ADJ
gsrj-62	88	105	and	and	CCONJ
gsrj-62	88	106	persistent	persistent	ADJ
gsrj-62	88	107	growth	growth	NOUN
gsrj-62	88	108	”	"	PUNCT
gsrj-62	88	109	of	of	ADP
gsrj-62	88	110	dendritic	dendritic	ADJ
gsrj-62	88	111	spines	spine	NOUN
gsrj-62	88	112	in	in	ADP
gsrj-62	88	113	the	the	DET
gsrj-62	88	114	frontal	frontal	ADJ
gsrj-62	88	115	cortex	cortex	NOUN
gsrj-62	88	116	of	of	ADP
gsrj-62	88	117	mice.28	mice.28	PROPN
gsrj-62	88	118	shao	shao	PROPN
gsrj-62	88	119	et	et	PROPN
gsrj-62	88	120	al	al	PROPN
gsrj-62	88	121	.	.	PROPN
gsrj-62	88	122	reported	report	VERB
gsrj-62	88	123	these	these	DET
gsrj-62	88	124	observations	observation	NOUN
gsrj-62	88	125	but	but	CCONJ
gsrj-62	88	126	did	do	AUX
gsrj-62	88	127	not	not	PART
gsrj-62	88	128	propose	propose	VERB
gsrj-62	88	129	a	a	DET
gsrj-62	88	130	molecular	molecular	ADJ
gsrj-62	88	131	mechanism	mechanism	NOUN
gsrj-62	88	132	as	as	ADP
gsrj-62	88	133	to	to	ADP
gsrj-62	88	134	why	why	SCONJ
gsrj-62	88	135	this	this	PRON
gsrj-62	88	136	occurs	occur	VERB
gsrj-62	88	137	.	.	PUNCT
gsrj-62	89	1	upon	upon	SCONJ
gsrj-62	89	2	further	further	ADJ
gsrj-62	89	3	examination	examination	NOUN
gsrj-62	89	4	of	of	ADP
gsrj-62	89	5	new	new	ADJ
gsrj-62	89	6	research	research	NOUN
gsrj-62	89	7	and	and	CCONJ
gsrj-62	89	8	the	the	DET
gsrj-62	89	9	results	result	NOUN
gsrj-62	89	10	from	from	ADP
gsrj-62	89	11	shao	shao	PROPN
gsrj-62	89	12	et	et	PROPN
gsrj-62	89	13	al	al	PROPN
gsrj-62	89	14	.	.	PROPN
gsrj-62	89	15	,	,	PUNCT
gsrj-62	89	16	it	it	PRON
gsrj-62	89	17	seems	seem	VERB
gsrj-62	89	18	to	to	PART
gsrj-62	89	19	be	be	AUX
gsrj-62	89	20	possible	possible	ADJ
gsrj-62	89	21	that	that	SCONJ
gsrj-62	89	22	the	the	DET
gsrj-62	89	23	rapid	rapid	ADJ
gsrj-62	89	24	and	and	CCONJ
gsrj-62	89	25	persistent	persistent	ADJ
gsrj-62	89	26	growth	growth	NOUN
gsrj-62	89	27	of	of	ADP
gsrj-62	89	28	dendritic	dendritic	ADJ
gsrj-62	89	29	spines	spine	NOUN
gsrj-62	89	30	,	,	PUNCT
gsrj-62	89	31	as	as	SCONJ
gsrj-62	89	32	seen	see	VERB
gsrj-62	89	33	in	in	ADP
gsrj-62	89	34	shao	shao	PROPN
gsrj-62	89	35	et	et	PROPN
gsrj-62	89	36	al	al	PROPN
gsrj-62	89	37	.	.	PROPN
gsrj-62	89	38	,	,	PUNCT
gsrj-62	89	39	could	could	AUX
gsrj-62	89	40	be	be	AUX
gsrj-62	89	41	caused	cause	VERB
gsrj-62	89	42	by	by	ADP
gsrj-62	89	43	a	a	DET
gsrj-62	89	44	complicated	complicate	VERB
gsrj-62	89	45	molecular	molecular	ADJ
gsrj-62	89	46	pathway	pathway	NOUN
gsrj-62	89	47	involving	involve	VERB
gsrj-62	89	48	5ht2ar	5ht2ar	NUM
gsrj-62	89	49	-	-	PUNCT
gsrj-62	89	50	mglur2	mglur2	NOUN
gsrj-62	89	51	complex	complex	ADJ
gsrj-62	89	52	formation	formation	NOUN
gsrj-62	89	53	,	,	PUNCT
gsrj-62	89	54	c	c	NOUN
gsrj-62	89	55	-	-	PUNCT
gsrj-62	89	56	fos	fos	NOUN
gsrj-62	89	57	and	and	CCONJ
gsrj-62	89	58	bdnf	bdnf	ADJ
gsrj-62	89	59	upregulation	upregulation	NOUN
gsrj-62	89	60	upon	upon	SCONJ
gsrj-62	89	61	activation	activation	NOUN
gsrj-62	89	62	of	of	ADP
gsrj-62	89	63	this	this	DET
gsrj-62	89	64	complex	complex	NOUN
gsrj-62	89	65	,	,	PUNCT
gsrj-62	89	66	and	and	CCONJ
gsrj-62	89	67	a	a	DET
gsrj-62	89	68	bdnf	bdnf	ADJ
gsrj-62	89	69	-	-	PUNCT
gsrj-62	89	70	trkb	trkb	NOUN
gsrj-62	89	71	signaling	signal	VERB
gsrj-62	89	72	pathway	pathway	NOUN
gsrj-62	89	73	.	.	PUNCT
gsrj-62	90	1	55	55	NUM
gsrj-62	90	2	..	..	PUNCT
gsrj-62	90	3	ccoonncclluussiioonn	ccoonncclluussiioonn	PROPN
gsrj-62	90	4	aanndd	aanndd	PROPN
gsrj-62	90	5	tthhoouugghhttss	tthhoouugghhttss	PROPN
gsrj-62	90	6	ffoorr	ffoorr	PROPN
gsrj-62	90	7	tthhee	tthhee	PROPN
gsrj-62	90	8	ffuuttuurree	ffuuttuurree	PROPN
gsrj-62	90	9	psilocybin	psilocybin	NOUN
gsrj-62	90	10	and	and	CCONJ
gsrj-62	90	11	other	other	ADJ
gsrj-62	90	12	psychedelics	psychedelic	NOUN
gsrj-62	90	13	are	be	AUX
gsrj-62	90	14	increasingly	increasingly	ADV
gsrj-62	90	15	being	be	AUX
gsrj-62	90	16	explored	explore	VERB
gsrj-62	90	17	for	for	ADP
gsrj-62	90	18	therapeutic	therapeutic	ADJ
gsrj-62	90	19	purposes	purpose	NOUN
gsrj-62	90	20	.	.	PUNCT
gsrj-62	91	1	initial	initial	ADJ
gsrj-62	91	2	experiments	experiment	NOUN
gsrj-62	91	3	show	show	VERB
gsrj-62	91	4	promising	promising	ADJ
gsrj-62	91	5	results	result	NOUN
gsrj-62	91	6	for	for	ADP
gsrj-62	91	7	psilocybin	psilocybin	NOUN
gsrj-62	91	8	in	in	ADP
gsrj-62	91	9	treating	treat	VERB
gsrj-62	91	10	clinical	clinical	ADJ
gsrj-62	91	11	depression	depression	NOUN
gsrj-62	91	12	,	,	PUNCT
gsrj-62	91	13	particularly	particularly	ADV
gsrj-62	91	14	treatment	treatment	NOUN
gsrj-62	91	15	-	-	PUNCT
gsrj-62	91	16	resistant	resistant	ADJ
gsrj-62	91	17	depression	depression	NOUN
gsrj-62	91	18	.	.	PUNCT
gsrj-62	92	1	psychedelic	psychedelic	ADJ
gsrj-62	92	2	applications	application	NOUN
gsrj-62	92	3	could	could	AUX
gsrj-62	92	4	revolutionize	revolutionize	VERB
gsrj-62	92	5	depression	depression	NOUN
gsrj-62	92	6	treatments	treatment	NOUN
gsrj-62	92	7	as	as	SCONJ
gsrj-62	92	8	experiments	experiment	NOUN
gsrj-62	92	9	suggest	suggest	VERB
gsrj-62	92	10	the	the	DET
gsrj-62	92	11	therapeutic	therapeutic	ADJ
gsrj-62	92	12	effects	effect	NOUN
gsrj-62	92	13	of	of	ADP
gsrj-62	92	14	psilocybin	psilocybin	NOUN
gsrj-62	92	15	may	may	AUX
gsrj-62	92	16	be	be	AUX
gsrj-62	92	17	prevalent	prevalent	ADJ
gsrj-62	92	18	after	after	ADP
gsrj-62	92	19	only	only	ADV
gsrj-62	92	20	one	one	NUM
gsrj-62	92	21	or	or	CCONJ
gsrj-62	92	22	two	two	NUM
gsrj-62	92	23	dosages	dosage	NOUN
gsrj-62	92	24	,	,	PUNCT
gsrj-62	92	25	as	as	SCONJ
gsrj-62	92	26	opposed	oppose	VERB
gsrj-62	92	27	to	to	ADP
gsrj-62	92	28	the	the	DET
gsrj-62	92	29	daily	daily	ADJ
gsrj-62	92	30	dosages	dosage	NOUN
gsrj-62	92	31	required	require	VERB
gsrj-62	92	32	for	for	ADP
gsrj-62	92	33	many	many	ADJ
gsrj-62	92	34	antidepressants	antidepressant	NOUN
gsrj-62	92	35	.	.	PUNCT
gsrj-62	93	1	furthermore	furthermore	ADV
gsrj-62	93	2	,	,	PUNCT
gsrj-62	93	3	many	many	ADJ
gsrj-62	93	4	antidepressants	antidepressant	NOUN
gsrj-62	93	5	have	have	VERB
gsrj-62	93	6	unwanted	unwanted	ADJ
gsrj-62	93	7	side	side	NOUN
gsrj-62	93	8	effects	effect	NOUN
gsrj-62	93	9	,	,	PUNCT
gsrj-62	93	10	such	such	ADJ
gsrj-62	93	11	as	as	ADP
gsrj-62	93	12	drowsiness	drowsiness	NOUN
gsrj-62	93	13	,	,	PUNCT
gsrj-62	93	14	that	that	SCONJ
gsrj-62	93	15	psychedelic	psychedelic	ADJ
gsrj-62	93	16	therapy	therapy	NOUN
gsrj-62	93	17	could	could	AUX
gsrj-62	93	18	avoid	avoid	VERB
gsrj-62	93	19	.	.	PUNCT
gsrj-62	94	1	26	26	NUM
gsrj-62	94	2	georgetown	georgetown	PROPN
gsrj-62	94	3	scientific	scientific	PROPN
gsrj-62	94	4	research	research	PROPN
gsrj-62	94	5	journal	journal	NOUN
gsrj-62	94	6	psilocybin	psilocybin	NOUN
gsrj-62	94	7	acts	act	VERB
gsrj-62	94	8	on	on	ADP
gsrj-62	94	9	the	the	DET
gsrj-62	94	10	5	5	NUM
gsrj-62	94	11	-	-	SYM
gsrj-62	94	12	ht2ar	ht2ar	NUM
gsrj-62	94	13	.	.	PUNCT
gsrj-62	95	1	hallucinogens	hallucinogen	NOUN
gsrj-62	95	2	stabilize	stabilize	VERB
gsrj-62	95	3	a	a	DET
gsrj-62	95	4	specific	specific	ADJ
gsrj-62	95	5	response	response	NOUN
gsrj-62	95	6	at	at	ADP
gsrj-62	95	7	this	this	DET
gsrj-62	95	8	receptor	receptor	NOUN
gsrj-62	95	9	that	that	PRON
gsrj-62	95	10	results	result	VERB
gsrj-62	95	11	in	in	ADP
gsrj-62	95	12	a	a	DET
gsrj-62	95	13	hallucinogenic	hallucinogenic	ADJ
gsrj-62	95	14	specific	specific	ADJ
gsrj-62	95	15	response	response	NOUN
gsrj-62	95	16	.	.	PUNCT
gsrj-62	96	1	also	also	ADV
gsrj-62	96	2	vital	vital	ADJ
gsrj-62	96	3	to	to	ADP
gsrj-62	96	4	the	the	DET
gsrj-62	96	5	molecular	molecular	ADJ
gsrj-62	96	6	mechanism	mechanism	NOUN
gsrj-62	96	7	of	of	ADP
gsrj-62	96	8	psilocybin	psilocybin	NOUN
gsrj-62	96	9	is	be	AUX
gsrj-62	96	10	the	the	DET
gsrj-62	96	11	formation	formation	NOUN
gsrj-62	96	12	of	of	ADP
gsrj-62	96	13	a	a	DET
gsrj-62	96	14	5	5	NUM
gsrj-62	96	15	-	-	SYM
gsrj-62	96	16	ht2ar	ht2ar	NOUN
gsrj-62	96	17	and	and	CCONJ
gsrj-62	96	18	mglur2	mglur2	NOUN
gsrj-62	96	19	complex	complex	ADJ
gsrj-62	96	20	.	.	PUNCT
gsrj-62	97	1	specifically	specifically	ADV
gsrj-62	97	2	,	,	PUNCT
gsrj-62	97	3	glutamate	glutamate	ADJ
gsrj-62	97	4	release	release	NOUN
gsrj-62	97	5	activates	activate	VERB
gsrj-62	97	6	downstream	downstream	ADJ
gsrj-62	97	7	receptors	receptor	NOUN
gsrj-62	97	8	,	,	PUNCT
gsrj-62	98	1	which	which	PRON
gsrj-62	98	2	in	in	ADP
gsrj-62	98	3	turn	turn	NOUN
gsrj-62	98	4	release	release	NOUN
gsrj-62	98	5	transcription	transcription	NOUN
gsrj-62	98	6	factor	factor	NOUN
gsrj-62	98	7	c	c	NOUN
gsrj-62	98	8	-	-	PUNCT
gsrj-62	98	9	fos	fos	NOUN
gsrj-62	98	10	and	and	CCONJ
gsrj-62	98	11	bdnf	bdnf	ADJ
gsrj-62	98	12	.	.	PUNCT
gsrj-62	99	1	furthermore	furthermore	ADV
gsrj-62	99	2	,	,	PUNCT
gsrj-62	99	3	bdnf	bdnf	PROPN
gsrj-62	99	4	binds	bind	VERB
gsrj-62	99	5	to	to	ADP
gsrj-62	99	6	trk	trk	PROPN
gsrj-62	99	7	,	,	PUNCT
gsrj-62	99	8	resulting	result	VERB
gsrj-62	99	9	in	in	ADP
gsrj-62	99	10	the	the	DET
gsrj-62	99	11	bdnf	bdnf	ADJ
gsrj-62	99	12	-	-	PUNCT
gsrj-62	99	13	trkb	trkb	NOUN
gsrj-62	99	14	signaling	signal	VERB
gsrj-62	99	15	pathway	pathway	NOUN
gsrj-62	99	16	which	which	PRON
gsrj-62	99	17	has	have	VERB
gsrj-62	99	18	a	a	DET
gsrj-62	99	19	role	role	NOUN
gsrj-62	99	20	in	in	ADP
gsrj-62	99	21	processes	process	NOUN
gsrj-62	99	22	including	include	VERB
gsrj-62	99	23	synaptogenesis	synaptogenesis	NOUN
gsrj-62	99	24	and	and	CCONJ
gsrj-62	99	25	synaptic	synaptic	ADJ
gsrj-62	99	26	plasticity	plasticity	NOUN
gsrj-62	99	27	.	.	PUNCT
gsrj-62	100	1	psilocybin	psilocybin	NOUN
gsrj-62	100	2	has	have	AUX
gsrj-62	100	3	also	also	ADV
gsrj-62	100	4	been	be	AUX
gsrj-62	100	5	shown	show	VERB
gsrj-62	100	6	to	to	PART
gsrj-62	100	7	increase	increase	VERB
gsrj-62	100	8	synaptogenesis	synaptogenesis	NOUN
gsrj-62	100	9	in	in	ADP
gsrj-62	100	10	the	the	DET
gsrj-62	100	11	prefrontal	prefrontal	ADJ
gsrj-62	100	12	cortex	cortex	NOUN
gsrj-62	100	13	.	.	PUNCT
gsrj-62	101	1	this	this	DET
gsrj-62	101	2	finding	finding	NOUN
gsrj-62	101	3	is	be	AUX
gsrj-62	101	4	particularly	particularly	ADV
gsrj-62	101	5	significant	significant	ADJ
gsrj-62	101	6	as	as	SCONJ
gsrj-62	101	7	synaptic	synaptic	ADJ
gsrj-62	101	8	atrophy	atrophy	NOUN
gsrj-62	101	9	in	in	ADP
gsrj-62	101	10	the	the	DET
gsrj-62	101	11	prefrontal	prefrontal	ADJ
gsrj-62	101	12	cortex	cortex	NOUN
gsrj-62	101	13	is	be	AUX
gsrj-62	101	14	associated	associate	VERB
gsrj-62	101	15	with	with	ADP
gsrj-62	101	16	depression	depression	NOUN
gsrj-62	101	17	.	.	PUNCT
gsrj-62	102	1	more	more	ADJ
gsrj-62	102	2	experiments	experiment	NOUN
gsrj-62	102	3	should	should	AUX
gsrj-62	102	4	be	be	AUX
gsrj-62	102	5	conducted	conduct	VERB
gsrj-62	102	6	to	to	PART
gsrj-62	102	7	determine	determine	VERB
gsrj-62	102	8	the	the	DET
gsrj-62	102	9	precise	precise	ADJ
gsrj-62	102	10	connection	connection	NOUN
gsrj-62	102	11	between	between	ADP
gsrj-62	102	12	these	these	DET
gsrj-62	102	13	findings	finding	NOUN
gsrj-62	102	14	,	,	PUNCT
gsrj-62	102	15	including	include	VERB
gsrj-62	102	16	how	how	SCONJ
gsrj-62	102	17	egr-2	egr-2	PRON
gsrj-62	102	18	may	may	AUX
gsrj-62	102	19	play	play	VERB
gsrj-62	102	20	a	a	DET
gsrj-62	102	21	role	role	NOUN
gsrj-62	102	22	,	,	PUNCT
gsrj-62	102	23	but	but	CCONJ
gsrj-62	102	24	existing	exist	VERB
gsrj-62	102	25	research	research	NOUN
gsrj-62	102	26	supports	support	VERB
gsrj-62	102	27	psilocybin	psilocybin	NOUN
gsrj-62	102	28	’s	’s	PART
gsrj-62	102	29	potential	potential	NOUN
gsrj-62	102	30	as	as	ADP
gsrj-62	102	31	an	an	DET
gsrj-62	102	32	antidepressant	antidepressant	NOUN
gsrj-62	102	33	.	.	PUNCT
gsrj-62	103	1	combining	combine	VERB
gsrj-62	103	2	the	the	DET
gsrj-62	103	3	research	research	NOUN
gsrj-62	103	4	indicating	indicate	VERB
gsrj-62	103	5	the	the	DET
gsrj-62	103	6	upregulation	upregulation	NOUN
gsrj-62	103	7	of	of	ADP
gsrj-62	103	8	c	c	NOUN
gsrj-62	103	9	-	-	PUNCT
gsrj-62	103	10	fos	fos	NOUN
gsrj-62	103	11	,	,	PUNCT
gsrj-62	103	12	egr-2	egr-2	ADV
gsrj-62	103	13	,	,	PUNCT
gsrj-62	103	14	and	and	CCONJ
gsrj-62	103	15	bdnf	bdnf	ADJ
gsrj-62	103	16	as	as	ADP
gsrj-62	103	17	a	a	DET
gsrj-62	103	18	result	result	NOUN
gsrj-62	103	19	of	of	ADP
gsrj-62	103	20	5	5	NUM
gsrj-62	103	21	-	-	PUNCT
gsrj-62	103	22	ht2ar	ht2ar	NOUN
gsrj-62	103	23	activation	activation	NOUN
gsrj-62	103	24	by	by	ADP
gsrj-62	103	25	psilocybin	psilocybin	NOUN
gsrj-62	103	26	and	and	CCONJ
gsrj-62	103	27	the	the	DET
gsrj-62	103	28	synaptogenesis	synaptogenesis	NOUN
gsrj-62	103	29	seen	see	VERB
gsrj-62	103	30	in	in	ADP
gsrj-62	103	31	the	the	DET
gsrj-62	103	32	prefrontal	prefrontal	ADJ
gsrj-62	103	33	cortex	cortex	NOUN
gsrj-62	103	34	,	,	PUNCT
gsrj-62	103	35	we	we	PRON
gsrj-62	103	36	put	put	VERB
gsrj-62	103	37	forth	forth	ADP
gsrj-62	103	38	a	a	DET
gsrj-62	103	39	hypothesis	hypothesis	NOUN
gsrj-62	103	40	to	to	PART
gsrj-62	103	41	explain	explain	VERB
gsrj-62	103	42	how	how	SCONJ
gsrj-62	103	43	these	these	DET
gsrj-62	103	44	results	result	NOUN
gsrj-62	103	45	may	may	AUX
gsrj-62	103	46	work	work	VERB
gsrj-62	103	47	in	in	ADP
gsrj-62	103	48	conjunction	conjunction	NOUN
gsrj-62	103	49	with	with	ADP
gsrj-62	103	50	each	each	DET
gsrj-62	103	51	other	other	ADJ
gsrj-62	103	52	.	.	PUNCT
gsrj-62	104	1	the	the	DET
gsrj-62	104	2	upregulation	upregulation	NOUN
gsrj-62	104	3	of	of	ADP
gsrj-62	104	4	c	c	NOUN
gsrj-62	104	5	-	-	PUNCT
gsrj-62	104	6	fos	fos	NOUN
gsrj-62	104	7	,	,	PUNCT
gsrj-62	104	8	egr-2	egr-2	ADV
gsrj-62	104	9	,	,	PUNCT
gsrj-62	104	10	and	and	CCONJ
gsrj-62	104	11	bdnf	bdnf	PROPN
gsrj-62	104	12	(	(	PUNCT
gsrj-62	104	13	connecting	connect	VERB
gsrj-62	104	14	with	with	ADP
gsrj-62	104	15	the	the	DET
gsrj-62	104	16	bdnf	bdnf	ADJ
gsrj-62	104	17	-	-	PUNCT
gsrj-62	104	18	trkb	trkb	NOUN
gsrj-62	104	19	signaling	signal	VERB
gsrj-62	104	20	pathway	pathway	NOUN
gsrj-62	104	21	)	)	PUNCT
gsrj-62	104	22	may	may	AUX
gsrj-62	104	23	be	be	AUX
gsrj-62	104	24	the	the	DET
gsrj-62	104	25	molecular	molecular	ADJ
gsrj-62	104	26	mechanism	mechanism	NOUN
gsrj-62	104	27	underlying	underlie	VERB
gsrj-62	104	28	synaptogenesis	synaptogenesis	NOUN
gsrj-62	104	29	.	.	PUNCT
gsrj-62	105	1	one	one	NUM
gsrj-62	105	2	way	way	NOUN
gsrj-62	105	3	to	to	PART
gsrj-62	105	4	elucidate	elucidate	VERB
gsrj-62	105	5	this	this	DET
gsrj-62	105	6	mechanism	mechanism	NOUN
gsrj-62	105	7	would	would	AUX
gsrj-62	105	8	be	be	AUX
gsrj-62	105	9	to	to	PART
gsrj-62	105	10	administer	administer	VERB
gsrj-62	105	11	psilocin	psilocin	NOUN
gsrj-62	105	12	and	and	CCONJ
gsrj-62	105	13	track	track	VERB
gsrj-62	105	14	c	c	NOUN
gsrj-62	105	15	-	-	PUNCT
gsrj-62	105	16	fos	fos	VERB
gsrj-62	105	17	,	,	PUNCT
gsrj-62	105	18	egr-2	egr-2	ADJ
gsrj-62	105	19	and	and	CCONJ
gsrj-62	105	20	bdnf	bdnf	PROPN
gsrj-62	105	21	’s	’s	PART
gsrj-62	105	22	expression	expression	NOUN
gsrj-62	105	23	throughout	throughout	ADP
gsrj-62	105	24	the	the	DET
gsrj-62	105	25	brain	brain	NOUN
gsrj-62	105	26	.	.	PUNCT
gsrj-62	106	1	a	a	DET
gsrj-62	106	2	few	few	ADJ
gsrj-62	106	3	questions	question	NOUN
gsrj-62	106	4	appear	appear	VERB
gsrj-62	106	5	from	from	ADP
gsrj-62	106	6	this	this	DET
gsrj-62	106	7	line	line	NOUN
gsrj-62	106	8	of	of	ADP
gsrj-62	106	9	investigation	investigation	NOUN
gsrj-62	106	10	:	:	PUNCT
gsrj-62	106	11	does	do	AUX
gsrj-62	106	12	expression	expression	NOUN
gsrj-62	106	13	of	of	ADP
gsrj-62	106	14	these	these	DET
gsrj-62	106	15	growth	growth	NOUN
gsrj-62	106	16	and	and	CCONJ
gsrj-62	106	17	plasticity	plasticity	NOUN
gsrj-62	106	18	related	relate	VERB
gsrj-62	106	19	factors	factor	NOUN
gsrj-62	106	20	appear	appear	VERB
gsrj-62	106	21	more	more	ADV
gsrj-62	106	22	in	in	ADP
gsrj-62	106	23	the	the	DET
gsrj-62	106	24	prefrontal	prefrontal	ADJ
gsrj-62	106	25	cortex	cortex	NOUN
gsrj-62	106	26	?	?	PUNCT
gsrj-62	107	1	does	do	AUX
gsrj-62	107	2	this	this	DET
gsrj-62	107	3	expression	expression	NOUN
gsrj-62	107	4	coincide	coincide	NOUN
gsrj-62	107	5	with	with	ADP
gsrj-62	107	6	synaptic	synaptic	ADJ
gsrj-62	107	7	growth	growth	NOUN
gsrj-62	107	8	and	and	CCONJ
gsrj-62	107	9	schwann	schwann	PROPN
gsrj-62	107	10	cell	cell	NOUN
gsrj-62	107	11	migration	migration	NOUN
gsrj-62	107	12	?	?	PUNCT
gsrj-62	108	1	how	how	SCONJ
gsrj-62	108	2	might	might	AUX
gsrj-62	108	3	these	these	DET
gsrj-62	108	4	factors	factor	NOUN
gsrj-62	108	5	and	and	CCONJ
gsrj-62	108	6	growth	growth	NOUN
gsrj-62	108	7	be	be	AUX
gsrj-62	108	8	related	relate	VERB
gsrj-62	108	9	to	to	PART
gsrj-62	108	10	mglur2	mglur2	VERB
gsrj-62	108	11	complex	complex	ADJ
gsrj-62	108	12	formation	formation	NOUN
gsrj-62	108	13	?	?	PUNCT
gsrj-62	109	1	exploring	explore	VERB
gsrj-62	109	2	questions	question	NOUN
gsrj-62	109	3	like	like	ADP
gsrj-62	109	4	these	these	PRON
gsrj-62	109	5	are	be	AUX
gsrj-62	109	6	on	on	ADP
gsrj-62	109	7	the	the	DET
gsrj-62	109	8	forefront	forefront	NOUN
gsrj-62	109	9	of	of	ADP
gsrj-62	109	10	the	the	DET
gsrj-62	109	11	emerging	emerge	VERB
gsrj-62	109	12	field	field	NOUN
gsrj-62	109	13	of	of	ADP
gsrj-62	109	14	psychedelic	psychedelic	ADJ
gsrj-62	109	15	medicine	medicine	NOUN
gsrj-62	109	16	.	.	PUNCT
gsrj-62	110	1	in	in	ADP
gsrj-62	110	2	the	the	DET
gsrj-62	110	3	future	future	NOUN
gsrj-62	110	4	,	,	PUNCT
gsrj-62	110	5	psilocybin	psilocybin	NOUN
gsrj-62	110	6	and	and	CCONJ
gsrj-62	110	7	other	other	ADJ
gsrj-62	110	8	psychedelics	psychedelic	NOUN
gsrj-62	110	9	like	like	ADP
gsrj-62	110	10	lsd	lsd	NOUN
gsrj-62	110	11	and	and	CCONJ
gsrj-62	110	12	doi	doi	NOUN
gsrj-62	110	13	may	may	AUX
gsrj-62	110	14	play	play	VERB
gsrj-62	110	15	a	a	DET
gsrj-62	110	16	vital	vital	ADJ
gsrj-62	110	17	role	role	NOUN
gsrj-62	110	18	in	in	ADP
gsrj-62	110	19	the	the	DET
gsrj-62	110	20	treatment	treatment	NOUN
gsrj-62	110	21	of	of	ADP
gsrj-62	110	22	depression	depression	NOUN
gsrj-62	110	23	,	,	PUNCT
gsrj-62	110	24	impacting	impact	VERB
gsrj-62	110	25	the	the	DET
gsrj-62	110	26	lives	life	NOUN
gsrj-62	110	27	of	of	ADP
gsrj-62	110	28	many	many	ADJ
gsrj-62	110	29	and	and	CCONJ
gsrj-62	110	30	spurring	spur	VERB
gsrj-62	110	31	research	research	NOUN
gsrj-62	110	32	into	into	ADP
gsrj-62	110	33	new	new	ADJ
gsrj-62	110	34	therapeutic	therapeutic	ADJ
gsrj-62	110	35	applications	application	NOUN
gsrj-62	110	36	.	.	PUNCT
gsrj-62	111	1	aacckknnoowwlleeddggeemmeennttss	aacckknnoowwlleeddggeemmeennttss	NOUN
gsrj-62	111	2	we	we	PRON
gsrj-62	111	3	would	would	AUX
gsrj-62	111	4	like	like	VERB
gsrj-62	111	5	to	to	PART
gsrj-62	111	6	thank	thank	VERB
gsrj-62	111	7	professor	professor	PROPN
gsrj-62	111	8	katherine	katherine	PROPN
gsrj-62	111	9	maguire	maguire	PROPN
gsrj-62	111	10	-	-	PUNCT
gsrj-62	111	11	zeiss	zeiss	PROPN
gsrj-62	111	12	for	for	ADP
gsrj-62	111	13	her	her	PRON
gsrj-62	111	14	wonderful	wonderful	ADJ
gsrj-62	111	15	direction	direction	NOUN
gsrj-62	111	16	on	on	ADP
gsrj-62	111	17	this	this	DET
gsrj-62	111	18	project	project	NOUN
gsrj-62	111	19	during	during	ADP
gsrj-62	111	20	our	our	PRON
gsrj-62	111	21	synaptic	synaptic	ADJ
gsrj-62	111	22	transmission	transmission	NOUN
gsrj-62	111	23	class	class	NOUN
gsrj-62	111	24	and	and	CCONJ
gsrj-62	111	25	the	the	DET
gsrj-62	111	26	department	department	NOUN
gsrj-62	111	27	of	of	ADP
gsrj-62	111	28	biology	biology	NOUN
gsrj-62	111	29	at	at	ADP
gsrj-62	111	30	georgetown	georgetown	PROPN
gsrj-62	111	31	university	university	PROPN
gsrj-62	111	32	.	.	PUNCT
gsrj-62	112	1	rreeffeerreenncceess	rreeffeerreenncceess	PROPN
gsrj-62	112	2	1	1	NUM
gsrj-62	113	1	.	.	PUNCT
gsrj-62	113	2	frazer	frazer	PROPN
gsrj-62	113	3	,	,	PUNCT
gsrj-62	113	4	a.	a.	PROPN
gsrj-62	113	5	,	,	PUNCT
gsrj-62	113	6	&	&	CCONJ
gsrj-62	113	7	hensler	hensler	NOUN
gsrj-62	113	8	,	,	PUNCT
gsrj-62	113	9	j.	j.	PROPN
gsrj-62	113	10	g.	g.	PROPN
gsrj-62	113	11	(	(	PUNCT
gsrj-62	113	12	1999	1999	NUM
gsrj-62	113	13	)	)	PUNCT
gsrj-62	113	14	.	.	PUNCT
gsrj-62	114	1	serotonin	serotonin	NOUN
gsrj-62	114	2	receptors	receptor	NOUN
gsrj-62	114	3	.	.	PUNCT
gsrj-62	115	1	national	national	ADJ
gsrj-62	115	2	library	library	NOUN
gsrj-62	115	3	of	of	ADP
gsrj-62	115	4	medicine	medicine	NOUN
gsrj-62	115	5	.	.	PUNCT
gsrj-62	116	1	http://www.ncbi.nlm.nih.gov/books/nbk28234/	http://www.ncbi.nlm.nih.gov/books/nbk28234/	ADJ
gsrj-62	116	2	2	2	NUM
gsrj-62	116	3	.	.	PUNCT
gsrj-62	116	4	lópez	lópez	NOUN
gsrj-62	116	5	-	-	PUNCT
gsrj-62	116	6	giménez	giménez	PROPN
gsrj-62	116	7	,	,	PUNCT
gsrj-62	116	8	j.	j.	PROPN
gsrj-62	116	9	f.	f.	PROPN
gsrj-62	116	10	,	,	PUNCT
gsrj-62	116	11	&	&	CCONJ
gsrj-62	116	12	gonzález	gonzález	PROPN
gsrj-62	116	13	-	-	PUNCT
gsrj-62	116	14	maeso	maeso	PROPN
gsrj-62	116	15	,	,	PUNCT
gsrj-62	116	16	j.	j.	PROPN
gsrj-62	116	17	(	(	PUNCT
gsrj-62	116	18	2018	2018	NUM
gsrj-62	116	19	)	)	PUNCT
gsrj-62	116	20	.	.	PUNCT
gsrj-62	117	1	hallucinogens	hallucinogen	NOUN
gsrj-62	117	2	and	and	CCONJ
gsrj-62	117	3	serotonin	serotonin	VERB
gsrj-62	117	4	5	5	NUM
gsrj-62	117	5	-	-	PUNCT
gsrj-62	117	6	ht2a	ht2a	NOUN
gsrj-62	117	7	receptor	receptor	NOUN
gsrj-62	117	8	-	-	PUNCT
gsrj-62	117	9	mediated	mediate	VERB
gsrj-62	117	10	signaling	signal	VERB
gsrj-62	117	11	pathways	pathway	NOUN
gsrj-62	117	12	.	.	PUNCT
gsrj-62	118	1	current	current	ADJ
gsrj-62	118	2	topics	topic	NOUN
gsrj-62	118	3	in	in	ADP
gsrj-62	118	4	behavioral	behavioral	ADJ
gsrj-62	118	5	neurosciences	neuroscience	NOUN
gsrj-62	118	6	,	,	PUNCT
gsrj-62	118	7	36	36	NUM
gsrj-62	118	8	,	,	PUNCT
gsrj-62	118	9	45–73	45–73	NUM
gsrj-62	118	10	.	.	PUNCT
gsrj-62	119	1	https://doi.org/10.1007/7854_2017_478	https://doi.org/10.1007/7854_2017_478	PROPN
gsrj-62	119	2	3	3	X
gsrj-62	119	3	.	.	X
gsrj-62	119	4	hofmann	hofmann	PROPN
gsrj-62	119	5	,	,	PUNCT
gsrj-62	119	6	a.	a.	NOUN
gsrj-62	119	7	(	(	PUNCT
gsrj-62	119	8	1979	1979	NUM
gsrj-62	119	9	)	)	PUNCT
gsrj-62	119	10	.	.	PUNCT
gsrj-62	120	1	how	how	SCONJ
gsrj-62	120	2	lsd	lsd	NOUN
gsrj-62	120	3	originated	originate	VERB
gsrj-62	120	4	.	.	PUNCT
gsrj-62	121	1	journal	journal	NOUN
gsrj-62	121	2	of	of	ADP
gsrj-62	121	3	psychedelic	psychedelic	ADJ
gsrj-62	121	4	drugs	drug	NOUN
gsrj-62	121	5	,	,	PUNCT
gsrj-62	121	6	11(1–2	11(1–2	PROPN
gsrj-62	121	7	)	)	PUNCT
gsrj-62	121	8	,	,	PUNCT
gsrj-62	121	9	53–60	53–60	PROPN
gsrj-62	121	10	.	.	PUNCT
gsrj-62	122	1	https://doi.org/10.1080/02791072.1979.1047209	https://doi.org/10.1080/02791072.1979.1047209	PROPN
gsrj-62	122	2	2	2	NUM
gsrj-62	122	3	4	4	NUM
gsrj-62	122	4	.	.	PUNCT
gsrj-62	123	1	bauer	bauer	PROPN
gsrj-62	123	2	,	,	PUNCT
gsrj-62	123	3	b.	b.	PROPN
gsrj-62	123	4	(	(	PUNCT
gsrj-62	123	5	2019	2019	NUM
gsrj-62	123	6	,	,	PUNCT
gsrj-62	123	7	december	december	PROPN
gsrj-62	123	8	05	05	NUM
gsrj-62	123	9	)	)	PUNCT
gsrj-62	123	10	.	.	PUNCT
gsrj-62	124	1	the	the	DET
gsrj-62	124	2	serotonin	serotonin	NOUN
gsrj-62	124	3	receptors	receptor	NOUN
gsrj-62	124	4	:	:	PUNCT
gsrj-62	124	5	comparing	compare	VERB
gsrj-62	124	6	the	the	DET
gsrj-62	124	7	binding	bind	VERB
gsrj-62	124	8	affinity	affinity	NOUN
gsrj-62	124	9	of	of	ADP
gsrj-62	124	10	5	5	NUM
gsrj-62	124	11	psychedelics	psychedelic	NOUN
gsrj-62	124	12	.	.	PUNCT
gsrj-62	125	1	psychedelic	psychedelic	ADJ
gsrj-62	125	2	science	science	NOUN
gsrj-62	125	3	review	review	NOUN
gsrj-62	125	4	.	.	PUNCT
gsrj-62	126	1	https://psychedelicreview.com/the-serotoninreceptors-comparing-the-binding-affinity-of-5psychedelics/	https://psychedelicreview.com/the-serotoninreceptors-comparing-the-binding-affinity-of-5psychedelics/	PROPN
gsrj-62	126	2	5	5	NUM
gsrj-62	126	3	.	.	PUNCT
gsrj-62	127	1	garcia	garcia	PROPN
gsrj-62	127	2	-	-	PUNCT
gsrj-62	127	3	romeu	romeu	PROPN
gsrj-62	127	4	,	,	PUNCT
gsrj-62	127	5	a.	a.	NOUN
gsrj-62	127	6	,	,	PUNCT
gsrj-62	127	7	kersgaard	kersgaard	NOUN
gsrj-62	127	8	,	,	PUNCT
gsrj-62	127	9	b.	b.	PROPN
gsrj-62	127	10	,	,	PUNCT
gsrj-62	127	11	&	&	CCONJ
gsrj-62	127	12	addy	addy	PROPN
gsrj-62	127	13	,	,	PUNCT
gsrj-62	127	14	p.	p.	NOUN
gsrj-62	127	15	h.	h.	PROPN
gsrj-62	127	16	(	(	PUNCT
gsrj-62	127	17	2016	2016	NUM
gsrj-62	127	18	)	)	PUNCT
gsrj-62	127	19	.	.	PUNCT
gsrj-62	128	1	clinical	clinical	ADJ
gsrj-62	128	2	applications	application	NOUN
gsrj-62	128	3	of	of	ADP
gsrj-62	128	4	hallucinogens	hallucinogen	NOUN
gsrj-62	128	5	:	:	PUNCT
gsrj-62	128	6	a	a	DET
gsrj-62	128	7	review	review	NOUN
gsrj-62	128	8	.	.	PUNCT
gsrj-62	129	1	experimental	experimental	ADJ
gsrj-62	129	2	and	and	CCONJ
gsrj-62	129	3	clinical	clinical	ADJ
gsrj-62	129	4	psychopharmacology	psychopharmacology	NOUN
gsrj-62	129	5	,	,	PUNCT
gsrj-62	129	6	24(4	24(4	NUM
gsrj-62	129	7	)	)	PUNCT
gsrj-62	129	8	,	,	PUNCT
gsrj-62	129	9	229–268	229–268	NUM
gsrj-62	129	10	.	.	PUNCT
gsrj-62	130	1	https://doi.org/10.1037/pha0000084	https://doi.org/10.1037/pha0000084	NOUN
gsrj-62	130	2	6	6	NUM
gsrj-62	130	3	.	.	PUNCT
gsrj-62	131	1	zhdanava	zhdanava	PROPN
gsrj-62	131	2	,	,	PUNCT
gsrj-62	131	3	m.	m.	NOUN
gsrj-62	131	4	,	,	PUNCT
gsrj-62	131	5	pilon	pilon	PROPN
gsrj-62	131	6	,	,	PUNCT
gsrj-62	131	7	d.	d.	PROPN
gsrj-62	131	8	,	,	PUNCT
gsrj-62	131	9	ghelerter	ghelerter	PROPN
gsrj-62	131	10	,	,	PUNCT
gsrj-62	131	11	i.	i.	PROPN
gsrj-62	131	12	,	,	PUNCT
gsrj-62	131	13	chow	chow	PROPN
gsrj-62	131	14	,	,	PUNCT
gsrj-62	131	15	w.	w.	PROPN
gsrj-62	131	16	,	,	PUNCT
gsrj-62	131	17	joshi	joshi	PROPN
gsrj-62	131	18	,	,	PUNCT
gsrj-62	131	19	k.	k.	PROPN
gsrj-62	131	20	,	,	PUNCT
gsrj-62	131	21	lefebvre	lefebvre	PROPN
gsrj-62	131	22	,	,	PUNCT
gsrj-62	131	23	p.	p.	PROPN
gsrj-62	131	24	,	,	PUNCT
gsrj-62	131	25	&	&	CCONJ
gsrj-62	131	26	sheehan	sheehan	PROPN
gsrj-62	131	27	,	,	PUNCT
gsrj-62	131	28	j.	j.	PROPN
gsrj-62	131	29	j.	j.	PROPN
gsrj-62	131	30	(	(	PUNCT
gsrj-62	131	31	2021	2021	NUM
gsrj-62	131	32	)	)	PUNCT
gsrj-62	131	33	.	.	PUNCT
gsrj-62	132	1	the	the	DET
gsrj-62	132	2	prevalence	prevalence	NOUN
gsrj-62	132	3	and	and	CCONJ
gsrj-62	132	4	national	national	ADJ
gsrj-62	132	5	burden	burden	NOUN
gsrj-62	132	6	of	of	ADP
gsrj-62	132	7	treatmentresistant	treatmentresistant	ADJ
gsrj-62	132	8	depression	depression	NOUN
gsrj-62	132	9	and	and	CCONJ
gsrj-62	132	10	major	major	ADJ
gsrj-62	132	11	depressive	depressive	ADJ
gsrj-62	132	12	disorder	disorder	NOUN
gsrj-62	132	13	in	in	ADP
gsrj-62	132	14	the	the	DET
gsrj-62	132	15	united	united	PROPN
gsrj-62	132	16	states	states	PROPN
gsrj-62	132	17	.	.	PUNCT
gsrj-62	133	1	the	the	DET
gsrj-62	133	2	journal	journal	NOUN
gsrj-62	133	3	of	of	ADP
gsrj-62	133	4	clinical	clinical	ADJ
gsrj-62	133	5	psychiatry	psychiatry	NOUN
gsrj-62	133	6	,	,	PUNCT
gsrj-62	133	7	82(2	82(2	NUM
gsrj-62	133	8	)	)	PUNCT
gsrj-62	133	9	,	,	PUNCT
gsrj-62	133	10	20m13699	20m13699	NUM
gsrj-62	133	11	.	.	PUNCT
gsrj-62	134	1	https://doi.org/10.4088/jcp.20m13699	https://doi.org/10.4088/jcp.20m13699	ADJ
gsrj-62	134	2	7	7	NUM
gsrj-62	134	3	.	.	PUNCT
gsrj-62	134	4	compass	compass	ADJ
gsrj-62	134	5	pathways	pathway	NOUN
gsrj-62	134	6	.	.	PUNCT
gsrj-62	135	1	(	(	PUNCT
gsrj-62	135	2	2022	2022	NUM
gsrj-62	135	3	)	)	PUNCT
gsrj-62	135	4	.	.	PUNCT
gsrj-62	136	1	the	the	DET
gsrj-62	136	2	safety	safety	NOUN
gsrj-62	136	3	and	and	CCONJ
gsrj-62	136	4	efficacy	efficacy	NOUN
gsrj-62	136	5	of	of	ADP
gsrj-62	136	6	psilocybin	psilocybin	NOUN
gsrj-62	136	7	in	in	ADP
gsrj-62	136	8	participants	participant	NOUN
gsrj-62	136	9	with	with	ADP
gsrj-62	136	10	treatment	treatment	NOUN
gsrj-62	136	11	resistant	resistant	ADJ
gsrj-62	136	12	depression	depression	NOUN
gsrj-62	136	13	(	(	PUNCT
gsrj-62	136	14	clinical	clinical	ADJ
gsrj-62	136	15	trial	trial	NOUN
gsrj-62	136	16	registration	registration	NOUN
gsrj-62	136	17	no	no	NOUN
gsrj-62	136	18	.	.	PUNCT
gsrj-62	136	19	nct03775200	nct03775200	PROPN
gsrj-62	136	20	)	)	PUNCT
gsrj-62	136	21	.	.	PUNCT
gsrj-62	137	1	clinicaltrials.gov	clinicaltrials.gov	X
gsrj-62	137	2	.	.	PUNCT
gsrj-62	138	1	https://clinicaltrials.gov/ct2/show/nct03775200	https://clinicaltrials.gov/ct2/show/nct03775200	PROPN
gsrj-62	138	2	8	8	NUM
gsrj-62	138	3	.	.	PUNCT
gsrj-62	139	1	usona	usona	PROPN
gsrj-62	139	2	institute	institute	PROPN
gsrj-62	139	3	.	.	PUNCT
gsrj-62	140	1	(	(	PUNCT
gsrj-62	140	2	2022	2022	NUM
gsrj-62	140	3	)	)	PUNCT
gsrj-62	140	4	.	.	PUNCT
gsrj-62	141	1	a	a	DET
gsrj-62	141	2	randomized	randomized	ADJ
gsrj-62	141	3	,	,	PUNCT
gsrj-62	141	4	doubleblind	doubleblind	NOUN
gsrj-62	141	5	,	,	PUNCT
gsrj-62	141	6	support	support	NOUN
gsrj-62	141	7	-	-	PUNCT
gsrj-62	141	8	of	of	ADP
gsrj-62	141	9	-	-	PUNCT
gsrj-62	141	10	concept	concept	NOUN
gsrj-62	141	11	phase	phase	NOUN
gsrj-62	141	12	2	2	NUM
gsrj-62	141	13	study	study	NOUN
gsrj-62	141	14	of	of	ADP
gsrj-62	141	15	single27	single27	PROPN
gsrj-62	141	16	georgetown	georgetown	PROPN
gsrj-62	141	17	scientific	scientific	PROPN
gsrj-62	141	18	research	research	PROPN
gsrj-62	141	19	journal	journal	PROPN
gsrj-62	141	20	dose	dose	NOUN
gsrj-62	141	21	psilocybin	psilocybin	NOUN
gsrj-62	141	22	for	for	ADP
gsrj-62	141	23	major	major	ADJ
gsrj-62	141	24	depressive	depressive	ADJ
gsrj-62	141	25	disorder	disorder	NOUN
gsrj-62	141	26	(	(	PUNCT
gsrj-62	141	27	mdd	mdd	PROPN
gsrj-62	141	28	)	)	PUNCT
gsrj-62	141	29	(	(	PUNCT
gsrj-62	141	30	clinical	clinical	ADJ
gsrj-62	141	31	trial	trial	NOUN
gsrj-62	141	32	registration	registration	NOUN
gsrj-62	141	33	no	no	NOUN
gsrj-62	141	34	.	.	PUNCT
gsrj-62	141	35	nct03866174	nct03866174	ADJ
gsrj-62	141	36	)	)	PUNCT
gsrj-62	141	37	.	.	PUNCT
gsrj-62	142	1	clinicaltrials.gov	clinicaltrials.gov	X
gsrj-62	142	2	.	.	PUNCT
gsrj-62	142	3	https://clinicaltrials.gov/ct2/show/nct03866174	https://clinicaltrials.gov/ct2/show/nct03866174	PROPN
gsrj-62	143	1	9	9	NUM
gsrj-62	143	2	.	.	X
gsrj-62	143	3	hamilton	hamilton	PROPN
gsrj-62	143	4	,	,	PUNCT
gsrj-62	143	5	j.	j.	PROPN
gsrj-62	143	6	p.	p.	PROPN
gsrj-62	143	7	,	,	PUNCT
gsrj-62	143	8	furman	furman	PROPN
gsrj-62	143	9	,	,	PUNCT
gsrj-62	143	10	d.	d.	PROPN
gsrj-62	143	11	j.	j.	PROPN
gsrj-62	143	12	,	,	PUNCT
gsrj-62	143	13	chang	chang	PROPN
gsrj-62	143	14	,	,	PUNCT
gsrj-62	143	15	c.	c.	PROPN
gsrj-62	143	16	,	,	PUNCT
gsrj-62	143	17	thomason	thomason	PROPN
gsrj-62	143	18	,	,	PUNCT
gsrj-62	143	19	m.	m.	PROPN
gsrj-62	143	20	e.	e.	PROPN
gsrj-62	143	21	,	,	PUNCT
gsrj-62	143	22	dennis	dennis	PROPN
gsrj-62	143	23	,	,	PUNCT
gsrj-62	143	24	e.	e.	PROPN
gsrj-62	143	25	,	,	PUNCT
gsrj-62	143	26	&	&	CCONJ
gsrj-62	143	27	gotlib	gotlib	PROPN
gsrj-62	143	28	,	,	PUNCT
gsrj-62	143	29	i.	i.	PROPN
gsrj-62	143	30	h.	h.	PROPN
gsrj-62	143	31	(	(	PUNCT
gsrj-62	143	32	2011	2011	NUM
gsrj-62	143	33	)	)	PUNCT
gsrj-62	143	34	.	.	PUNCT
gsrj-62	144	1	default	default	NOUN
gsrj-62	144	2	-	-	PUNCT
gsrj-62	144	3	mode	mode	NOUN
gsrj-62	144	4	and	and	CCONJ
gsrj-62	144	5	task	task	NOUN
gsrj-62	144	6	-	-	PUNCT
gsrj-62	144	7	positive	positive	ADJ
gsrj-62	144	8	network	network	NOUN
gsrj-62	144	9	activity	activity	NOUN
gsrj-62	144	10	in	in	ADP
gsrj-62	144	11	major	major	ADJ
gsrj-62	144	12	depressive	depressive	ADJ
gsrj-62	144	13	disorder	disorder	NOUN
gsrj-62	144	14	:	:	PUNCT
gsrj-62	144	15	implications	implication	NOUN
gsrj-62	144	16	for	for	ADP
gsrj-62	144	17	adaptive	adaptive	ADJ
gsrj-62	144	18	and	and	CCONJ
gsrj-62	144	19	maladaptive	maladaptive	ADJ
gsrj-62	144	20	rumination	rumination	NOUN
gsrj-62	144	21	.	.	PUNCT
gsrj-62	145	1	biological	biological	ADJ
gsrj-62	145	2	psychiatry	psychiatry	NOUN
gsrj-62	145	3	,	,	PUNCT
gsrj-62	145	4	70(4	70(4	NUM
gsrj-62	145	5	)	)	PUNCT
gsrj-62	145	6	,	,	PUNCT
gsrj-62	145	7	327–333	327–333	NUM
gsrj-62	145	8	.	.	PUNCT
gsrj-62	145	9	https://doi.org/10.1016/j.biopsych.2011.02.003	https://doi.org/10.1016/j.biopsych.2011.02.003	PROPN
gsrj-62	145	10	10	10	NUM
gsrj-62	145	11	.	.	PUNCT
gsrj-62	146	1	daws	daws	PROPN
gsrj-62	146	2	,	,	PUNCT
gsrj-62	146	3	r.	r.	PROPN
gsrj-62	146	4	e.	e.	PROPN
gsrj-62	146	5	,	,	PUNCT
gsrj-62	146	6	timmermann	timmermann	PROPN
gsrj-62	146	7	,	,	PUNCT
gsrj-62	146	8	c.	c.	PROPN
gsrj-62	146	9	,	,	PUNCT
gsrj-62	146	10	giribaldi	giribaldi	PROPN
gsrj-62	146	11	,	,	PUNCT
gsrj-62	146	12	b.	b.	PROPN
gsrj-62	146	13	,	,	PUNCT
gsrj-62	146	14	sexton	sexton	PROPN
gsrj-62	146	15	,	,	PUNCT
gsrj-62	146	16	j.	j.	PROPN
gsrj-62	146	17	d.	d.	PROPN
gsrj-62	146	18	,	,	PUNCT
gsrj-62	146	19	wall	wall	PROPN
gsrj-62	146	20	,	,	PUNCT
gsrj-62	146	21	m.	m.	PROPN
gsrj-62	146	22	b.	b.	PROPN
gsrj-62	146	23	,	,	PUNCT
gsrj-62	146	24	erritzoe	erritzoe	PROPN
gsrj-62	146	25	,	,	PUNCT
gsrj-62	146	26	d.	d.	PROPN
gsrj-62	146	27	,	,	PUNCT
gsrj-62	146	28	roseman	roseman	PROPN
gsrj-62	146	29	,	,	PUNCT
gsrj-62	146	30	l.	l.	PROPN
gsrj-62	146	31	,	,	PUNCT
gsrj-62	146	32	nutt	nutt	PROPN
gsrj-62	146	33	,	,	PUNCT
gsrj-62	146	34	d.	d.	PROPN
gsrj-62	146	35	,	,	PUNCT
gsrj-62	146	36	&	&	CCONJ
gsrj-62	146	37	carhart	carhart	NOUN
gsrj-62	146	38	-	-	PUNCT
gsrj-62	146	39	harris	harris	PROPN
gsrj-62	146	40	,	,	PUNCT
gsrj-62	146	41	r.	r.	PROPN
gsrj-62	146	42	(	(	PUNCT
gsrj-62	146	43	2022	2022	NUM
gsrj-62	146	44	)	)	PUNCT
gsrj-62	146	45	.	.	PUNCT
gsrj-62	147	1	increased	increase	VERB
gsrj-62	147	2	global	global	ADJ
gsrj-62	147	3	integration	integration	NOUN
gsrj-62	147	4	in	in	ADP
gsrj-62	147	5	the	the	DET
gsrj-62	147	6	brain	brain	NOUN
gsrj-62	147	7	after	after	ADP
gsrj-62	147	8	psilocybin	psilocybin	NOUN
gsrj-62	147	9	therapy	therapy	NOUN
gsrj-62	147	10	for	for	ADP
gsrj-62	147	11	depression	depression	NOUN
gsrj-62	147	12	.	.	PUNCT
gsrj-62	148	1	nature	nature	NOUN
gsrj-62	148	2	medicine	medicine	NOUN
gsrj-62	148	3	,	,	PUNCT
gsrj-62	148	4	28(4	28(4	NUM
gsrj-62	148	5	)	)	PUNCT
gsrj-62	148	6	,	,	PUNCT
gsrj-62	148	7	article	article	NOUN
gsrj-62	148	8	4	4	NUM
gsrj-62	148	9	.	.	PUNCT
gsrj-62	149	1	https://doi.org/10.1038/s41591-022-01744-z	https://doi.org/10.1038/s41591-022-01744-z	PROPN
gsrj-62	149	2	11	11	NUM
gsrj-62	149	3	.	.	PUNCT
gsrj-62	150	1	carhart	carhart	NOUN
gsrj-62	150	2	-	-	PUNCT
gsrj-62	150	3	harris	harris	PROPN
gsrj-62	150	4	,	,	PUNCT
gsrj-62	150	5	r.	r.	PROPN
gsrj-62	150	6	,	,	PUNCT
gsrj-62	150	7	giribaldi	giribaldi	PROPN
gsrj-62	150	8	,	,	PUNCT
gsrj-62	150	9	b.	b.	PROPN
gsrj-62	150	10	,	,	PUNCT
gsrj-62	150	11	watts	watts	PROPN
gsrj-62	150	12	,	,	PUNCT
gsrj-62	150	13	r.	r.	PROPN
gsrj-62	150	14	,	,	PUNCT
gsrj-62	150	15	baker	baker	PROPN
gsrj-62	150	16	-	-	PUNCT
gsrj-62	150	17	jones	jones	PROPN
gsrj-62	150	18	,	,	PUNCT
gsrj-62	150	19	m.	m.	NOUN
gsrj-62	150	20	,	,	PUNCT
gsrj-62	150	21	murphy	murphy	NOUN
gsrj-62	150	22	-	-	PUNCT
gsrj-62	150	23	beiner	beiner	NOUN
gsrj-62	150	24	,	,	PUNCT
gsrj-62	150	25	a.	a.	PROPN
gsrj-62	150	26	,	,	PUNCT
gsrj-62	150	27	murphy	murphy	PROPN
gsrj-62	150	28	,	,	PUNCT
gsrj-62	150	29	r.	r.	PROPN
gsrj-62	150	30	,	,	PUNCT
gsrj-62	150	31	martell	martell	PROPN
gsrj-62	150	32	,	,	PUNCT
gsrj-62	150	33	j.	j.	PROPN
gsrj-62	150	34	,	,	PUNCT
gsrj-62	150	35	blemings	bleming	NOUN
gsrj-62	150	36	,	,	PUNCT
gsrj-62	150	37	a.	a.	NOUN
gsrj-62	150	38	,	,	PUNCT
gsrj-62	150	39	erritzoe	erritzoe	PROPN
gsrj-62	150	40	,	,	PUNCT
gsrj-62	150	41	d.	d.	PROPN
gsrj-62	150	42	,	,	PUNCT
gsrj-62	150	43	&	&	CCONJ
gsrj-62	150	44	nutt	nutt	PROPN
gsrj-62	150	45	,	,	PUNCT
gsrj-62	150	46	d.	d.	PROPN
gsrj-62	150	47	j.	j.	PROPN
gsrj-62	150	48	(	(	PUNCT
gsrj-62	150	49	2021	2021	NUM
gsrj-62	150	50	)	)	PUNCT
gsrj-62	150	51	.	.	PUNCT
gsrj-62	151	1	trial	trial	NOUN
gsrj-62	151	2	of	of	ADP
gsrj-62	151	3	psilocybin	psilocybin	NOUN
gsrj-62	151	4	versus	versus	ADP
gsrj-62	151	5	escitalopram	escitalopram	PROPN
gsrj-62	151	6	for	for	ADP
gsrj-62	151	7	depression	depression	NOUN
gsrj-62	151	8	.	.	PUNCT
gsrj-62	152	1	the	the	DET
gsrj-62	152	2	new	new	PROPN
gsrj-62	152	3	england	england	PROPN
gsrj-62	152	4	journal	journal	PROPN
gsrj-62	152	5	of	of	ADP
gsrj-62	152	6	medicine	medicine	NOUN
gsrj-62	152	7	,	,	PUNCT
gsrj-62	152	8	384(15	384(15	NUM
gsrj-62	152	9	)	)	PUNCT
gsrj-62	152	10	,	,	PUNCT
gsrj-62	152	11	1402–1411	1402–1411	NUM
gsrj-62	152	12	.	.	PUNCT
gsrj-62	153	1	https://doi.org/10.1056/nejmoa2032994	https://doi.org/10.1056/nejmoa2032994	PROPN
gsrj-62	153	2	12	12	NUM
gsrj-62	153	3	.	.	PUNCT
gsrj-62	154	1	luppi	luppi	PROPN
gsrj-62	154	2	,	,	PUNCT
gsrj-62	154	3	a.	a.	NOUN
gsrj-62	154	4	i.	i.	PROPN
gsrj-62	154	5	,	,	PUNCT
gsrj-62	154	6	carhart	carhart	NOUN
gsrj-62	154	7	-	-	PUNCT
gsrj-62	154	8	harris	harris	PROPN
gsrj-62	154	9	,	,	PUNCT
gsrj-62	154	10	r.	r.	PROPN
gsrj-62	154	11	l.	l.	PROPN
gsrj-62	154	12	,	,	PUNCT
gsrj-62	154	13	roseman	roseman	PROPN
gsrj-62	154	14	,	,	PUNCT
gsrj-62	154	15	l.	l.	PROPN
gsrj-62	154	16	,	,	PUNCT
gsrj-62	154	17	pappas	pappas	PROPN
gsrj-62	154	18	,	,	PUNCT
gsrj-62	154	19	i.	i.	PROPN
gsrj-62	154	20	,	,	PUNCT
gsrj-62	154	21	menon	menon	PROPN
gsrj-62	154	22	,	,	PUNCT
gsrj-62	154	23	d.	d.	PROPN
gsrj-62	154	24	k.	k.	PROPN
gsrj-62	154	25	,	,	PUNCT
gsrj-62	154	26	&	&	CCONJ
gsrj-62	154	27	stamatakis	stamatakis	PROPN
gsrj-62	154	28	,	,	PUNCT
gsrj-62	154	29	e.	e.	PROPN
gsrj-62	154	30	a.	a.	PROPN
gsrj-62	154	31	(	(	PUNCT
gsrj-62	154	32	2021	2021	NUM
gsrj-62	154	33	)	)	PUNCT
gsrj-62	154	34	.	.	PUNCT
gsrj-62	155	1	lsd	lsd	PROPN
gsrj-62	155	2	alters	alter	VERB
gsrj-62	155	3	dynamic	dynamic	ADJ
gsrj-62	155	4	integration	integration	NOUN
gsrj-62	155	5	and	and	CCONJ
gsrj-62	155	6	segregation	segregation	NOUN
gsrj-62	155	7	in	in	ADP
gsrj-62	155	8	the	the	DET
gsrj-62	155	9	human	human	ADJ
gsrj-62	155	10	brain	brain	NOUN
gsrj-62	155	11	.	.	PUNCT
gsrj-62	156	1	neuroimage	neuroimage	NOUN
gsrj-62	156	2	,	,	PUNCT
gsrj-62	156	3	227	227	NUM
gsrj-62	156	4	,	,	PUNCT
gsrj-62	156	5	117653	117653	NUM
gsrj-62	156	6	.	.	PUNCT
gsrj-62	157	1	https://doi.org/10.1016/j.neuroimage.2020.11765	https://doi.org/10.1016/j.neuroimage.2020.11765	PROPN
gsrj-62	157	2	3	3	NUM
gsrj-62	157	3	13	13	NUM
gsrj-62	157	4	.	.	PUNCT
gsrj-62	158	1	gonzález	gonzález	PROPN
gsrj-62	158	2	-	-	PUNCT
gsrj-62	158	3	maeso	maeso	PROPN
gsrj-62	158	4	,	,	PUNCT
gsrj-62	158	5	j.	j.	PROPN
gsrj-62	158	6	,	,	PUNCT
gsrj-62	158	7	weisstaub	weisstaub	VERB
gsrj-62	158	8	,	,	PUNCT
gsrj-62	158	9	n.	n.	PROPN
gsrj-62	159	1	v.	v.	PROPN
gsrj-62	159	2	,	,	PUNCT
gsrj-62	159	3	zhou	zhou	PROPN
gsrj-62	159	4	,	,	PUNCT
gsrj-62	159	5	m.	m.	NOUN
gsrj-62	159	6	,	,	PUNCT
gsrj-62	159	7	chan	chan	PROPN
gsrj-62	159	8	,	,	PUNCT
gsrj-62	159	9	p.	p.	PROPN
gsrj-62	159	10	,	,	PUNCT
gsrj-62	159	11	ivic	ivic	PROPN
gsrj-62	159	12	,	,	PUNCT
gsrj-62	159	13	l.	l.	PROPN
gsrj-62	159	14	,	,	PUNCT
gsrj-62	159	15	ang	ang	PROPN
gsrj-62	159	16	,	,	PUNCT
gsrj-62	159	17	r.	r.	PROPN
gsrj-62	159	18	,	,	PUNCT
gsrj-62	159	19	lira	lira	PROPN
gsrj-62	159	20	,	,	PUNCT
gsrj-62	159	21	a.	a.	NOUN
gsrj-62	159	22	,	,	PUNCT
gsrj-62	159	23	bradleymoore	bradleymoore	ADV
gsrj-62	159	24	,	,	PUNCT
gsrj-62	159	25	m.	m.	NOUN
gsrj-62	159	26	,	,	PUNCT
gsrj-62	159	27	ge	ge	PROPN
gsrj-62	159	28	,	,	PUNCT
gsrj-62	159	29	y.	y.	PROPN
gsrj-62	159	30	,	,	PUNCT
gsrj-62	159	31	zhou	zhou	PROPN
gsrj-62	159	32	,	,	PUNCT
gsrj-62	159	33	q.	q.	PROPN
gsrj-62	159	34	,	,	PUNCT
gsrj-62	159	35	sealfon	sealfon	PROPN
gsrj-62	159	36	,	,	PUNCT
gsrj-62	159	37	s.	s.	PROPN
gsrj-62	159	38	c.	c.	PROPN
gsrj-62	159	39	,	,	PUNCT
gsrj-62	159	40	&	&	CCONJ
gsrj-62	159	41	gingrich	gingrich	PROPN
gsrj-62	159	42	,	,	PUNCT
gsrj-62	159	43	j.	j.	PROPN
gsrj-62	159	44	a.	a.	PROPN
gsrj-62	159	45	(	(	PUNCT
gsrj-62	159	46	2007	2007	NUM
gsrj-62	159	47	)	)	PUNCT
gsrj-62	159	48	.	.	PUNCT
gsrj-62	160	1	hallucinogens	hallucinogen	NOUN
gsrj-62	160	2	recruit	recruit	VERB
gsrj-62	160	3	specific	specific	ADJ
gsrj-62	160	4	cortical	cortical	ADJ
gsrj-62	160	5	5	5	NUM
gsrj-62	160	6	-	-	PUNCT
gsrj-62	160	7	ht2a	ht2a	NOUN
gsrj-62	160	8	receptor	receptor	NOUN
gsrj-62	160	9	-	-	PUNCT
gsrj-62	160	10	mediated	mediate	VERB
gsrj-62	160	11	signaling	signal	VERB
gsrj-62	160	12	pathways	pathway	NOUN
gsrj-62	160	13	to	to	PART
gsrj-62	160	14	affect	affect	VERB
gsrj-62	160	15	behavior	behavior	NOUN
gsrj-62	160	16	.	.	PUNCT
gsrj-62	161	1	neuron	neuron	PROPN
gsrj-62	161	2	,	,	PUNCT
gsrj-62	161	3	53(3	53(3	NUM
gsrj-62	161	4	)	)	PUNCT
gsrj-62	161	5	,	,	PUNCT
gsrj-62	161	6	439–452	439–452	NUM
gsrj-62	161	7	.	.	PUNCT
gsrj-62	162	1	https://doi.org/10.1016/j.neuron.2007.01.008	https://doi.org/10.1016/j.neuron.2007.01.008	NOUN
gsrj-62	162	2	14	14	NUM
gsrj-62	162	3	.	.	PUNCT
gsrj-62	163	1	ling	ling	PROPN
gsrj-62	163	2	,	,	PUNCT
gsrj-62	163	3	s.	s.	PROPN
gsrj-62	163	4	,	,	PUNCT
gsrj-62	163	5	ceban	ceban	PROPN
gsrj-62	163	6	,	,	PUNCT
gsrj-62	163	7	f.	f.	PROPN
gsrj-62	163	8	,	,	PUNCT
gsrj-62	163	9	lui	lui	PROPN
gsrj-62	163	10	,	,	PUNCT
gsrj-62	163	11	l.	l.	PROPN
gsrj-62	163	12	m.	m.	PROPN
gsrj-62	163	13	w.	w.	PROPN
gsrj-62	163	14	,	,	PUNCT
gsrj-62	163	15	lee	lee	PROPN
gsrj-62	163	16	,	,	PUNCT
gsrj-62	163	17	y.	y.	PROPN
gsrj-62	163	18	,	,	PUNCT
gsrj-62	163	19	teopiz	teopiz	VERB
gsrj-62	163	20	,	,	PUNCT
gsrj-62	163	21	k.	k.	PROPN
gsrj-62	163	22	m.	m.	PROPN
gsrj-62	163	23	,	,	PUNCT
gsrj-62	163	24	rodrigues	rodrigues	PROPN
gsrj-62	163	25	,	,	PUNCT
gsrj-62	163	26	n.	n.	PROPN
gsrj-62	163	27	b.	b.	PROPN
gsrj-62	163	28	,	,	PUNCT
gsrj-62	163	29	lipsitz	lipsitz	PROPN
gsrj-62	163	30	,	,	PUNCT
gsrj-62	163	31	o.	o.	NOUN
gsrj-62	163	32	,	,	PUNCT
gsrj-62	163	33	gill	gill	PROPN
gsrj-62	163	34	,	,	PUNCT
gsrj-62	163	35	h.	h.	PROPN
gsrj-62	163	36	,	,	PUNCT
gsrj-62	163	37	subramaniapillai	subramaniapillai	PROPN
gsrj-62	163	38	,	,	PUNCT
gsrj-62	163	39	m.	m.	NOUN
gsrj-62	163	40	,	,	PUNCT
gsrj-62	163	41	mansur	mansur	PROPN
gsrj-62	163	42	,	,	PUNCT
gsrj-62	163	43	r.	r.	PROPN
gsrj-62	163	44	b.	b.	PROPN
gsrj-62	163	45	,	,	PUNCT
gsrj-62	163	46	lin	lin	PROPN
gsrj-62	163	47	,	,	PUNCT
gsrj-62	163	48	k.	k.	PROPN
gsrj-62	163	49	,	,	PUNCT
gsrj-62	163	50	ho	ho	PROPN
gsrj-62	163	51	,	,	PUNCT
gsrj-62	163	52	r.	r.	PROPN
gsrj-62	163	53	,	,	PUNCT
gsrj-62	163	54	rosenblat	rosenblat	NOUN
gsrj-62	163	55	,	,	PUNCT
gsrj-62	163	56	j.	j.	PROPN
gsrj-62	163	57	d.	d.	PROPN
gsrj-62	163	58	,	,	PUNCT
gsrj-62	163	59	castle	castle	PROPN
gsrj-62	163	60	,	,	PUNCT
gsrj-62	163	61	d.	d.	PROPN
gsrj-62	163	62	,	,	PUNCT
gsrj-62	163	63	&	&	CCONJ
gsrj-62	163	64	mcintyre	mcintyre	PROPN
gsrj-62	163	65	,	,	PUNCT
gsrj-62	163	66	r.	r.	PROPN
gsrj-62	163	67	s.	s.	PROPN
gsrj-62	163	68	(	(	PUNCT
gsrj-62	163	69	2022	2022	NUM
gsrj-62	163	70	)	)	PUNCT
gsrj-62	163	71	.	.	PUNCT
gsrj-62	164	1	molecular	molecular	ADJ
gsrj-62	164	2	mechanisms	mechanism	NOUN
gsrj-62	164	3	of	of	ADP
gsrj-62	164	4	psilocybin	psilocybin	NOUN
gsrj-62	164	5	and	and	CCONJ
gsrj-62	164	6	implications	implication	NOUN
gsrj-62	164	7	for	for	ADP
gsrj-62	164	8	the	the	DET
gsrj-62	164	9	treatment	treatment	NOUN
gsrj-62	164	10	of	of	ADP
gsrj-62	164	11	depression	depression	NOUN
gsrj-62	164	12	.	.	PUNCT
gsrj-62	165	1	cns	cns	NOUN
gsrj-62	165	2	drugs	drug	NOUN
gsrj-62	165	3	,	,	PUNCT
gsrj-62	165	4	36(1	36(1	NUM
gsrj-62	165	5	)	)	PUNCT
gsrj-62	165	6	,	,	PUNCT
gsrj-62	165	7	17–30	17–30	NUM
gsrj-62	165	8	.	.	PUNCT
gsrj-62	166	1	https://doi.org/10.1007/s40263-021-00877-y	https://doi.org/10.1007/s40263-021-00877-y	PROPN
gsrj-62	166	2	15	15	NUM
gsrj-62	166	3	.	.	PUNCT
gsrj-62	167	1	gonzález	gonzález	PROPN
gsrj-62	167	2	-	-	PUNCT
gsrj-62	167	3	maeso	maeso	PROPN
gsrj-62	167	4	,	,	PUNCT
gsrj-62	167	5	j.	j.	PROPN
gsrj-62	167	6	,	,	PUNCT
gsrj-62	167	7	ang	ang	PROPN
gsrj-62	167	8	,	,	PUNCT
gsrj-62	167	9	r.	r.	PROPN
gsrj-62	167	10	,	,	PUNCT
gsrj-62	167	11	yuen	yuen	PROPN
gsrj-62	167	12	,	,	PUNCT
gsrj-62	167	13	t.	t.	PROPN
gsrj-62	167	14	,	,	PUNCT
gsrj-62	167	15	weisstaub	weisstaub	NOUN
gsrj-62	167	16	,	,	PUNCT
gsrj-62	167	17	n.	n.	PROPN
gsrj-62	167	18	v.	v.	PROPN
gsrj-62	167	19	,	,	PUNCT
gsrj-62	167	20	lópez	lópez	NOUN
gsrj-62	167	21	-	-	PUNCT
gsrj-62	167	22	giménez	giménez	PROPN
gsrj-62	167	23	,	,	PUNCT
gsrj-62	167	24	j.	j.	PROPN
gsrj-62	167	25	f.	f.	PROPN
gsrj-62	167	26	,	,	PUNCT
gsrj-62	167	27	zhou	zhou	PROPN
gsrj-62	167	28	,	,	PUNCT
gsrj-62	167	29	m.	m.	NOUN
gsrj-62	167	30	,	,	PUNCT
gsrj-62	167	31	okawa	okawa	PROPN
gsrj-62	167	32	,	,	PUNCT
gsrj-62	167	33	y.	y.	PROPN
gsrj-62	167	34	,	,	PUNCT
gsrj-62	167	35	callado	callado	X
gsrj-62	167	36	,	,	PUNCT
gsrj-62	167	37	l.	l.	PROPN
gsrj-62	167	38	f.	f.	PROPN
gsrj-62	167	39	,	,	PUNCT
gsrj-62	167	40	milligan	milligan	PROPN
gsrj-62	167	41	,	,	PUNCT
gsrj-62	167	42	g.	g.	PROPN
gsrj-62	167	43	,	,	PUNCT
gsrj-62	167	44	gingrich	gingrich	PROPN
gsrj-62	167	45	,	,	PUNCT
gsrj-62	167	46	j.	j.	PROPN
gsrj-62	167	47	a.	a.	PROPN
gsrj-62	167	48	,	,	PUNCT
gsrj-62	167	49	filizola	filizola	PROPN
gsrj-62	167	50	,	,	PUNCT
gsrj-62	167	51	m.	m.	NOUN
gsrj-62	167	52	,	,	PUNCT
gsrj-62	167	53	meana	meana	PROPN
gsrj-62	167	54	,	,	PUNCT
gsrj-62	167	55	j.	j.	PROPN
gsrj-62	167	56	j.	j.	PROPN
gsrj-62	167	57	,	,	PUNCT
gsrj-62	167	58	&	&	CCONJ
gsrj-62	167	59	sealfon	sealfon	PROPN
gsrj-62	167	60	,	,	PUNCT
gsrj-62	167	61	s.	s.	PROPN
gsrj-62	167	62	c.	c.	PROPN
gsrj-62	167	63	(	(	PUNCT
gsrj-62	167	64	2008	2008	NUM
gsrj-62	167	65	)	)	PUNCT
gsrj-62	167	66	.	.	PUNCT
gsrj-62	168	1	identification	identification	NOUN
gsrj-62	168	2	of	of	ADP
gsrj-62	168	3	a	a	DET
gsrj-62	168	4	novel	novel	NOUN
gsrj-62	168	5	serotonin	serotonin	NOUN
gsrj-62	168	6	/	/	SYM
gsrj-62	168	7	glutamate	glutamate	NOUN
gsrj-62	168	8	receptor	receptor	NOUN
gsrj-62	168	9	complex	complex	NOUN
gsrj-62	168	10	implicated	implicate	VERB
gsrj-62	168	11	in	in	ADP
gsrj-62	168	12	psychosis	psychosis	NOUN
gsrj-62	168	13	.	.	PUNCT
gsrj-62	169	1	nature	nature	NOUN
gsrj-62	169	2	,	,	PUNCT
gsrj-62	169	3	452(7183	452(7183	NUM
gsrj-62	169	4	)	)	PUNCT
gsrj-62	169	5	,	,	PUNCT
gsrj-62	169	6	93–97	93–97	NUM
gsrj-62	169	7	.	.	PUNCT
gsrj-62	170	1	https://doi.org/10.1038/nature06612	https://doi.org/10.1038/nature06612	PROPN
gsrj-62	170	2	16	16	NUM
gsrj-62	170	3	.	.	PUNCT
gsrj-62	171	1	moreno	moreno	PROPN
gsrj-62	171	2	,	,	PUNCT
gsrj-62	171	3	j.	j.	PROPN
gsrj-62	171	4	l.	l.	PROPN
gsrj-62	171	5	,	,	PUNCT
gsrj-62	171	6	holloway	holloway	PROPN
gsrj-62	171	7	,	,	PUNCT
gsrj-62	171	8	t.	t.	PROPN
gsrj-62	171	9	,	,	PUNCT
gsrj-62	171	10	albizu	albizu	PROPN
gsrj-62	171	11	,	,	PUNCT
gsrj-62	171	12	l.	l.	PROPN
gsrj-62	171	13	,	,	PUNCT
gsrj-62	171	14	sealfon	sealfon	PROPN
gsrj-62	171	15	,	,	PUNCT
gsrj-62	171	16	s.	s.	PROPN
gsrj-62	171	17	c.	c.	PROPN
gsrj-62	171	18	,	,	PUNCT
gsrj-62	171	19	&	&	CCONJ
gsrj-62	171	20	gonzález	gonzález	PROPN
gsrj-62	171	21	-	-	PUNCT
gsrj-62	171	22	maeso	maeso	PROPN
gsrj-62	171	23	,	,	PUNCT
gsrj-62	171	24	j.	j.	PROPN
gsrj-62	171	25	(	(	PUNCT
gsrj-62	171	26	2011	2011	NUM
gsrj-62	171	27	)	)	PUNCT
gsrj-62	171	28	.	.	PUNCT
gsrj-62	172	1	metabotropic	metabotropic	NOUN
gsrj-62	172	2	glutamate	glutamate	PROPN
gsrj-62	172	3	mglu2	mglu2	NOUN
gsrj-62	172	4	receptor	receptor	NOUN
gsrj-62	172	5	is	be	AUX
gsrj-62	172	6	necessary	necessary	ADJ
gsrj-62	172	7	for	for	ADP
gsrj-62	172	8	the	the	DET
gsrj-62	172	9	pharmacological	pharmacological	ADJ
gsrj-62	172	10	and	and	CCONJ
gsrj-62	172	11	behavioral	behavioral	ADJ
gsrj-62	172	12	effects	effect	NOUN
gsrj-62	172	13	induced	induce	VERB
gsrj-62	172	14	by	by	ADP
gsrj-62	172	15	hallucinogenic	hallucinogenic	ADJ
gsrj-62	172	16	5	5	NUM
gsrj-62	172	17	-	-	PUNCT
gsrj-62	172	18	ht2a	ht2a	NOUN
gsrj-62	172	19	receptor	receptor	NOUN
gsrj-62	172	20	agonists	agonist	NOUN
gsrj-62	172	21	.	.	PUNCT
gsrj-62	173	1	neuroscience	neuroscience	NOUN
gsrj-62	173	2	letters	letter	NOUN
gsrj-62	173	3	,	,	PUNCT
gsrj-62	173	4	493(3	493(3	NUM
gsrj-62	173	5	)	)	PUNCT
gsrj-62	173	6	,	,	PUNCT
gsrj-62	173	7	76–79	76–79	ADV
gsrj-62	173	8	.	.	PUNCT
gsrj-62	174	1	https://doi.org/10.1016/j.neulet.2011.01.046	https://doi.org/10.1016/j.neulet.2011.01.046	NOUN
gsrj-62	174	2	17	17	NUM
gsrj-62	174	3	.	.	PUNCT
gsrj-62	175	1	halberstadt	halberstadt	NOUN
gsrj-62	175	2	,	,	PUNCT
gsrj-62	175	3	a.	a.	PROPN
gsrj-62	175	4	l.	l.	PROPN
gsrj-62	175	5	,	,	PUNCT
gsrj-62	175	6	&	&	CCONJ
gsrj-62	175	7	geyer	geyer	PROPN
gsrj-62	175	8	,	,	PUNCT
gsrj-62	175	9	m.	m.	NOUN
gsrj-62	175	10	a.	a.	NOUN
gsrj-62	175	11	(	(	PUNCT
gsrj-62	175	12	2013	2013	NUM
gsrj-62	175	13	)	)	PUNCT
gsrj-62	175	14	.	.	PUNCT
gsrj-62	176	1	characterization	characterization	NOUN
gsrj-62	176	2	of	of	ADP
gsrj-62	176	3	the	the	DET
gsrj-62	176	4	head	head	NOUN
gsrj-62	176	5	-	-	PUNCT
gsrj-62	176	6	twitch	twitch	NOUN
gsrj-62	176	7	response	response	NOUN
gsrj-62	176	8	induced	induce	VERB
gsrj-62	176	9	by	by	ADP
gsrj-62	176	10	hallucinogens	hallucinogen	NOUN
gsrj-62	176	11	in	in	ADP
gsrj-62	176	12	mice	mouse	NOUN
gsrj-62	176	13	:	:	PUNCT
gsrj-62	176	14	detection	detection	NOUN
gsrj-62	176	15	of	of	ADP
gsrj-62	176	16	the	the	DET
gsrj-62	176	17	behavior	behavior	NOUN
gsrj-62	176	18	based	base	VERB
gsrj-62	176	19	on	on	ADP
gsrj-62	176	20	the	the	DET
gsrj-62	176	21	dynamics	dynamic	NOUN
gsrj-62	176	22	of	of	ADP
gsrj-62	176	23	head	head	NOUN
gsrj-62	176	24	movement	movement	NOUN
gsrj-62	176	25	.	.	PUNCT
gsrj-62	177	1	psychopharmacology	psychopharmacology	NOUN
gsrj-62	177	2	,	,	PUNCT
gsrj-62	177	3	227(4	227(4	NUM
gsrj-62	177	4	)	)	PUNCT
gsrj-62	177	5	,	,	PUNCT
gsrj-62	177	6	10.1007	10.1007	NUM
gsrj-62	177	7	/	/	SYM
gsrj-62	177	8	s00213013	s00213013	PROPN
gsrj-62	177	9	-	-	PUNCT
gsrj-62	177	10	3006	3006	NUM
gsrj-62	177	11	-	-	PUNCT
gsrj-62	177	12	z.	z.	PROPN
gsrj-62	177	13	https://doi.org/10.1007/s00213-0133006-z	https://doi.org/10.1007/s00213-0133006-z	NUM
gsrj-62	177	14	18	18	NUM
gsrj-62	177	15	.	.	PUNCT
gsrj-62	178	1	benvenga	benvenga	PROPN
gsrj-62	178	2	,	,	PUNCT
gsrj-62	178	3	m.	m.	PROPN
gsrj-62	178	4	j.	j.	PROPN
gsrj-62	178	5	,	,	PUNCT
gsrj-62	178	6	chaney	chaney	PROPN
gsrj-62	178	7	,	,	PUNCT
gsrj-62	178	8	s.	s.	PROPN
gsrj-62	178	9	f.	f.	PROPN
gsrj-62	178	10	,	,	PUNCT
gsrj-62	178	11	baez	baez	PROPN
gsrj-62	178	12	,	,	PUNCT
gsrj-62	178	13	m.	m.	NOUN
gsrj-62	178	14	,	,	PUNCT
gsrj-62	178	15	britton	britton	PROPN
gsrj-62	178	16	,	,	PUNCT
gsrj-62	178	17	t.	t.	PROPN
gsrj-62	178	18	c.	c.	PROPN
gsrj-62	178	19	,	,	PUNCT
gsrj-62	178	20	hornback	hornback	NOUN
gsrj-62	178	21	,	,	PUNCT
gsrj-62	178	22	w.	w.	PROPN
gsrj-62	178	23	j.	j.	PROPN
gsrj-62	178	24	,	,	PUNCT
gsrj-62	178	25	monn	monn	PROPN
gsrj-62	178	26	,	,	PUNCT
gsrj-62	178	27	j.	j.	PROPN
gsrj-62	178	28	a.	a.	PROPN
gsrj-62	178	29	,	,	PUNCT
gsrj-62	178	30	&	&	CCONJ
gsrj-62	178	31	marek	marek	PROPN
gsrj-62	178	32	,	,	PUNCT
gsrj-62	178	33	g.	g.	PROPN
gsrj-62	178	34	j.	j.	PROPN
gsrj-62	178	35	(	(	PUNCT
gsrj-62	178	36	2018	2018	NUM
gsrj-62	178	37	)	)	PUNCT
gsrj-62	178	38	.	.	PUNCT
gsrj-62	179	1	metabotropic	metabotropic	NOUN
gsrj-62	179	2	glutamate2	glutamate2	NOUN
gsrj-62	179	3	receptors	receptor	NOUN
gsrj-62	179	4	play	play	VERB
gsrj-62	179	5	a	a	DET
gsrj-62	179	6	key	key	ADJ
gsrj-62	179	7	role	role	NOUN
gsrj-62	179	8	in	in	ADP
gsrj-62	179	9	modulating	modulate	VERB
gsrj-62	179	10	head	head	NOUN
gsrj-62	179	11	twitches	twitch	NOUN
gsrj-62	179	12	induced	induce	VERB
gsrj-62	179	13	by	by	ADP
gsrj-62	179	14	a	a	DET
gsrj-62	179	15	serotonergic	serotonergic	ADJ
gsrj-62	179	16	hallucinogen	hallucinogen	NOUN
gsrj-62	179	17	in	in	ADP
gsrj-62	179	18	mice	mouse	NOUN
gsrj-62	179	19	.	.	PUNCT
gsrj-62	180	1	frontiers	frontier	NOUN
gsrj-62	180	2	in	in	ADP
gsrj-62	180	3	pharmacology	pharmacology	NOUN
gsrj-62	180	4	,	,	PUNCT
gsrj-62	180	5	9	9	NUM
gsrj-62	180	6	,	,	PUNCT
gsrj-62	180	7	208	208	NUM
gsrj-62	180	8	.	.	PUNCT
gsrj-62	181	1	https://doi.org/10.3389/fphar.2018.00208	https://doi.org/10.3389/fphar.2018.00208	PROPN
gsrj-62	181	2	19	19	NUM
gsrj-62	181	3	.	.	PUNCT
gsrj-62	181	4	delille	delille	PROPN
gsrj-62	181	5	,	,	PUNCT
gsrj-62	181	6	h.	h.	PROPN
gsrj-62	181	7	k.	k.	PROPN
gsrj-62	181	8	,	,	PUNCT
gsrj-62	181	9	becker	becker	PROPN
gsrj-62	181	10	,	,	PUNCT
gsrj-62	181	11	j.	j.	PROPN
gsrj-62	181	12	m.	m.	PROPN
gsrj-62	181	13	,	,	PUNCT
gsrj-62	181	14	burkhardt	burkhardt	PROPN
gsrj-62	181	15	,	,	PUNCT
gsrj-62	181	16	s.	s.	PROPN
gsrj-62	181	17	,	,	PUNCT
gsrj-62	181	18	bleher	bleher	PROPN
gsrj-62	181	19	,	,	PUNCT
gsrj-62	181	20	b.	b.	PROPN
gsrj-62	181	21	,	,	PUNCT
gsrj-62	181	22	terstappen	terstappen	NOUN
gsrj-62	181	23	,	,	PUNCT
gsrj-62	181	24	g.	g.	PROPN
gsrj-62	181	25	c.	c.	PROPN
gsrj-62	181	26	,	,	PUNCT
gsrj-62	181	27	schmidt	schmidt	PROPN
gsrj-62	181	28	,	,	PUNCT
gsrj-62	181	29	m.	m.	NOUN
gsrj-62	181	30	,	,	PUNCT
gsrj-62	181	31	meyer	meyer	PROPN
gsrj-62	181	32	,	,	PUNCT
gsrj-62	181	33	a.	a.	PROPN
gsrj-62	181	34	h.	h.	PROPN
gsrj-62	181	35	,	,	PUNCT
gsrj-62	181	36	unger	unger	PROPN
gsrj-62	181	37	,	,	PUNCT
gsrj-62	181	38	l.	l.	PROPN
gsrj-62	181	39	,	,	PUNCT
gsrj-62	181	40	marek	marek	PROPN
gsrj-62	181	41	,	,	PUNCT
gsrj-62	181	42	g.	g.	PROPN
gsrj-62	181	43	j.	j.	PROPN
gsrj-62	181	44	,	,	PUNCT
gsrj-62	181	45	&	&	CCONJ
gsrj-62	181	46	mezler	mezler	NOUN
gsrj-62	181	47	,	,	PUNCT
gsrj-62	181	48	m.	m.	NOUN
gsrj-62	181	49	(	(	PUNCT
gsrj-62	181	50	2012	2012	NUM
gsrj-62	181	51	)	)	PUNCT
gsrj-62	181	52	.	.	PUNCT
gsrj-62	182	1	heterocomplex	heterocomplex	ADJ
gsrj-62	182	2	formation	formation	NOUN
gsrj-62	182	3	of	of	ADP
gsrj-62	182	4	5	5	NUM
gsrj-62	182	5	-	-	PUNCT
gsrj-62	182	6	ht2a	ht2a	NUM
gsrj-62	182	7	-	-	PUNCT
gsrj-62	182	8	mglu2	mglu2	NOUN
gsrj-62	182	9	and	and	CCONJ
gsrj-62	182	10	its	its	PRON
gsrj-62	182	11	relevance	relevance	NOUN
gsrj-62	182	12	for	for	ADP
gsrj-62	182	13	cellular	cellular	ADJ
gsrj-62	182	14	signaling	signal	VERB
gsrj-62	182	15	cascades	cascade	NOUN
gsrj-62	182	16	.	.	PUNCT
gsrj-62	183	1	neuropharmacology	neuropharmacology	NOUN
gsrj-62	183	2	,	,	PUNCT
gsrj-62	183	3	62(7	62(7	NOUN
gsrj-62	183	4	)	)	PUNCT
gsrj-62	183	5	,	,	PUNCT
gsrj-62	183	6	2184–2191	2184–2191	NUM
gsrj-62	183	7	.	.	PUNCT
gsrj-62	184	1	https://doi.org/10.1016/j.neuropharm.2012.01.01	https://doi.org/10.1016/j.neuropharm.2012.01.01	ADJ
gsrj-62	184	2	0	0	NUM
gsrj-62	184	3	20	20	NUM
gsrj-62	184	4	.	.	PUNCT
gsrj-62	184	5	murat	murat	PROPN
gsrj-62	184	6	,	,	PUNCT
gsrj-62	184	7	s.	s.	PROPN
gsrj-62	184	8	,	,	PUNCT
gsrj-62	184	9	bigot	bigot	ADJ
gsrj-62	184	10	,	,	PUNCT
gsrj-62	184	11	m.	m.	NOUN
gsrj-62	184	12	,	,	PUNCT
gsrj-62	184	13	chapron	chapron	NOUN
gsrj-62	184	14	,	,	PUNCT
gsrj-62	184	15	j.	j.	PROPN
gsrj-62	184	16	,	,	PUNCT
gsrj-62	184	17	könig	könig	PROPN
gsrj-62	184	18	,	,	PUNCT
gsrj-62	184	19	g.	g.	PROPN
gsrj-62	184	20	m.	m.	PROPN
gsrj-62	184	21	,	,	PUNCT
gsrj-62	184	22	kostenis	kostenis	PROPN
gsrj-62	184	23	,	,	PUNCT
gsrj-62	184	24	e.	e.	PROPN
gsrj-62	184	25	,	,	PUNCT
gsrj-62	184	26	battaglia	battaglia	PROPN
gsrj-62	184	27	,	,	PUNCT
gsrj-62	184	28	g.	g.	PROPN
gsrj-62	184	29	,	,	PUNCT
gsrj-62	184	30	nicoletti	nicoletti	PROPN
gsrj-62	184	31	,	,	PUNCT
gsrj-62	184	32	f.	f.	PROPN
gsrj-62	184	33	,	,	PUNCT
gsrj-62	184	34	bourinet	bourinet	PROPN
gsrj-62	184	35	,	,	PUNCT
gsrj-62	184	36	e.	e.	PROPN
gsrj-62	184	37	,	,	PUNCT
gsrj-62	184	38	bockaert	bockaert	PROPN
gsrj-62	184	39	,	,	PUNCT
gsrj-62	184	40	j.	j.	PROPN
gsrj-62	184	41	,	,	PUNCT
gsrj-62	184	42	marin	marin	NOUN
gsrj-62	184	43	,	,	PUNCT
gsrj-62	184	44	p.	p.	PROPN
gsrj-62	184	45	,	,	PUNCT
gsrj-62	184	46	&	&	CCONJ
gsrj-62	184	47	vandermoere	vandermoere	ADV
gsrj-62	184	48	,	,	PUNCT
gsrj-62	184	49	f.	f.	PROPN
gsrj-62	184	50	(	(	PUNCT
gsrj-62	184	51	2019	2019	NUM
gsrj-62	184	52	)	)	PUNCT
gsrj-62	184	53	.	.	PUNCT
gsrj-62	185	1	5	5	NUM
gsrj-62	185	2	-	-	PUNCT
gsrj-62	185	3	ht2a	ht2a	NOUN
gsrj-62	185	4	receptor	receptor	NOUN
gsrj-62	185	5	-	-	PUNCT
gsrj-62	185	6	dependent	dependent	ADJ
gsrj-62	185	7	phosphorylation	phosphorylation	NOUN
gsrj-62	185	8	of	of	ADP
gsrj-62	185	9	mglu2	mglu2	NOUN
gsrj-62	185	10	receptor	receptor	NOUN
gsrj-62	185	11	at	at	ADP
gsrj-62	185	12	serine	serine	NOUN
gsrj-62	185	13	843	843	NUM
gsrj-62	185	14	promotes	promote	VERB
gsrj-62	185	15	mglu2	mglu2	NOUN
gsrj-62	185	16	receptor	receptor	NOUN
gsrj-62	185	17	-	-	PUNCT
gsrj-62	185	18	operated	operate	VERB
gsrj-62	185	19	gi	gi	NOUN
gsrj-62	185	20	/	/	SYM
gsrj-62	185	21	o	o	NOUN
gsrj-62	185	22	signaling	signal	VERB
gsrj-62	185	23	.	.	PUNCT
gsrj-62	186	1	molecular	molecular	ADJ
gsrj-62	186	2	psychiatry	psychiatry	NOUN
gsrj-62	186	3	,	,	PUNCT
gsrj-62	186	4	24(11	24(11	NUM
gsrj-62	186	5	)	)	PUNCT
gsrj-62	186	6	,	,	PUNCT
gsrj-62	186	7	1610	1610	NUM
gsrj-62	186	8	–	–	PUNCT
gsrj-62	186	9	1626	1626	NUM
gsrj-62	186	10	.	.	PUNCT
gsrj-62	187	1	https://doi.org/10.1038/s41380-018-00696	https://doi.org/10.1038/s41380-018-00696	NOUN
gsrj-62	187	2	21	21	NUM
gsrj-62	187	3	.	.	PUNCT
gsrj-62	188	1	taddeucci	taddeucci	PROPN
gsrj-62	188	2	,	,	PUNCT
gsrj-62	188	3	a.	a.	NOUN
gsrj-62	188	4	,	,	PUNCT
gsrj-62	188	5	olivero	olivero	PROPN
gsrj-62	188	6	,	,	PUNCT
gsrj-62	188	7	g.	g.	PROPN
gsrj-62	188	8	,	,	PUNCT
gsrj-62	188	9	roggeri	roggeri	PROPN
gsrj-62	188	10	,	,	PUNCT
gsrj-62	188	11	a.	a.	NOUN
gsrj-62	188	12	,	,	PUNCT
gsrj-62	188	13	milanese	milanese	NOUN
gsrj-62	188	14	,	,	PUNCT
gsrj-62	188	15	c.	c.	PROPN
gsrj-62	188	16	,	,	PUNCT
gsrj-62	188	17	giorgio	giorgio	PROPN
gsrj-62	188	18	,	,	PUNCT
gsrj-62	188	19	f.	f.	PROPN
gsrj-62	188	20	p.	p.	PROPN
gsrj-62	188	21	d.	d.	PROPN
gsrj-62	188	22	,	,	PUNCT
gsrj-62	188	23	grilli	grilli	PROPN
gsrj-62	188	24	,	,	PUNCT
gsrj-62	188	25	m.	m.	NOUN
gsrj-62	188	26	,	,	PUNCT
gsrj-62	188	27	marchi	marchi	PROPN
gsrj-62	188	28	,	,	PUNCT
gsrj-62	188	29	m.	m.	NOUN
gsrj-62	188	30	,	,	PUNCT
gsrj-62	188	31	garrone	garrone	NOUN
gsrj-62	188	32	,	,	PUNCT
gsrj-62	188	33	b.	b.	PROPN
gsrj-62	188	34	,	,	PUNCT
gsrj-62	188	35	&	&	CCONJ
gsrj-62	188	36	pittaluga	pittaluga	PROPN
gsrj-62	188	37	,	,	PUNCT
gsrj-62	188	38	a.	a.	NOUN
gsrj-62	188	39	(	(	PUNCT
gsrj-62	188	40	2022	2022	NUM
gsrj-62	188	41	)	)	PUNCT
gsrj-62	188	42	.	.	PUNCT
gsrj-62	189	1	presynaptic	presynaptic	ADJ
gsrj-62	189	2	5ht2a	5ht2a	NUM
gsrj-62	189	3	-	-	PUNCT
gsrj-62	189	4	mglu2/3	mglu2/3	ADJ
gsrj-62	189	5	receptor	receptor	NOUN
gsrj-62	189	6	-	-	PUNCT
gsrj-62	189	7	receptor	receptor	NOUN
gsrj-62	189	8	crosstalk	crosstalk	NOUN
gsrj-62	189	9	in	in	ADP
gsrj-62	189	10	the	the	DET
gsrj-62	189	11	prefrontal	prefrontal	ADJ
gsrj-62	189	12	cortex	cortex	NOUN
gsrj-62	189	13	:	:	PUNCT
gsrj-62	189	14	metamodulation	metamodulation	NOUN
gsrj-62	189	15	of	of	ADP
gsrj-62	189	16	glutamate	glutamate	NOUN
gsrj-62	189	17	28	28	NUM
gsrj-62	189	18	georgetown	georgetown	PROPN
gsrj-62	189	19	scientific	scientific	ADJ
gsrj-62	189	20	research	research	NOUN
gsrj-62	189	21	journal	journal	NOUN
gsrj-62	189	22	exocytosis	exocytosis	NOUN
gsrj-62	189	23	.	.	PUNCT
gsrj-62	190	1	cells	cell	NOUN
gsrj-62	190	2	,	,	PUNCT
gsrj-62	190	3	11(19	11(19	PROPN
gsrj-62	190	4	)	)	PUNCT
gsrj-62	190	5	,	,	PUNCT
gsrj-62	190	6	3035	3035	NUM
gsrj-62	190	7	.	.	PUNCT
gsrj-62	191	1	https://doi.org/10.3390/cells11193035	https://doi.org/10.3390/cells11193035	PROPN
gsrj-62	191	2	22	22	NUM
gsrj-62	191	3	.	.	PUNCT
gsrj-62	192	1	scruggs	scruggs	PROPN
gsrj-62	192	2	,	,	PUNCT
gsrj-62	192	3	j.	j.	PROPN
gsrj-62	192	4	l.	l.	PROPN
gsrj-62	192	5	,	,	PUNCT
gsrj-62	192	6	schmidt	schmidt	PROPN
gsrj-62	192	7	,	,	PUNCT
gsrj-62	192	8	d.	d.	PROPN
gsrj-62	192	9	,	,	PUNCT
gsrj-62	192	10	&	&	CCONJ
gsrj-62	192	11	deutch	deutch	PROPN
gsrj-62	192	12	,	,	PUNCT
gsrj-62	192	13	a.	a.	PROPN
gsrj-62	192	14	y.	y.	PROPN
gsrj-62	192	15	(	(	PUNCT
gsrj-62	192	16	2003	2003	NUM
gsrj-62	192	17	)	)	PUNCT
gsrj-62	192	18	.	.	PUNCT
gsrj-62	193	1	the	the	DET
gsrj-62	193	2	hallucinogen	hallucinogen	NOUN
gsrj-62	193	3	1-[2,5	1-[2,5	ADV
gsrj-62	193	4	-	-	PUNCT
gsrj-62	193	5	dimethoxy-4iodophenyl]-2	dimethoxy-4iodophenyl]-2	ADJ
gsrj-62	193	6	-	-	PUNCT
gsrj-62	193	7	aminopropane	aminopropane	NOUN
gsrj-62	193	8	(	(	PUNCT
gsrj-62	193	9	doi	doi	NOUN
gsrj-62	193	10	)	)	PUNCT
gsrj-62	193	11	increases	increase	VERB
gsrj-62	193	12	cortical	cortical	ADJ
gsrj-62	193	13	extracellular	extracellular	ADJ
gsrj-62	193	14	glutamate	glutamate	NOUN
gsrj-62	193	15	levels	level	NOUN
gsrj-62	193	16	in	in	ADP
gsrj-62	193	17	rats	rat	NOUN
gsrj-62	193	18	.	.	PUNCT
gsrj-62	194	1	neuroscience	neuroscience	NOUN
gsrj-62	194	2	letters	letter	NOUN
gsrj-62	194	3	,	,	PUNCT
gsrj-62	194	4	346(3	346(3	NUM
gsrj-62	194	5	)	)	PUNCT
gsrj-62	194	6	,	,	PUNCT
gsrj-62	194	7	137–140	137–140	NUM
gsrj-62	194	8	.	.	PUNCT
gsrj-62	195	1	https://doi.org/10.1016/s0304-3940(03)00547-0	https://doi.org/10.1016/s0304-3940(03)00547-0	PROPN
gsrj-62	195	2	23	23	NUM
gsrj-62	195	3	.	.	PUNCT
gsrj-62	196	1	garcia	garcia	PROPN
gsrj-62	196	2	,	,	PUNCT
gsrj-62	196	3	e.	e.	PROPN
gsrj-62	196	4	e.	e.	PROPN
gsrj-62	196	5	,	,	PUNCT
gsrj-62	196	6	smith	smith	PROPN
gsrj-62	196	7	,	,	PUNCT
gsrj-62	196	8	r.	r.	PROPN
gsrj-62	196	9	l.	l.	PROPN
gsrj-62	196	10	,	,	PUNCT
gsrj-62	196	11	&	&	CCONJ
gsrj-62	196	12	sanders	sanders	PROPN
gsrj-62	196	13	-	-	PUNCT
gsrj-62	196	14	bush	bush	PROPN
gsrj-62	196	15	,	,	PUNCT
gsrj-62	196	16	e.	e.	PROPN
gsrj-62	196	17	(	(	PUNCT
gsrj-62	196	18	2007	2007	NUM
gsrj-62	196	19	)	)	PUNCT
gsrj-62	196	20	.	.	PUNCT
gsrj-62	197	1	role	role	NOUN
gsrj-62	197	2	of	of	ADP
gsrj-62	197	3	gq	gq	NOUN
gsrj-62	197	4	protein	protein	NOUN
gsrj-62	197	5	in	in	ADP
gsrj-62	197	6	behavioral	behavioral	ADJ
gsrj-62	197	7	effects	effect	NOUN
gsrj-62	197	8	of	of	ADP
gsrj-62	197	9	the	the	DET
gsrj-62	197	10	hallucinogenic	hallucinogenic	ADJ
gsrj-62	197	11	drug	drug	NOUN
gsrj-62	197	12	1-(2,5	1-(2,5	NUM
gsrj-62	197	13	-	-	PUNCT
gsrj-62	197	14	dimethoxy-4iodophenyl)-2	dimethoxy-4iodophenyl)-2	NOUN
gsrj-62	197	15	-	-	PUNCT
gsrj-62	197	16	aminopropane	aminopropane	ADJ
gsrj-62	197	17	.	.	PUNCT
gsrj-62	198	1	neuropharmacology	neuropharmacology	NOUN
gsrj-62	198	2	,	,	PUNCT
gsrj-62	198	3	52(8	52(8	NUM
gsrj-62	198	4	)	)	PUNCT
gsrj-62	198	5	,	,	PUNCT
gsrj-62	198	6	1671–1677	1671–1677	NUM
gsrj-62	198	7	.	.	PUNCT
gsrj-62	199	1	https://doi.org/10.1016/j.neuropharm.2007.03.01	https://doi.org/10.1016/j.neuropharm.2007.03.01	PRON
gsrj-62	199	2	3	3	NUM
gsrj-62	199	3	24	24	NUM
gsrj-62	199	4	.	.	PUNCT
gsrj-62	200	1	parman	parman	NOUN
gsrj-62	200	2	,	,	PUNCT
gsrj-62	200	3	y.	y.	PROPN
gsrj-62	200	4	,	,	PUNCT
gsrj-62	200	5	&	&	CCONJ
gsrj-62	200	6	battaloğlu	battaloğlu	PROPN
gsrj-62	200	7	,	,	PUNCT
gsrj-62	200	8	e.	e.	PROPN
gsrj-62	200	9	(	(	PUNCT
gsrj-62	200	10	2013	2013	NUM
gsrj-62	200	11	)	)	PUNCT
gsrj-62	200	12	.	.	PUNCT
gsrj-62	201	1	chapter	chapter	NOUN
gsrj-62	201	2	48	48	NUM
gsrj-62	201	3	—	—	PUNCT
gsrj-62	201	4	recessively	recessively	ADV
gsrj-62	201	5	transmitted	transmit	VERB
gsrj-62	201	6	predominantly	predominantly	ADV
gsrj-62	201	7	motor	motor	NOUN
gsrj-62	201	8	neuropathies	neuropathy	NOUN
gsrj-62	201	9	.	.	PUNCT
gsrj-62	202	1	handbook	handbook	NOUN
gsrj-62	202	2	of	of	ADP
gsrj-62	202	3	clinical	clinical	ADJ
gsrj-62	202	4	neurology	neurology	NOUN
gsrj-62	202	5	,	,	PUNCT
gsrj-62	202	6	115	115	NUM
gsrj-62	202	7	,	,	PUNCT
gsrj-62	202	8	847–861	847–861	NUM
gsrj-62	202	9	.	.	PUNCT
gsrj-62	203	1	https://doi.org/10.1016/b978-0444-52902-2.00048-5	https://doi.org/10.1016/b978-0444-52902-2.00048-5	PROPN
gsrj-62	203	2	25	25	NUM
gsrj-62	203	3	.	.	PUNCT
gsrj-62	204	1	chen	chen	PROPN
gsrj-62	204	2	,	,	PUNCT
gsrj-62	204	3	c.	c.	PROPN
gsrj-62	204	4	z.	z.	PROPN
gsrj-62	204	5	,	,	PUNCT
gsrj-62	204	6	neumann	neumann	PROPN
gsrj-62	204	7	,	,	PUNCT
gsrj-62	204	8	b.	b.	PROPN
gsrj-62	204	9	,	,	PUNCT
gsrj-62	204	10	förster	förster	NOUN
gsrj-62	204	11	,	,	PUNCT
gsrj-62	204	12	s.	s.	PROPN
gsrj-62	204	13	,	,	PUNCT
gsrj-62	204	14	&	&	CCONJ
gsrj-62	204	15	franklin	franklin	PROPN
gsrj-62	204	16	,	,	PUNCT
gsrj-62	204	17	r.	r.	PROPN
gsrj-62	204	18	j.	j.	PROPN
gsrj-62	204	19	m.	m.	PROPN
gsrj-62	204	20	(	(	PUNCT
gsrj-62	204	21	2021	2021	NUM
gsrj-62	204	22	)	)	PUNCT
gsrj-62	204	23	.	.	PUNCT
gsrj-62	205	1	schwann	schwann	PROPN
gsrj-62	205	2	cell	cell	PROPN
gsrj-62	205	3	remyelination	remyelination	NOUN
gsrj-62	205	4	of	of	ADP
gsrj-62	205	5	the	the	DET
gsrj-62	205	6	central	central	ADJ
gsrj-62	205	7	nervous	nervous	ADJ
gsrj-62	205	8	system	system	NOUN
gsrj-62	205	9	:	:	PUNCT
gsrj-62	205	10	why	why	SCONJ
gsrj-62	205	11	does	do	AUX
gsrj-62	205	12	it	it	PRON
gsrj-62	205	13	happen	happen	VERB
gsrj-62	205	14	and	and	CCONJ
gsrj-62	205	15	what	what	PRON
gsrj-62	205	16	are	be	AUX
gsrj-62	205	17	the	the	DET
gsrj-62	205	18	benefits	benefit	NOUN
gsrj-62	205	19	?	?	PUNCT
gsrj-62	206	1	open	open	ADJ
gsrj-62	206	2	biology	biology	NOUN
gsrj-62	206	3	,	,	PUNCT
gsrj-62	206	4	11(1	11(1	NUM
gsrj-62	206	5	)	)	PUNCT
gsrj-62	206	6	,	,	PUNCT
gsrj-62	206	7	200352	200352	NUM
gsrj-62	206	8	.	.	PUNCT
gsrj-62	207	1	https://doi.org/10.1098/rsob.200352	https://doi.org/10.1098/rsob.200352	NOUN
gsrj-62	207	2	26	26	NUM
gsrj-62	207	3	.	.	PUNCT
gsrj-62	208	1	vollenweider	vollenweider	ADV
gsrj-62	208	2	,	,	PUNCT
gsrj-62	208	3	f.	f.	PROPN
gsrj-62	208	4	x.	x.	PROPN
gsrj-62	208	5	,	,	PUNCT
gsrj-62	208	6	&	&	CCONJ
gsrj-62	208	7	kometer	kometer	PROPN
gsrj-62	208	8	,	,	PUNCT
gsrj-62	208	9	m.	m.	NOUN
gsrj-62	208	10	(	(	PUNCT
gsrj-62	208	11	2010	2010	NUM
gsrj-62	208	12	)	)	PUNCT
gsrj-62	208	13	.	.	PUNCT
gsrj-62	209	1	the	the	DET
gsrj-62	209	2	neurobiology	neurobiology	NOUN
gsrj-62	209	3	of	of	ADP
gsrj-62	209	4	psychedelic	psychedelic	ADJ
gsrj-62	209	5	drugs	drug	NOUN
gsrj-62	209	6	:	:	PUNCT
gsrj-62	209	7	implications	implication	NOUN
gsrj-62	209	8	for	for	ADP
gsrj-62	209	9	the	the	DET
gsrj-62	209	10	treatment	treatment	NOUN
gsrj-62	209	11	of	of	ADP
gsrj-62	209	12	mood	mood	NOUN
gsrj-62	209	13	disorders	disorder	NOUN
gsrj-62	209	14	.	.	PUNCT
gsrj-62	210	1	nature	nature	NOUN
gsrj-62	210	2	reviews	review	VERB
gsrj-62	210	3	neuroscience	neuroscience	NOUN
gsrj-62	210	4	,	,	PUNCT
gsrj-62	210	5	11(9	11(9	PROPN
gsrj-62	210	6	)	)	PUNCT
gsrj-62	210	7	,	,	PUNCT
gsrj-62	210	8	article	article	NOUN
gsrj-62	210	9	9	9	NUM
gsrj-62	210	10	.	.	PUNCT
gsrj-62	211	1	https://doi.org/10.1038/nrn2884	https://doi.org/10.1038/nrn2884	PROPN
gsrj-62	211	2	27	27	NUM
gsrj-62	211	3	.	.	PUNCT
gsrj-62	212	1	holmes	holmes	PROPN
gsrj-62	212	2	,	,	PUNCT
gsrj-62	212	3	s.	s.	PROPN
gsrj-62	212	4	e.	e.	PROPN
gsrj-62	212	5	,	,	PUNCT
gsrj-62	212	6	scheinost	scheinost	PROPN
gsrj-62	212	7	,	,	PUNCT
gsrj-62	212	8	d.	d.	PROPN
gsrj-62	212	9	,	,	PUNCT
gsrj-62	212	10	finnema	finnema	PROPN
gsrj-62	212	11	,	,	PUNCT
gsrj-62	212	12	s.	s.	PROPN
gsrj-62	212	13	j.	j.	PROPN
gsrj-62	212	14	,	,	PUNCT
gsrj-62	212	15	naganawa	naganawa	PROPN
gsrj-62	212	16	,	,	PUNCT
gsrj-62	212	17	m.	m.	NOUN
gsrj-62	212	18	,	,	PUNCT
gsrj-62	212	19	davis	davis	PROPN
gsrj-62	212	20	,	,	PUNCT
gsrj-62	212	21	m.	m.	NOUN
gsrj-62	212	22	t.	t.	PROPN
gsrj-62	212	23	,	,	PUNCT
gsrj-62	212	24	dellagioia	dellagioia	NOUN
gsrj-62	212	25	,	,	PUNCT
gsrj-62	212	26	n.	n.	NOUN
gsrj-62	212	27	,	,	PUNCT
gsrj-62	212	28	nabulsi	nabulsi	PROPN
gsrj-62	212	29	,	,	PUNCT
gsrj-62	212	30	n.	n.	NOUN
gsrj-62	212	31	,	,	PUNCT
gsrj-62	212	32	matuskey	matuskey	NOUN
gsrj-62	212	33	,	,	PUNCT
gsrj-62	212	34	d.	d.	PROPN
gsrj-62	212	35	,	,	PUNCT
gsrj-62	212	36	angarita	angarita	PROPN
gsrj-62	212	37	,	,	PUNCT
gsrj-62	212	38	g.	g.	PROPN
gsrj-62	212	39	a.	a.	PROPN
gsrj-62	212	40	,	,	PUNCT
gsrj-62	212	41	pietrzak	pietrzak	PROPN
gsrj-62	212	42	,	,	PUNCT
gsrj-62	212	43	r.	r.	PROPN
gsrj-62	212	44	h.	h.	PROPN
gsrj-62	212	45	,	,	PUNCT
gsrj-62	212	46	duman	duman	PROPN
gsrj-62	212	47	,	,	PUNCT
gsrj-62	212	48	r.	r.	PROPN
gsrj-62	212	49	s.	s.	PROPN
gsrj-62	212	50	,	,	PUNCT
gsrj-62	212	51	sanacora	sanacora	PROPN
gsrj-62	212	52	,	,	PUNCT
gsrj-62	212	53	g.	g.	PROPN
gsrj-62	212	54	,	,	PUNCT
gsrj-62	212	55	krystal	krystal	PROPN
gsrj-62	212	56	,	,	PUNCT
gsrj-62	212	57	j.	j.	PROPN
gsrj-62	212	58	h.	h.	PROPN
gsrj-62	212	59	,	,	PUNCT
gsrj-62	212	60	carson	carson	PROPN
gsrj-62	212	61	,	,	PUNCT
gsrj-62	212	62	r.	r.	PROPN
gsrj-62	212	63	e.	e.	PROPN
gsrj-62	212	64	,	,	PUNCT
gsrj-62	212	65	&	&	CCONJ
gsrj-62	212	66	esterlis	esterlis	PROPN
gsrj-62	212	67	,	,	PUNCT
gsrj-62	212	68	i.	i.	PROPN
gsrj-62	212	69	(	(	PUNCT
gsrj-62	212	70	2019	2019	NUM
gsrj-62	212	71	)	)	PUNCT
gsrj-62	212	72	.	.	PUNCT
gsrj-62	213	1	lower	low	ADJ
gsrj-62	213	2	synaptic	synaptic	ADJ
gsrj-62	213	3	density	density	NOUN
gsrj-62	213	4	is	be	AUX
gsrj-62	213	5	associated	associate	VERB
gsrj-62	213	6	with	with	ADP
gsrj-62	213	7	depression	depression	NOUN
gsrj-62	213	8	severity	severity	NOUN
gsrj-62	213	9	and	and	CCONJ
gsrj-62	213	10	network	network	NOUN
gsrj-62	213	11	alterations	alteration	NOUN
gsrj-62	213	12	.	.	PUNCT
gsrj-62	214	1	nature	nature	NOUN
gsrj-62	214	2	communications	communication	NOUN
gsrj-62	214	3	,	,	PUNCT
gsrj-62	214	4	10(1	10(1	NUM
gsrj-62	214	5	)	)	PUNCT
gsrj-62	214	6	,	,	PUNCT
gsrj-62	214	7	article	article	NOUN
gsrj-62	214	8	1	1	NUM
gsrj-62	214	9	.	.	PUNCT
gsrj-62	214	10	https://doi.org/10.1038/s41467-019-09562-7	https://doi.org/10.1038/s41467-019-09562-7	PROPN
gsrj-62	214	11	28	28	NUM
gsrj-62	214	12	.	.	PUNCT
gsrj-62	215	1	shao	shao	PROPN
gsrj-62	215	2	,	,	PUNCT
gsrj-62	215	3	l.-x	l.-x	PROPN
gsrj-62	215	4	.	.	PROPN
gsrj-62	215	5	,	,	PUNCT
gsrj-62	215	6	liao	liao	PROPN
gsrj-62	215	7	,	,	PUNCT
gsrj-62	215	8	c.	c.	PROPN
gsrj-62	215	9	,	,	PUNCT
gsrj-62	215	10	gregg	gregg	PROPN
gsrj-62	215	11	,	,	PUNCT
gsrj-62	215	12	i.	i.	PROPN
gsrj-62	215	13	,	,	PUNCT
gsrj-62	215	14	davoudian	davoudian	ADJ
gsrj-62	215	15	,	,	PUNCT
gsrj-62	215	16	p.	p.	NOUN
gsrj-62	215	17	a.	a.	NOUN
gsrj-62	215	18	,	,	PUNCT
gsrj-62	215	19	savalia	savalia	PROPN
gsrj-62	215	20	,	,	PUNCT
gsrj-62	215	21	n.	n.	PROPN
gsrj-62	215	22	k.	k.	PROPN
gsrj-62	215	23	,	,	PUNCT
gsrj-62	215	24	delagarza	delagarza	PROPN
gsrj-62	215	25	,	,	PUNCT
gsrj-62	215	26	k.	k.	PROPN
gsrj-62	215	27	,	,	PUNCT
gsrj-62	215	28	&	&	CCONJ
gsrj-62	215	29	kwan	kwan	PROPN
gsrj-62	215	30	,	,	PUNCT
gsrj-62	215	31	a.	a.	PROPN
gsrj-62	215	32	c.	c.	PROPN
gsrj-62	215	33	(	(	PUNCT
gsrj-62	215	34	2021	2021	NUM
gsrj-62	215	35	)	)	PUNCT
gsrj-62	215	36	.	.	PUNCT
gsrj-62	216	1	psilocybin	psilocybin	NOUN
gsrj-62	216	2	induces	induce	VERB
gsrj-62	216	3	rapid	rapid	ADJ
gsrj-62	216	4	and	and	CCONJ
gsrj-62	216	5	persistent	persistent	ADJ
gsrj-62	216	6	growth	growth	NOUN
gsrj-62	216	7	of	of	ADP
gsrj-62	216	8	dendritic	dendritic	ADJ
gsrj-62	216	9	spines	spine	NOUN
gsrj-62	216	10	in	in	ADP
gsrj-62	216	11	frontal	frontal	ADJ
gsrj-62	216	12	cortex	cortex	NOUN
gsrj-62	216	13	in	in	ADP
gsrj-62	216	14	vivo	vivo	NOUN
gsrj-62	216	15	.	.	PUNCT
gsrj-62	217	1	neuron	neuron	PROPN
gsrj-62	217	2	,	,	PUNCT
gsrj-62	217	3	109(16	109(16	NUM
gsrj-62	217	4	)	)	PUNCT
gsrj-62	217	5	,	,	PUNCT
gsrj-62	217	6	2535	2535	NUM
gsrj-62	217	7	-	-	SYM
gsrj-62	217	8	2544.e4	2544.e4	NUM
gsrj-62	217	9	.	.	PUNCT
gsrj-62	218	1	https://doi.org/10.1016/j.neuron.2021.06.008	https://doi.org/10.1016/j.neuron.2021.06.008	NOUN
gsrj-62	218	2	29	29	NUM
gsrj-62	218	3	.	.	PUNCT
gsrj-62	219	1	duman	duman	PROPN
gsrj-62	219	2	,	,	PUNCT
gsrj-62	219	3	r.	r.	PROPN
gsrj-62	219	4	s.	s.	PROPN
gsrj-62	219	5	,	,	PUNCT
gsrj-62	219	6	aghajanian	aghajanian	PROPN
gsrj-62	219	7	,	,	PUNCT
gsrj-62	219	8	g.	g.	PROPN
gsrj-62	219	9	k.	k.	PROPN
gsrj-62	219	10	,	,	PUNCT
gsrj-62	219	11	sanacora	sanacora	PROPN
gsrj-62	219	12	,	,	PUNCT
gsrj-62	219	13	g.	g.	PROPN
gsrj-62	219	14	,	,	PUNCT
gsrj-62	219	15	&	&	CCONJ
gsrj-62	219	16	krystal	krystal	PROPN
gsrj-62	219	17	,	,	PUNCT
gsrj-62	219	18	j.	j.	PROPN
gsrj-62	219	19	h.	h.	PROPN
gsrj-62	219	20	(	(	PUNCT
gsrj-62	219	21	2016	2016	NUM
gsrj-62	219	22	)	)	PUNCT
gsrj-62	219	23	.	.	PUNCT
gsrj-62	220	1	synaptic	synaptic	ADJ
gsrj-62	220	2	plasticity	plasticity	NOUN
gsrj-62	220	3	and	and	CCONJ
gsrj-62	220	4	depression	depression	NOUN
gsrj-62	220	5	:	:	PUNCT
gsrj-62	220	6	new	new	ADJ
gsrj-62	220	7	insights	insight	NOUN
gsrj-62	220	8	from	from	ADP
gsrj-62	220	9	stress	stress	NOUN
gsrj-62	220	10	and	and	CCONJ
gsrj-62	220	11	rapidacting	rapidacte	VERB
gsrj-62	220	12	antidepressants	antidepressant	NOUN
gsrj-62	220	13	.	.	PUNCT
gsrj-62	221	1	nature	nature	NOUN
gsrj-62	221	2	medicine	medicine	NOUN
gsrj-62	221	3	,	,	PUNCT
gsrj-62	221	4	22(3	22(3	NUM
gsrj-62	221	5	)	)	PUNCT
gsrj-62	221	6	,	,	PUNCT
gsrj-62	221	7	238–249	238–249	NUM
gsrj-62	221	8	.	.	PUNCT
gsrj-62	222	1	https://doi.org/10.1038/nm.4050	https://doi.org/10.1038/nm.4050	PROPN
gsrj-62	222	2	30	30	NUM
gsrj-62	222	3	.	.	PUNCT
gsrj-62	223	1	macdonald	macdonald	PROPN
gsrj-62	223	2	,	,	PUNCT
gsrj-62	223	3	r.	r.	PROPN
gsrj-62	223	4	,	,	PUNCT
gsrj-62	223	5	barbat	barbat	NOUN
gsrj-62	223	6	-	-	PUNCT
gsrj-62	223	7	artigas	artigas	NOUN
gsrj-62	223	8	,	,	PUNCT
gsrj-62	223	9	s.	s.	PROPN
gsrj-62	223	10	,	,	PUNCT
gsrj-62	223	11	cho	cho	PROPN
gsrj-62	223	12	,	,	PUNCT
gsrj-62	223	13	c.	c.	PROPN
gsrj-62	223	14	,	,	PUNCT
gsrj-62	223	15	peng	peng	PROPN
gsrj-62	223	16	,	,	PUNCT
gsrj-62	223	17	h.	h.	PROPN
gsrj-62	223	18	,	,	PUNCT
gsrj-62	223	19	shang	shang	PROPN
gsrj-62	223	20	,	,	PUNCT
gsrj-62	223	21	j.	j.	PROPN
gsrj-62	223	22	,	,	PUNCT
gsrj-62	223	23	moustaine	moustaine	NOUN
gsrj-62	223	24	,	,	PUNCT
gsrj-62	223	25	a.	a.	NOUN
gsrj-62	223	26	,	,	PUNCT
gsrj-62	223	27	carbonetto	carbonetto	PROPN
gsrj-62	223	28	,	,	PUNCT
gsrj-62	223	29	s.	s.	PROPN
gsrj-62	223	30	,	,	PUNCT
gsrj-62	223	31	robitaille	robitaille	PROPN
gsrj-62	223	32	,	,	PUNCT
gsrj-62	223	33	r.	r.	PROPN
gsrj-62	223	34	,	,	PUNCT
gsrj-62	223	35	chalifour	chalifour	NOUN
gsrj-62	223	36	,	,	PUNCT
gsrj-62	223	37	l.	l.	PROPN
gsrj-62	223	38	e.	e.	PROPN
gsrj-62	223	39	,	,	PUNCT
gsrj-62	223	40	&	&	CCONJ
gsrj-62	223	41	paudel	paudel	PROPN
gsrj-62	223	42	,	,	PUNCT
gsrj-62	223	43	h.	h.	PROPN
gsrj-62	223	44	(	(	PUNCT
gsrj-62	223	45	2017	2017	NUM
gsrj-62	223	46	)	)	PUNCT
gsrj-62	223	47	.	.	PUNCT
gsrj-62	224	1	a	a	DET
gsrj-62	224	2	novel	novel	ADJ
gsrj-62	224	3	egr-1	egr-1	NUM
gsrj-62	224	4	-	-	PUNCT
gsrj-62	224	5	agrin	agrin	NOUN
gsrj-62	224	6	pathway	pathway	NOUN
gsrj-62	224	7	and	and	CCONJ
gsrj-62	224	8	potential	potential	ADJ
gsrj-62	224	9	implications	implication	NOUN
gsrj-62	224	10	for	for	ADP
gsrj-62	224	11	regulation	regulation	NOUN
gsrj-62	224	12	of	of	ADP
gsrj-62	224	13	synaptic	synaptic	ADJ
gsrj-62	224	14	physiology	physiology	NOUN
gsrj-62	224	15	and	and	CCONJ
gsrj-62	224	16	homeostasis	homeostasis	NOUN
gsrj-62	224	17	at	at	ADP
gsrj-62	224	18	the	the	DET
gsrj-62	224	19	neuromuscular	neuromuscular	ADJ
gsrj-62	224	20	junction	junction	NOUN
gsrj-62	224	21	.	.	PUNCT
gsrj-62	225	1	frontiers	frontier	NOUN
gsrj-62	225	2	in	in	ADP
gsrj-62	225	3	aging	age	VERB
gsrj-62	225	4	neuroscience	neuroscience	NOUN
gsrj-62	225	5	,	,	PUNCT
gsrj-62	225	6	9	9	NUM
gsrj-62	225	7	,	,	PUNCT
gsrj-62	225	8	258	258	NUM
gsrj-62	225	9	.	.	PUNCT
gsrj-62	226	1	https://doi.org/10.3389/fnagi.2017.00258	https://doi.org/10.3389/fnagi.2017.00258	PROPN
gsrj-62	226	2	31	31	NUM
gsrj-62	226	3	.	.	PUNCT
gsrj-62	227	1	ludwig	ludwig	PROPN
gsrj-62	227	2	,	,	PUNCT
gsrj-62	227	3	a.	a.	PROPN
gsrj-62	227	4	,	,	PUNCT
gsrj-62	227	5	uvarov	uvarov	ADJ
gsrj-62	227	6	,	,	PUNCT
gsrj-62	227	7	p.	p.	PROPN
gsrj-62	227	8	,	,	PUNCT
gsrj-62	227	9	soni	soni	PROPN
gsrj-62	227	10	,	,	PUNCT
gsrj-62	227	11	s.	s.	PROPN
gsrj-62	227	12	,	,	PUNCT
gsrj-62	227	13	thomascrusells	thomascrusells	PROPN
gsrj-62	227	14	,	,	PUNCT
gsrj-62	227	15	j.	j.	PROPN
gsrj-62	227	16	,	,	PUNCT
gsrj-62	227	17	airaksinen	airaksinen	NOUN
gsrj-62	227	18	,	,	PUNCT
gsrj-62	227	19	m.	m.	NOUN
gsrj-62	227	20	s.	s.	PROPN
gsrj-62	227	21	,	,	PUNCT
gsrj-62	227	22	&	&	CCONJ
gsrj-62	227	23	rivera	rivera	PROPN
gsrj-62	227	24	,	,	PUNCT
gsrj-62	227	25	c.	c.	PROPN
gsrj-62	227	26	(	(	PUNCT
gsrj-62	227	27	2011	2011	NUM
gsrj-62	227	28	)	)	PUNCT
gsrj-62	227	29	.	.	PUNCT
gsrj-62	228	1	early	early	ADJ
gsrj-62	228	2	growth	growth	NOUN
gsrj-62	228	3	response	response	NOUN
gsrj-62	228	4	4	4	NUM
gsrj-62	228	5	mediates	mediate	NOUN
gsrj-62	228	6	bdnf	bdnf	ADJ
gsrj-62	228	7	induction	induction	NOUN
gsrj-62	228	8	of	of	ADP
gsrj-62	228	9	potassium	potassium	NOUN
gsrj-62	228	10	chloride	chloride	NOUN
gsrj-62	228	11	cotransporter	cotransporter	NOUN
gsrj-62	228	12	2	2	NUM
gsrj-62	228	13	transcription	transcription	NOUN
gsrj-62	228	14	.	.	PUNCT
gsrj-62	229	1	journal	journal	NOUN
gsrj-62	229	2	of	of	ADP
gsrj-62	229	3	neuroscience	neuroscience	NOUN
gsrj-62	229	4	,	,	PUNCT
gsrj-62	229	5	31(2	31(2	NUM
gsrj-62	229	6	)	)	PUNCT
gsrj-62	229	7	,	,	PUNCT
gsrj-62	229	8	644	644	NUM
gsrj-62	229	9	–	–	PUNCT
gsrj-62	229	10	649	649	NUM
gsrj-62	229	11	.	.	PUNCT
gsrj-62	230	1	https://doi.org/10.1523/jneurosci.200610.2011	https://doi.org/10.1523/jneurosci.200610.2011	PROPN
gsrj-62	230	2	32	32	NUM
gsrj-62	230	3	.	.	PUNCT
gsrj-62	231	1	warner	warner	PROPN
gsrj-62	231	2	,	,	PUNCT
gsrj-62	231	3	l.	l.	PROPN
gsrj-62	231	4	e.	e.	PROPN
gsrj-62	231	5	,	,	PUNCT
gsrj-62	231	6	mancias	mancia	NOUN
gsrj-62	231	7	,	,	PUNCT
gsrj-62	231	8	p.	p.	NOUN
gsrj-62	231	9	,	,	PUNCT
gsrj-62	231	10	butler	butler	PROPN
gsrj-62	231	11	,	,	PUNCT
gsrj-62	231	12	i.	i.	PROPN
gsrj-62	231	13	j.	j.	PROPN
gsrj-62	231	14	,	,	PUNCT
gsrj-62	231	15	mcdonald	mcdonald	PROPN
gsrj-62	231	16	,	,	PUNCT
gsrj-62	231	17	c.	c.	PROPN
gsrj-62	231	18	m.	m.	NOUN
gsrj-62	231	19	,	,	PUNCT
gsrj-62	231	20	keppen	keppen	ADJ
gsrj-62	231	21	,	,	PUNCT
gsrj-62	231	22	l.	l.	PROPN
gsrj-62	231	23	,	,	PUNCT
gsrj-62	231	24	koob	koob	PROPN
gsrj-62	231	25	,	,	PUNCT
gsrj-62	231	26	k.	k.	PROPN
gsrj-62	231	27	g.	g.	PROPN
gsrj-62	231	28	,	,	PUNCT
gsrj-62	231	29	&	&	CCONJ
gsrj-62	231	30	lupski	lupski	PROPN
gsrj-62	231	31	,	,	PUNCT
gsrj-62	231	32	j.	j.	PROPN
gsrj-62	231	33	r.	r.	PROPN
gsrj-62	231	34	(	(	PUNCT
gsrj-62	231	35	1998	1998	NUM
gsrj-62	231	36	)	)	PUNCT
gsrj-62	231	37	.	.	PUNCT
gsrj-62	232	1	mutations	mutation	NOUN
gsrj-62	232	2	in	in	ADP
gsrj-62	232	3	the	the	DET
gsrj-62	232	4	early	early	ADJ
gsrj-62	232	5	growth	growth	NOUN
gsrj-62	232	6	response	response	NOUN
gsrj-62	232	7	2	2	NUM
gsrj-62	232	8	(	(	PUNCT
gsrj-62	232	9	egr2	egr2	NOUN
gsrj-62	232	10	)	)	PUNCT
gsrj-62	232	11	gene	gene	NOUN
gsrj-62	232	12	are	be	AUX
gsrj-62	232	13	associated	associate	VERB
gsrj-62	232	14	with	with	ADP
gsrj-62	232	15	hereditary	hereditary	ADJ
gsrj-62	232	16	myelinopathies	myelinopathie	NOUN
gsrj-62	232	17	.	.	PUNCT
gsrj-62	233	1	nature	nature	NOUN
gsrj-62	233	2	genetics	genetic	NOUN
gsrj-62	233	3	,	,	PUNCT
gsrj-62	233	4	18(4	18(4	NUM
gsrj-62	233	5	)	)	PUNCT
gsrj-62	233	6	,	,	PUNCT
gsrj-62	233	7	article	article	NOUN
gsrj-62	233	8	4	4	NUM
gsrj-62	233	9	.	.	PUNCT
gsrj-62	233	10	https://doi.org/10.1038/ng0498-382	https://doi.org/10.1038/ng0498-382	X
gsrj-62	234	1	33	33	NUM
gsrj-62	234	2	.	.	PUNCT
gsrj-62	235	1	huang	huang	PROPN
gsrj-62	235	2	,	,	PUNCT
gsrj-62	235	3	e.	e.	PROPN
gsrj-62	235	4	j.	j.	PROPN
gsrj-62	235	5	,	,	PUNCT
gsrj-62	235	6	&	&	CCONJ
gsrj-62	235	7	reichardt	reichardt	PROPN
gsrj-62	235	8	,	,	PUNCT
gsrj-62	235	9	l.	l.	PROPN
gsrj-62	235	10	f.	f.	PROPN
gsrj-62	235	11	(	(	PUNCT
gsrj-62	235	12	2001	2001	NUM
gsrj-62	235	13	)	)	PUNCT
gsrj-62	235	14	.	.	PUNCT
gsrj-62	236	1	neurotrophins	neurotrophin	NOUN
gsrj-62	236	2	:	:	PUNCT
gsrj-62	236	3	roles	role	NOUN
gsrj-62	236	4	in	in	ADP
gsrj-62	236	5	neuronal	neuronal	ADJ
gsrj-62	236	6	development	development	NOUN
gsrj-62	236	7	and	and	CCONJ
gsrj-62	236	8	function	function	NOUN
gsrj-62	236	9	.	.	PUNCT
gsrj-62	237	1	annual	annual	ADJ
gsrj-62	237	2	review	review	NOUN
gsrj-62	237	3	of	of	ADP
gsrj-62	237	4	neuroscience	neuroscience	NOUN
gsrj-62	237	5	,	,	PUNCT
gsrj-62	237	6	24	24	NUM
gsrj-62	237	7	,	,	PUNCT
gsrj-62	237	8	677–736	677–736	NUM
gsrj-62	237	9	.	.	PUNCT
gsrj-62	237	10	https://doi.org/10.1146/annurev.neuro.24.1.677	https://doi.org/10.1146/annurev.neuro.24.1.677	PROPN
gsrj-62	237	11	34	34	NUM
gsrj-62	237	12	.	.	PUNCT
gsrj-62	237	13	barbacid	barbacid	NOUN
gsrj-62	237	14	,	,	PUNCT
gsrj-62	237	15	m.	m.	NOUN
gsrj-62	237	16	(	(	PUNCT
gsrj-62	237	17	n.d	n.d	PROPN
gsrj-62	237	18	.	.	PROPN
gsrj-62	237	19	)	)	PUNCT
gsrj-62	237	20	.	.	PUNCT
gsrj-62	238	1	the	the	DET
gsrj-62	238	2	trk	trk	PROPN
gsrj-62	238	3	family	family	NOUN
gsrj-62	238	4	of	of	ADP
gsrj-62	238	5	neurotrophin	neurotrophin	ADJ
gsrj-62	238	6	receptors	receptor	NOUN
gsrj-62	238	7	.	.	PUNCT
gsrj-62	239	1	semantic	semantic	ADJ
gsrj-62	239	2	scholar	scholar	NOUN
gsrj-62	239	3	.	.	PUNCT
gsrj-62	240	1	https://www.semanticscholar.org/paper/the-trkfamily-of-neurotrophin-receptors.barbacid/b08f94bcef0ae832a02857fd2e33416f2bd	https://www.semanticscholar.org/paper/the-trkfamily-of-neurotrophin-receptors.barbacid/b08f94bcef0ae832a02857fd2e33416f2bd	PROPN
gsrj-62	240	2	c5338	c5338	PROPN
gsrj-62	240	3	35	35	NUM
gsrj-62	240	4	.	.	PUNCT
gsrj-62	241	1	yacoubian	yacoubian	PROPN
gsrj-62	241	2	,	,	PUNCT
gsrj-62	241	3	t.	t.	PROPN
gsrj-62	241	4	a.	a.	PROPN
gsrj-62	241	5	,	,	PUNCT
gsrj-62	241	6	&	&	CCONJ
gsrj-62	241	7	lo	lo	PROPN
gsrj-62	241	8	,	,	PUNCT
gsrj-62	241	9	d.	d.	PROPN
gsrj-62	241	10	c.	c.	PROPN
gsrj-62	241	11	(	(	PUNCT
gsrj-62	241	12	2000	2000	NUM
gsrj-62	241	13	)	)	PUNCT
gsrj-62	241	14	.	.	PUNCT
gsrj-62	242	1	truncated	truncate	VERB
gsrj-62	242	2	and	and	CCONJ
gsrj-62	242	3	full	full	ADJ
gsrj-62	242	4	-	-	PUNCT
gsrj-62	242	5	length	length	NOUN
gsrj-62	242	6	trkb	trkb	NOUN
gsrj-62	242	7	receptors	receptor	NOUN
gsrj-62	242	8	regulate	regulate	VERB
gsrj-62	242	9	distinct	distinct	ADJ
gsrj-62	242	10	modes	mode	NOUN
gsrj-62	242	11	of	of	ADP
gsrj-62	242	12	dendritic	dendritic	ADJ
gsrj-62	242	13	growth	growth	NOUN
gsrj-62	242	14	.	.	PUNCT
gsrj-62	243	1	nature	nature	NOUN
gsrj-62	243	2	neuroscience	neuroscience	NOUN
gsrj-62	243	3	,	,	PUNCT
gsrj-62	243	4	3(4	3(4	NUM
gsrj-62	243	5	)	)	PUNCT
gsrj-62	243	6	,	,	PUNCT
gsrj-62	243	7	342–349	342–349	NUM
gsrj-62	243	8	.	.	PUNCT
gsrj-62	244	1	https://doi.org/10.1038/73911	https://doi.org/10.1038/73911	PROPN
gsrj-62	244	2	36	36	NUM
gsrj-62	244	3	.	.	PUNCT
gsrj-62	244	4	ohira	ohira	PROPN
gsrj-62	244	5	,	,	PUNCT
gsrj-62	244	6	k.	k.	PROPN
gsrj-62	244	7	,	,	PUNCT
gsrj-62	244	8	&	&	CCONJ
gsrj-62	244	9	hayashi	hayashi	PROPN
gsrj-62	244	10	,	,	PUNCT
gsrj-62	244	11	m.	m.	NOUN
gsrj-62	244	12	(	(	PUNCT
gsrj-62	244	13	2009	2009	NUM
gsrj-62	244	14	)	)	PUNCT
gsrj-62	244	15	.	.	PUNCT
gsrj-62	245	1	a	a	DET
gsrj-62	245	2	new	new	ADJ
gsrj-62	245	3	aspect	aspect	NOUN
gsrj-62	245	4	of	of	ADP
gsrj-62	245	5	the	the	DET
gsrj-62	245	6	trkb	trkb	NOUN
gsrj-62	245	7	signaling	signal	VERB
gsrj-62	245	8	pathway	pathway	NOUN
gsrj-62	245	9	in	in	ADP
gsrj-62	245	10	neural	neural	ADJ
gsrj-62	245	11	plasticity	plasticity	NOUN
gsrj-62	245	12	.	.	PUNCT
gsrj-62	246	1	current	current	ADJ
gsrj-62	246	2	neuropharmacology	neuropharmacology	NOUN
gsrj-62	246	3	,	,	PUNCT
gsrj-62	246	4	7(4	7(4	NUM
gsrj-62	246	5	)	)	PUNCT
gsrj-62	246	6	,	,	PUNCT
gsrj-62	246	7	276–285	276–285	NUM
gsrj-62	246	8	.	.	PUNCT
gsrj-62	247	1	https://doi.org/10.2174/157015909790031210	https://doi.org/10.2174/157015909790031210	PRON
gsrj-62	247	2	29	29	NUM
gsrj-62	247	3	30	30	NUM